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ABSTRACT 
  
Brevisamide was isolated from the red tide dinoflagellate Karenia brevis in 2007. 
Key features of brevisamide include a substituted tetrahydropyran core and conjugated 
3,4-dimethylhepta-2,4-dienal side chain. Total synthesis of brevisamide was highlighted 
by a stereoselective [4+2]-annulation of a (Z)-crotyl silane to furnish the substituted 
pyran core and Negishi cross-coupling to construct the conjugated dienal side chain. 
Successful application of the silane-based annulation methodology provided brevisamide 
in overall 17 steps and 6.4% overall yield from the known (Z)-crotyl silane.   
Isatisine A was isolated from the leaf and roots of Isatis indigotica in 2007. Total 
synthesis of isatisine A commenced with the development of a silyl-directed Mukaiyama-
type [3+2]-annulation of an ethoxy allylsilane to construct a tetrahydrofuran core. [3+2]-
Annulation reaction of an ethoxy allyl silane with 2-bromocinnamylaldehyde afforded the 
  
 
 
viii 
furan core as a single diastereomer. Further substrate-controlled indole addition and 
intramolecular copper(I)-mediated amidation provided (+)-isatisine A in overall 12 steps. 
One-pot Diels-Alder/annulation sequence was developed utilizing a silane-
substituted 1,3-diene to give a fused-cyclic scaffold. In this reaction sequence, initial 
Lewis-acid-promoted Diels-Alder reaction between the silyl-substituted diene and a 
naphthoquinone constructed an intermediate cyclic allylsilane, and subsequent addition of 
aldehyde and Lewis acid triggered the annulation to construct a complex cyclic 
compound with high diastereoselectivity. This one-pot three component reaction 
sequence allowed for a simple access to various fused-polycyclic compounds, which bear 
a tetrahydropyran core. 
Leiodolide A was isolated from the deep-water marine sponge Leiodermatium. 
Leiodolide A was found to be significantly cytotoxic against HCT-116 human colon 
carcinoma with IC50 values = 1.4 μg/mL (2.5 μM). Since the natural product leiodolide A 
was found to comprise less than 0.001% of the dry weight of the sponge, establishing an 
efficient synthetic method to provide a significant amount of the natural product would 
be valuable to further biological studies. Our effort to synthesized upper fragment of 
leiodolide A was conducted through a series of cross-coupling reactions involving Stille 
coupling. Although proper conditions for the oxidation of (Z)-olefin to introduce the 
contiguous C15-17 triol system in leiodolide A were not achieved, this synthetic pathway 
would be useful in the total synthesis of leiodolide A. 
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Chapter 1 
Total Synthesis of Brevisamide 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 
1.1 Introduction 
Natural products isolated from marine organisms or their secondary metabolites have 
been interesting research targets for many years, as those compounds exhibit potent 
bioactivities for new drug development. Also, their unique and intriguing structures make 
themselves synthetically challenging targets, which have led to valuable methods en route 
to developing efficient synthetic pathway to construct those compounds.  
Among those marine natural products, a family of “ladder-frame” fused or linear 
polycyclic ether toxins, which are produced by the red tide Dinoflagellate Karenia brevis, 
have attracted significant interest due to their toxicity and structural complexity. 1 
Specifically, the brevetoxins, which are known to exhibit potent neurotoxicity, cause an 
open state of the voltage-sensitive sodium channel (VSSC) and disturbs its inactivation, 
while brevenal exhibits antagonism against toxic effects caused by brevetoxins. These 
toxins isolated from K. brevis have attracted much interest from synthetic chemists due to 
their unique and synthetically challenging cyclic polyether frameworks as well as 
Figure 1. 1 Structures of brevisamide (1) and brevenal  
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3 
interesting biological activities.2  
Brevisamide (1) was recently isolated by Wright’s group (Center for Marine Science 
at University of North Carolina) while conducting experiments aimed at the identification 
of new metabolites from K. brevis.3 The structure elucidation, as well as the assignment 
of both relative and absolute stereochemistry of brevisamide (1), was initially established 
by various 1D and 2D NMR studies. 
Brevenal (Figure 1.1) displayed a UV absorption at 292 nm, which is spectroscopic 
characteristic of the conjugated 3,4-dimethylhepta-2,4-dienal side chain in the right-hand 
side chain. Brevisamide also showed similar UV absorption at 292 nm, which helped 
deduce the presence of a similar conjugated side chain and was confirmed by 1H-1H 
COSY and 1H-13C HMBC experiments. Relative stereochemistries of the tetrahydopyran 
core of brevisamide were confirmed by NOESY, though its absolute configuration was 
not determined at this point. 
Additionally, brevisamide is the only metabolite of K. brevis that contains an amide 
functionality. Since brevisamide is considered an intermediate of a stepwise or cascade 
epoxide opening reaction of a putative polyepoxide intermediate to form the ladder-frame 
fused ring system of brevenal in biosystem,4 a synthesis of brevisamide would shed light 
on the elucidation of biosynthetic pathways of these series of metabolites. Also, 
developing efficient and diversifying synthetic strategies would be expanded to further 
investigation of biological properties, which have not been disclosed to date. 
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1.2 Total synthesis efforts toward brevisamide 
Brevisamide has been an interesting target in that its structure is closely related to the 
left-hand side chain of brevenal, although its bioactivities remain unclear. To date, five 
total syntheses have been reported from Satake (2009), 5  Lindsley (2009),6  Ghosh 
(2009),7 Panek (2009),8 and Zakarian (2011)9. Also, two separate formal syntheses have 
been recently published from Smith10 and Sabitha11. The retrosynthetic analysis for each 
synthesis employed similar disconnections at the left-hand conjugated diene to give 2 key 
fragments: a tetrahydropyran core and olefin-bearing side chain. However, those 
synthetic approaches to a highly substituted tetrahydropyran core were featured by their 
unique strategies. Figure 1.2 illustrates key disconnections and methodologies used in the 
4 total syntheses of brevisamide.   
 
1.2.1 Satake’s total synthesis 
In 2009, the Satake laboratory reported the first total synthesis of brevisamide 
utilizing a Suzuki-Miyaura coupling as a fragment connecting methodology to construct 
the conjugated diene side chain (Scheme 1.1).5 They began the synthesis with brown 
O
Me OH
H
N
Me
Me
Me
O
H
O
Suzuki-Miyaura coupling;
Satake and Ghosh
HWE; Lindsley
Stille coupling; Zakarian
Pyran constructionGroup
Satake5 Brown allylation-lactonization
Lindsley6 SmI2 reductive coupling
Ghosh7 Hetero Diels-Alder reaction
Zakarian9 Achmatowicz rearrangement
1
Figure 1. 2 Synthetic strategies for brevisamide 1 
 
 
5 
crotylation of an aldehyde to form the C8, C9 chiral centers of lactone S3. The pyran core 
was furnished by carbon chain homologation at the terminal double bond and subsequent 
transformations to construct all of the required functionalities, including the acetamide 
group, in the right-hand side chain before the key coupling. Fragment connection 
between S5 and S6 was successfully conducted under Suzuki-Miyaura coupling 
conditions to give advanced intermediate S7, albeit in moderate yield. Chemoselective 
oxidation of the allylic alcohol utilizing MnO2 in the presence of a secondary alcohol 
completed the first total synthesis of brevisamide in a longest linear sequence of 21 steps, 
which confirmed the structure and absolute configuration of brevisamide. 
Scheme 1. 1 Satake’s total synthesis of brevisamide 1a 
O
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aReagents & conditions; a) TBDPSCl, imidazole, DMF, rt; b) O3, CH2Cl2, -78 oC; PPh3, rt; c) (Z)-
crotyl-(+)-Ipc2borane, Et2O-THF, -78 oC; 3N NaOH, 30% H2O2, 50 oC, 78% (3 steps); d) O3,
CH2Cl2, -78 oC; PPh3, rt; e) Ph3P=CHCO2Me, THF, rt; f) H2, Pd/C, EtOAc, rt; g) PPTS, benzene,
reflux, 71% (4 steps); h) 9-BBN, THF, rt; Cs2CO3, PdCl2(dppf), DMF, 45 oC; i) TBAF, THF, 0 oC,
40% (2 steps); j) MnO2, CH2Cl2, rt, 55%
8
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6 
1.2.2 Lindsley’s total synthesis 
A second total synthesis was recently reported from Lindsley’s laboratory which 
highlighted a SmI2 mediated cyclization and a Horner-Wadsworth-Emmons (HWE) 
reaction (Scheme 1.2).6 Similarly, the C8, C9 chiral centers were generated by Brown 
crotylation with 87% ee. Conjugate addition of the secondary alcohol L3 to ethyl 
propiolate provided an intermediate L4, which underwent cleavage of the silyl ether and 
oxidation of the resulting primary alcohol to afford the cyclization precursor L5. The key 
SmI2-mediated cyclization successfully provided the tetrahydropyran core with the 
desired diastereoselectivity via a metal-chelated chair-like transition state. The amino 
OH
O
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NHAc
EtO2C
L8
L1 L2 L3
a,b c,d
O
NHAc
OTBS
L7
g
aReagents & conditions; a) DMSO, (COCl)2, CH2Cl2, -78 oC; TEA; b) (Z)-crotyl-(+)-Ipc2borane,
THF, -78 oC; 3N NaOH/H2O2, 47% (2 steps); c) 9-BBN, THF; H2O2/NaOH; d) TBSCl, imidazole;
e) ethyl propiolate, NMM, MeCN, 93%; f) SmI2, MeOH, THF 0 oC, 69% (from L4); g) (E)-
EtO2CCH=C(CH3)CH(CH3)PO(OEt)2, n-BuLi, THF, -78 oC to rt, 80%
BnO
OH BnO
OH
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1
Scheme 1. 2 Lindsley’s total synthesis of brevisamide 1a 
 
 
7 
functionality in the right-hand side chain was introduced by a Curtius rearrangement with 
DPPA and conventional deprotection and oxidation gave an intermediate aldehyde L7, 
which was homologated by a HWE reaction with a phosphate ester to give advanced 
intermediate L8. Reduction of the terminal ethyl ester to an alcohol followed by 
oxidation to an aldehyde accomplished the second total synthesis of brevisamide in 21 
synthetic steps with a longest linear sequence of 18 steps. 
     
1.2.3 Ghosh’s total synthesis 
Ghosh’s total synthesis of brevisamide featured an enantioselective catalytic hetero-
Diels-Alder reaction to construct the pyran core (Scheme 1.3).7 The same Suzuki-
Miyaura coupling strategy, which was already proven to be successful in the Satake’s 
synthesis, was applied to form the 3,4-dimethylhepta-2,4-dienal side chain. Hetero-Diels-
Alder reaction of a silyl enol ether G1 with an aldehyde G2 in the presence of Jacobsen’s 
catalyst G8 afforded a dihydropyran with high levels of diastereoselectivity and 
enantioselectivity. Oxidation of the silyl enol ether to -hydroxyl ketone and subsequent 
elimination of the resulting ketone under Wolff-Kishner conditions provided a furan core. 
The amide functionality was introduced through a sequence of Mitsunobu reaction and 
acetylation, which was then subjected to Grieco elimination to provide the coupling 
partner G6. Fragment connection was accomplished under Suzuki-Miyaura conditions, 
which was previously used in the Satake’s synthesis, to give the known advanced 
intermediated G7. In the final oxidation, TEMPO oxidation provided a comparable result 
 
 
8 
to MnO2 oxidation (55% in Satake’s synthesis), which gave chemoselective oxidation of 
the allylic alcohol in the presence of a secondary alcohol to furnish brevisamide 1. 
 
1.2.4 Zakarian’s total synthesis 
The most recent total synthesis of brevisamide was completed by Zakarian’s 
laboratory and highlighted with an asymmetric Henry reaction and Achmatowicz 
rearrangement to construct the furan core (Scheme 1.4).9 Copper-catalyzed asymmetric 
Henry reaction of aldehyde Z1 in the presence of a tetraamine ligand Z2 afforded a nitro-
alcohol Z3 in 57% yield with some elimination byproduct (10%). The key Achmatowicz 
rearrangement of a furan Z3 in the presence of NBS furnished an intermediate cyclic 
hemiketal, which was treated with BF3·OEt2 and Et3SiH to provide an unsaturated 
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O
O
Cl
G1
G2
G3
Suzuki-Miyaura
coupling
G4
G5 G6
G8
aReagents & conditions; a) G8 (10 mol%), 4A MS, rt, 52%; b)mCPBA, NaHCO3, tol.,
rt, 60%; c) TsNHNH2, EtOH, rt; d) NaBH3CN, MeOH, rt; e) NaOAc, EtOH, 75
oC, 76%
(3 steps); f) TEMPO, PhI(OAc)2, CH2Cl2, rt, 87%
a b
c,d,e
f
Scheme 1. 3 Ghosh’s total synthesis of brevisamide 1a 
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lactone Z5. Installation of methyl group through a conjugate addition and subsequent 
reduction of the ketone functionality in Z5 provided all of the required substituents of the 
pyran core with the desired stereochemistries. The conjugated diene was constructed 
through Stille coupling of vinylstannane Z8 with (E)-vinyliodide Z7, after which the 
resulting advanced intermediate was oxidized to afford brevisamide 1 in 16 steps and an 
overall yield of 2.5%.  
 
 
Scheme 1. 4 Zakarian’s total synthesis of brevisamide 1a 
O
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O NHAc
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O
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Z6 Z7
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aReagents & conditions; a) Cu(OAc)2, MeNO2, EtOH, rt, 69%, 99% ee; b) LAH, THF, -15 oC to
reflux; c) Ac2O, EtOAc/MeOH, rt, 67% (2 steps); d) NBS, NaHCO3, NaOAc, THF/H2O, 0
oC; e)
Et3SiH, BF3 OEt, CH2Cl2, 0 oC, 54% (2 steps); f) Me2CuLi, Et2O, -60 oC, 81%, dr = 8:1; g)
NaBH4, THF/H2O, rt, 85%, dr = 1:1; h) Pd2(dba)3, Ph3As, CuBr DMS, THF/DMSO, rt, 78%; i)
TEMPO, PhI(OAc)2, CH2Cl2, rt, 90%
Ph
HN
PhHN
NH
Ph NH
TsTs
Ph
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1.2.5 Formal syntheses of brevisamide 
Smith and coworkers have reported a synthesis of a key intermediate of brevisamide, 
which was previously synthesized and used as a partner in the Suzuki-Miyaura coupling 
in the Satake’s total synthesis (Scheme 1.5).10 Triol S1, which was prepared through an 
Evans aldol reaction and asymmetric dihydroxylation, was subjected to a series of 
protection-deprotection and epoxidation reaction to give an epoxide S3. Intramolecular 
epoxide opening in the presence of CSA proceeded through a 6-exo-tert pathway to 
afford an intermediate pyran S4. Substitution of a hydroxyl group with azide under 
Mitsunobu conditions followed by a conventional acetamide formation provided the 
known intermediate S6. 
 
Another formal synthesis appeared shortly after from Sabitha laboratory, which 
highlighted their Pd-catalyzed isomerization of an allylic alcohol to an aldehyde (Scheme 
1.6).11 The conjugated ester S7 was similarly prepared by an Evans aldol and HWE 
OTIPS
OH
OH
OH OTIPS
OPMB
OH
OPMB
O
OH
OPMB
O
N3
OPMB
O
NHAc
OTBS
S1 S2 S3
S4 S5 S6
a,b c
d e,f g,h,i
aReagents & conditions; a) NaH, TPS-imid, THF, 0 oC; b) PMBBr, 0 oC to rt, 61% (2 steps);
c) TBAF, THF, 90%; d) CSA, CH2Cl2, rt; e) PPh3, DPPA; f) DIAD, THF, rt, 85% (3 steps); g)
DDQ, pH 7.0 buffer, CH2Cl2, 94%; TBSOTf, 2,6-lutidine, CH2Cl2, 89%; i) i.PPh3, THF-H2O;
ii. Ac2O pyr., 58%
O O
Scheme 1. 5 Smith’s formal synthesis of brevisamide 1a 
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reaction from a benzyloxybutanal. Reduction of the ester S7 and subsequent Pd-catalyzed 
isomerization of the resulting allylic alcohol S8 afforded an aldehyde S9. D-Proline 
catalyzed -aminoxylation of the aldehyde followed by HWE reaction gave an aminoxy 
olefinic ester, which was subjected to N-O bond cleavage in the presence of Cu(OAc)2 to 
furnish an hydroxyl unsaturated ester S10. Treatment of S10 with TBAF cleaved the TBS 
ether and triggered a spontaneous intramolecular oxa-conjugate addition to construct the 
pyran S11, which was previously prepared in Lindsley’s total synthesis. 
 
1.2.7 Total synthesis of brevisamide 
Our group has developed a family of enantioenriched crotylsilane reagents bearing 
C-Si chirality, which have shown significant and broad utilities in the area of 
stereocontrolled acyclic homoallylic alcohol and heterocycle syntheses. Among our 
aReagents & conditions; a) DIBAL-H, CH2Cl2, 0
oC, 92%; b) Pd(OH)2/C, Et3N, PhH,
rt, 90%; c) PhNO, D-proline, (EtO)2POCH2CO2Et, DMSO, Cs2CO3; then Cu(OAc)2,
EtOH, rt, 52%; d) TABF, THF, rt, 86%
BnO CO2Et
OTBS
BnO
OTBS
OH
BnO CHO
OTBS
BnO
OTBS
OH
CO2Et
O
BnO
OH
CO2Et
S7 S8
S9 S10
S11
a b
c
d
Scheme 1. 6 Sabitha’s formal synthesis of brevisamide 1a 
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established silane-based methodologies, organosilane reagent based [4+2]-annulations, 
which allow all possible combinations of stereochemical relationships in dihydropyrans, 
have proven to be a useful methodology in the total synthesis of pyran-bearing natural 
products.12 
The stereochemical outcome of the annulation products can be attributed to the C-Si 
configurations of the silane reagents as illustrated in Figure 1.3. In the case of a [4+2]-
annulation with a (E)-crotylsilane, a 5,6-trans-dihydropyran is always favored.12a 
Stereochemical relationships between the 2- and 6-substituents of dihydropyran are 
dictated by the syn- and anti- relationship of the crotylsilane. Therefore, syn- and anti-
(E)-crotylsilane give 2,6-cis- and 2,6-trans-dihydropyran, respectively (Figure 1.3, eqs 1 
CO2Me
SiMe2Ph
OTMS
O RMeO2C
MeTMSOTf
RCHO
CO2Me
SiMe2Ph
OTMS
O RMeO2C
Me
CO2Me
SiMe2Ph
OTMS
O RMeO2C
Me
CO2Me
SiMe2Ph
OTMS
O RMeO2C
Me
(E )-syn-silane
(E)-ant i-silane
(Z)-syn-silane
(Z)-anti -silane
H H
HH
HH
HH
cis-t rans -dihydropyran
t rans-t rans-dihydropyran
tr ans-cis-dihydropyran
cis-cis-dihydropyran
(Eq. 1)
(Eq. 2)
(Eq. 3)
(Eq. 4)
Figure 1.3 Stereochemical course of [4+2]-annulations of (E)- and (Z)-crotylsilane 
reagents 
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and 2). In contrast, annulations of (Z)-crotylsilane reagents selectively afford 5,6-cis-
dihydropyran.12b In addition, 2,3-syn- and 2,3-anti-relationships of (Z)-crotylsilane 
provide 2,6-trans- and 2,6-cis-dihydropyran, respectively (eqs 3 and 4), which is the 
opposite and complementary stereochemical outcome to those of the (E)-crotylsilanes.  
As a continuing study to find applications of the [4+2]-annulation in natural product 
syntheses, brevisamide 1 was determined to be an attractive target considering its 
structural features: a highly substituted pyran core and conjugated diene side chain. Also, 
a useful methodology for various conjugated diene scaffolds has been developed in our 
group utilizing modified Negishi conditions starting from an alkyne.13 Although our 
previous studies demonstrated the construction of trisubstituted conjugated diene systems, 
it would be equally useful in the construction of a tetrasubstituted diene scaffold, which is 
found in the side chain of brevisamide.  
H
O
H
N Me
O
Me OH
Me
MeO
O
Me OTBS
TBDPSO I
Me
+
BnO O
Me
CO2Me
SiMe2Ph
OTMS
+
BnO H
O
OTBS
2
3
4(Z)-anti -56
1
18
11 15
I
Mebrevisamide 1
Negishi coupling
OTBS
OH
6
[4+2]-annulation
&
hydroboration
8
9
12
Scheme 1. 7 Retrosynthetic analysis of brevisamide 1 
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Upon further structure analysis of brevisamide, two distinct fragments were 
identified, which led to the disconnection at C3-C4 to give two vinyl iodides 2 and 3 
(Scheme 1.7). In our plan, palladium-catalyzed Negishi cross-coupling will be used to 
connect these two key fragments. Iodoalkene 3 will be an immediate precursor to an 
alkenylzinc reagent generated in situ through lithium-halogen exchange and 
transmetalation with zinc chloride. The hydroxyl group with an (S)-configuration at C11 
will be introduced by substrate-controlled diastereoselective hydroboration of an 
intermediate dihydropyran. Further, the (E)-vinyl iodide in the side chain of fragment 2 
will be installed through SN2-type propynyl substitution at C6 and subsequent 
regioselective hydrozirconation followed by trapping with iodine. Based on the analysis 
of the stereochemical outcome in Figure 1.3, the tetrahydropyran fragment 4, which bears 
the required cis-cis relationship among the substituents at C8, C9, and C12, will be 
prepared through a [4+2]-annulation between (Z)-crotylsilane 5 and aldehyde 6. 
  
TMSOTf, 6
CH2Cl2, PhH
-50 oC, 70%
dr = 10:1
O
Me
CO2MeBnO
(Z)-anti -5
7
CO2Me
SiMe2Ph
OTMS
R2 O
HMe
HH
R1
SiMe2PhHH O R2
MeSi
R1 H
PhMe2
R1 = CO2Me
R2 = CH2CH2OBn
TS1 TS2
8
9
12
 
Scheme 1. 8 [4+2]-Annulation of (Z)-anti-silane 5 with aldehyde 6 
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The synthesis of the oxygenated tetrahydropyran fragment 2 was initiated with the 
[4+2]-annulation of known (Z)-crotylsilane 514 with an aldehyde 6 (Scheme 1.8), which 
gave 5,6-cis-trisubstituted dihydropyran 7 as a major diastereomer.12b After a series of 
experiments to find an optimal condition, the use of 2.0 equiv of aldehyde and TMSOTf 
under 4:1 mixture of CH2Cl2 and benzene was determined to be most efficient to produce 
the dihydropyran 7 in high yield and dr. The observed 2,5,6-cis-cis stereochemical 
outcome is attributed to the chair-like transition state TS2 in which bulky silane group is 
positioned at pseudo-equatorial orientation to minimize 1,3-diaxial interaction between 
the silane and vinyl methyl group (Scheme 1.8). 
O
Me
CO2MeBnO
8
OH
aReagents & conditions; a) BH3 SMe2, THF, 0
oC; then H2O2, 1M NaOH, 40%, dr = 2.5:1; b) LAH,
Et2O, 0 oC, 82%; c) TBSCl, imidazole, DMF, rt, 86%; d) DIAD, DPPA, PPh3, THF, rt, 82%; e)
PPh3, THF, H2O, rt, 81%; f) Ac2O, DMAP, Et3N, CH2Cl2, rt, 80%
40% yield
dr = 2.5:1
O
Me
BnO
4
OH
29% yield
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O
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O
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Scheme 1. 9 Hydroboration of dihydropyrans (7, 10, and 12)a 
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In our initial plan, we desired a substrate-controlled diastereoselective hydroboration 
of dihydropyran 7 to directly introduce the -hydroxyl functionality at C11 (Scheme 
1.9).15 Since a trans,trans-dihydropyran was proven to be an excellent substrate for the 
stereoselective hydroboration in our previous studies,15c,d we directly applied the 
conditions that were used in previous examples (2.0 M BH3·SMe2 in THF) to the 
hydroboration of cis,cis-dihydropyran 7. However, hydroboration of 7 was found to be 
problematic, which gave the desired product in 40% yield (dr = 2.5:1) with varying 
amounts of degradation including reduction of ester to alcohol. The experiments utilizing 
catecholborane in the presence of Wilkinson’s catalyst15a and 9-BBN15b also proved to be 
unsuccessful. Other substrates, 10 and 12, which were prepared through a reduction of 7 
and subsequent transformations of the resulting alcohol to the required functionalities, 
were exposed to the same reaction conditions used in the previous hydroboration. In the 
case of silyl ether 10, hydroboration utilizing BH3·SMe2 afforded the desired product in 
low yield (29%) albeit with a high level of diastereoselectivity. However, none of 
conditions utilizing amide 12 provided the desired hydroboration product. 
At this point, we concluded that the cis,cis-dihydropyrans, 7, 10, and 12, were not 
conformationally suitable for the desired stereochemical course of hydroboration. It had 
been proven that an alkylation of a cyclohexanone under kinetic conditions is dictated by 
stereoelectronic effects and proceeds through an early transition state. 16  When an 
electrophilic substitution occurs in an endocyclic enolate, an electrophile will prefer to 
approach perpendicular to the plane of the olefin to maximize overlap of the participating 
-orbitals and substitution will occur on the face that proceeds through a chair-like 
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transition state. We attempted to explain an unexpected issue in the hydroboration of 
cis,cis-dihydropyran utilizing combination of stereoelectronic effect and steric effect. 
Based on this analysis, we anticipated that the pathway, which allows for new bond 
formation on the less hindered face of the dihydropyran and simultaneously permits an 
axial substitution through a chair-like conformation, would be favored. In our previous 
examples, simple treatment of trans,trans-dihydropyrans 14 with BH3·SMe2 immediately 
furnished the desired 3-hydroxyl-bearing pyrans in high yield and diastereoselectivity 
(Scheme 1.10.a). This result was expected as hydroboration to the -face of the olefin 
should occur via the most favorable half chair conformer 14a, where two substituents are 
in the pseudo-equatorial position, and gives rise to the stereoelectronically favored chair 
conformer 15. Additionally, no 1,3-diaxial interaction will occur between the 
approaching borane and the oxygen in the pyran. However, hydroboration from the -
face of half chair 14a is disfavored not only because this approach is blocked by the 
methyl ester substituent, but also because it results in a twist boat conformer ds-15, which 
can explain the observed high yield and diastereoselectivity. 
In contrast, the most favorable transition state of cis,cis-dihydropyran 7 would be the 
half chair 7b, since two substituents are in the pseudo-equatorial orientation (Scheme 
1.10.b). Also, the interconversion of 7b to the disfavored 7a is highly restricted due to the 
1,3-diaxial interaction between the methyl ester and alkyl group. Therefore, 
hydroboration from the least hindered -face of 7 would proceed through the most 
favored half chair 7b to give the twist-boat-like intermediate 8, which is more stable than 
the chair 8 due to the severe 1,3-diaxial interaction in the chair conformer. 
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Scheme 1. 10 Transition state analysis of hydroboration of trans-trans and cis-cis 
dihydropyran (14 vs 7) 
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 Hydroboration from the -face of 7b (path a, scheme 1.10.b), which is responsible 
for the minor diastereomer ds-8, will be disfavored due to the developing 1,3-diaxial 
interaction between the borane and methyl substituent. However, this interaction will 
provide the relatively stable chair conformer ds-8, which gives rise to the observed lower 
diastereoselectivity (dr = 2.5:1). Additionally, it is possible that the regioisomeric 
addition (path b, scheme 1.10.b) could be operating since it produces the stable chair 
conformer regio-8. Although the formation of regioisomer has not been confirmed, it can 
be a possible reason for the observed low yield in this reaction.  
 
Scheme 1. 11 Preparation of tetrahydropyran 4a 
 
 
20 
Based on our analysis, we envisioned that elimination of one of the stereocenters on 
dihydropyran 7 would be helpful in improving yield by removing a chance of 
regioisomeric hydroboration (Scheme 1.11). In this case, high levels of 
diastereoselectivity were also anticipated since undesired -face hydroboration via the 
half chair conformer 17a will cause a disfavored 1,3-diaxial interaction between the 
approaching borane and methyl group. Therefore, we removed the chiral center at C12 by 
isomerization of the olefin into conjugation with the methyl ester in the presence of 
DBU,17 which could be regenerated through hydroboration of the allylic TBS ether. 
Then, LAH reduction of the methyl ester 16 and subsequent protection of the resulting 
allylic alcohol as a TBS ether gave a new hydroboration precursor 17. As anticipated, 
hydroboration using BH3·SMe2 at 0 °C afforded the desired oxygenated tetrahydropyran 
Scheme 1. 12 Preparation of fragment 2a 
aReagents & conditions; a) TBSOTf, 2,6-lutidine, CH2Cl2, 0
oC, 98%; b) Pd/C, H2,
EtOAc, rt, quant; c) Tf2O, 2,6-lutidine, CH2Cl2, -78 oC; d) 1-propynyllithium, THF, -78 oC
to rt, 78% (2 steps); e) Cp2ZrHCl, THF, 50 oC; then I2, THF, 0 oC, 88%, rr = 10:1
O
Me
HO
OTBS
OTBS
19
O
Me OTBS
OTBS
21
O
Me OTBS
OTBS
2
I
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O
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BnO
OH
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4 both in high yield and diastereoselectivity (90%, dr >11:1), and it was successfully 
carried out on a gram scale with equal levels of efficiency. 
With useful quantities of secondary alcohol 4 in hand, we turned our attention to 
extending the left-hand side chain. Intermediate alcohol 4 was protected as its TBS ether, 
and hydrogenolysis of the benzyl ether using dry Pd/C in ethyl acetate afforded primary 
alcohol 19 in quantitative yield (Scheme 1.12). Following this deprotection, a SN2-type 
alkyne substitution was employed to homologate three carbons at C6.18 Accordingly, 
triflation of primary alcohol 19 using Tf2O produced an unstable intermediate triflate 
ester 20, which was directly used for the next substitution reaction without purification. 
As such, triflic ester 20 was treated with 1-propynyllithium that was generated in situ by 
treatment of a condensed propyne gas in THF at -78 °C with n-BuLi to afford alkyne 21. 
However, this reaction turned out to be sensitive to the quantity of nucleophile and co-
solvent. For instance, 1.5 equiv of propynyllitihium afforded only decomposition of 
triflate ester after 12 h. The reaction using a mixture of THF/HMPA (10:1) gave the 
desired product 21 in 60% yield within 30 min, but this result was not reproducible when 
scaled up. An optimal condition was found when the triflate ester was treated with 5.0 
equiv of propynyllithium in THF for 3 h, affording 21 in 78% (two steps from triflation). 
Regioselective hydrozirconation of the internal alkyne 21 utilizing 2.0 equiv of Schwartz 
reagent in THF, followed by trapping of the organozirconium intermediate with 
molecular iodine successfully furnished the coupling precursor (E)-iodoalkene 2 in 88% 
yield (regioselectivity = 10:1).19 Alternatively, silylcupration (5.0 equiv of CuCN, 10 
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equiv of PhMe2SiLi) gave the desired vinyl iodide 2 with much lower regioselectivity (= 
2:1).20 
Vinyl iodide 3 was prepared from 2-butyn-1-ol in 3 steps through stannylation and 
subsequent substitution with iodine. Accordingly, regioselective copper-stannylation 
afforded vinyltin compound 23 in 80% yield with 10:1 regioselectivity.21 This vinyltin 
was eventually used to test the reactivity of Stille coupling toward the assembly of the 
tetrasubstituted (E,E)-diene side chain. Further substitution of tin with iodine and 
subsequent TBDPS protection of allylic alcohol provided the vinyl iodide 3, which was 
utilized for the originally planned fragment connection under Negishi conditions. 
 
The final stage of the synthesis required introduction of the aldehyde side chain with 
the assembly of the conjugated (E,E)-diene, which began with fragment coupling under 
Negishi13 or Stille conditions1f. Although it was previously reported that formation of this 
type of tetrasubstituted (E,E)-diene can be achieved utilizing Stille coupling conditions, 
the use of a silylprotected vinyl stannane version of intermediate 23 afforded the 
contaminated diene with its homocoupling product.1f Instead, the construction of the 
conjugated 3,4-dimethylhepta-2,4-dien side chain was initially conducted under modified 
HO SnBu3
Me
HO TBDPSO I
Me
23 322
aReagent & conditions; a) CuCN, n-BuLi, n-Bu3SnH, THF, -78 oC, 80%; b) I2, Na2CO3,
CH2Cl2, 0 oC, 70%; c) TBDPSCl, imidazole, DMF, rt, 94%
Scheme 1. 13 Preparation of the coupling partner 3a 
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Negishi coupling conditions, which have been previously established in our group to 
construct tri-subsitituted diene systems.13b,c 
Treatment of vinyl iodide 3 with an excess amount of t-BuLi and transmetalation of 
the resulting lithium anion with anhydrous ZnCl2 generated an intermediate vinlyzinc 
species. Coupling of the in situ prepared zinc intermediate with the vinyl iodide 2 in the 
presence of 10 mol % of Pd(PPh3)4 provided a crude diene, which was directly used in 
the next selective cleavage22 of the primary TBS ether utilizing CSA without purification 
to furnish an intermediate 24. Alternatively, Stille coupling of vinyltin 23 with vinyl 
iodide 2 was conducted in the presence of a stoichiometric amount of copper(I)-
thiophene-2-carboxylate (CuTC) to afford a conjugated diene 25 in 68% yield,1f which 
could potentially be transformed to the same intermediate 24 through silyl protection of 
25 with TBDPSCl followed by selective cleavage of a primary TBS ether. 
 
Scheme 1. 14 Fragment connections under Negishi and Stille conditionsa 
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In order to install an acetyl amide in the right-hand side chain, the resulting primary 
alcohol 24 was activated and substituted with azide using diphenylphosphoryl azide 
(DPPA) under Mitsunobu conditions23 to provide azide 26 (Scheme 1.15). Reduction of 
the azide under modified Staudinger conditions24 and subsequent acetylation of the 
resulting primary amine gave the acetyl amide 27 in 83% yield (two steps). Global 
deprotection of the two different silyl ethers using TBAF furnished an advanced diol 
intermediate, and chemoselective oxidation of the primary allylic alcohol in the presence 
of the secondary alcohol using excess amounts of MnO2 afforded the unsaturated 
aldehyde and completed the synthesis of brevisamide 1.1f,5,25 
 
 
 
aReagents & conditions; a) DIAD, PPh3, DPPA, THF, rt, 80%; b) PPh3, NH4OH, dioxane/MeOH, rt; c)
Ac2O, DMAP, CH2Cl2, rt, 83 % (2 steps); d) TBAF, THF, rt, 83%; e) MnO2, CH2Cl2, rt, 66%
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Scheme 1. 15 Completion of total synthesis of brevisamide 1a 
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1.3 Conclusion 
In summary, the total synthesis of the brevisamide was achieved in 17 steps with a 
6.4% overall yield starting from trans-(Z)-crotylsilane 5. The key feature of this synthesis 
relied on the formation of a highly substituted tetrahydropyran using our silicon-directed 
[4 +2]-annulation strategy. In addition, construction of the conjugated 3,4-dimethylhepta-
2,4-dienal side chain through a modified Negishi cross coupling demonstrated that this 
method can be useful for stereochemically challenging systems in complex molecule 
synthesis. 
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1.4 Experimental section 
 
(2S,5S,6S)-Methyl 6-(2-(benzyloxy)ethyl)-5-methyl-5,6-dihydro-2H-pyran-2 
carboxylate (7) Aldehyde 6 (2.7 g, 16.7 mmol) and crotylsilane 514 (2.9 g, 8.35 mmol) 
were added into a round bottom flask followed by methylene chloride and benzene (4:1 
mixture, 165 mL). The reaction was cooled to -50 °C and trimethylsilyl 
trifluoromethanesulfonate (3.0 mL, 16.7 mmol) was added in one portion. The solution 
was allowed to stir overnight at -50 °C before quenching with sat’d-NaHCO3 solution. 
Upon warming to room temperature, the layers were separated and the aqueous phase 
was extracted with methylene chloride (3 x 10.0 mL). The combined organic phases were 
dried over magnesium sulfate, filtered, and concentrated in vacuo to obtain an oil. 
Purification over silica gel with hexane/ethyl acetate (30/1 to 10/1 gradient elution) 
afforded dihydropyran 7 as a clear oil (1.68g, 70 %): [α]D
20 = -36.7 (c 1.2, CHCl3) 
1H NMR (C6D6, 400 MHz): δ 7.28-7.25 (m, 2H), 7.18-7.07 (m, 3H), 5.74 (ddd, J = 10.0, 
1.6, 0.8 Hz, 1H), 5.69 (ddd, J = 10.8, 5.2, 2.4 Hz, 1H), 4.75 (dd, J = 4.0, 2.4 Hz, 1H), 
4.64 (d, J = 3.6 Hz, 1H), 3.78 (dt, J = 9.2, 3.6 Hz, 1H), 3.56 (td, J = 8.8, 5.6 Hz, 1H), 3.41 
(ddd, J = 9.2, 6.0, 5.2 Hz, 1H), 3.26 (s, 3H), 1.89 (m, 1H), 1.62 (m, 2H), 0.92 (d, J = 
7.2Hz, 3H); 13C NMR (C6D6, 100 MHz): δ 169.7, 139.0, 133.7, 128.1, 127.2, 123.45, 
75.5, 72.7, 72.6, 66.6, 51.1, 32.7, 32.2, 13.4; IR (film) υmax 2957, 2875, 1760, 1439, 1217 
cm-1; HRMS (CI, NH3) m/z calc’d for C17H22NaO4 [M+Na]
+ 313.1416, found: 313.1421. 
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(5S,6S)-Methyl 6-(2-(benzyloxy)ethyl)-5-methyl-5,6-dihydro-4H-pyran-2-
carboxylate (16) To a solution of dihydropyran 7 (1.62 g, 5.58 mmol) in THF (56 mL) 
was added DBU at rt. The solution was allowed to stir overnight at rt. Ethyl acetate (100 
ml) and water (50 mL) was added and the layers were separated. The aqueous phase was 
extracted with ethyl acetate (30 mL). The combined organic phases were dried over 
magnesium sulfate, filtered, and concentrated in vacuo to obtain an oil. Purification over 
silica gel with hexane/ethyl acetate (20/1 to 10/1 gradient elution) afforded dihydropyran 
16 as a clear oil (1.39 g, 86 %): [α]D
20 = -38.8 (c 1.5, CHCl3) 
1H NMR (CDCl3, 400 MHz): δ 7.34-7.28 (m, 4H), 7.27-7.24 (m, 1H), 6.01 (t, J = 4.0 Hz, 
1H), 4.50 (d, J = 2.4 Hz, 2H), 4.10 (dt, J = 9.6, 3.2 Hz, 1H), 3.75 (s, 3H), 3.66-3.58 (m, 
2H), 2.36 (ddd, J = 18.4, 6.0, 3.2 Hz, 1H), 2.00-1.90 (m, 2H), 1.84 (dt, J = 18.8, 4.4 Hz, 
1H), 1.77-1.69 (m, 1H), 0.90 (d, J = 6.8 Hz, 3H); 13C NMR (CDCl3, 100 MHz): δ 163.6, 
143.2, 138.6, 127.8, 110.7, 76.3, 67.1, 52.2, 30.8, 29.0, 28.9, 14.0; IR (film) υmax 2954, 
2875, 1733, 1647, 1437 cm-1; HRMS (CI, NH3) m/z calc’d for C17H22NaO4 [M+Na]
+ 
313.1416, found: 313.1422. 
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(((5S,6S)-6-(2-(Benzyloxy)ethyl)-5-methyl-5,6-dihydro-4H-pyran-2-yl)methoxy)(tert-
butyl)dimethylsilane (17) Dihydropyran 16 (544 mg, 1.87 mmol) was dissolved in 
anhydrous diethyl ether (37 mL) under Ar and cooled to 0 oC. LiAlH4 (212 mg, 2.69 
mmol) was then added and stirred for 1 hr before slowly quenching with water (212 L). 
This reaction mixture was stirred for 10 min at the same temperature. 1N NaOH (200 L) 
and water (200 L) were successively added and the reaction mixture was stirred for 10 
min at rt. The layers separated and the resulting aqueous phase was extracted with diethyl 
ether (2 x 30 mL). The combined organic phases were dried over magnesium sulfate, 
filtered, and concentrated in vacuo to obtain primary alcohol 16a as an oil that was 
reacted directly.  
A solution of primary alcohol 16a (490 mg, 1.87 mmol) and imidazole (509 mg, 7.48 
mmol) in anhydrous DMF (18 mL) was added TBSCl (563 mg, 3.74 mmol) at rt. After 1 
hr, hexane (100 mL) and water (40 mL) were introduced into the reaction and layers were 
separated. The combined organic phases were dried over magnesium sulfate, filtered, and 
concentrated under reduced pressure to obtain an oil. Purification over silica gel with 
hexane/ethyl acetate (50/1) afforded TBS ether 17 as a clear oil (590 mg, 84 %, two 
steps): [α]D
20 = -39.4 (c 1.0, CHCl3) 
1H NMR (CDCl3, 400 MHz): δ 7.34-7.24 (m, 5H), 4.67 (t, J = 3.6 Hz, 1H), 4.49 (s, 2H), 
4.01 (dt, J = 9.6, 2.8 Hz, 1H), 3.94 (s, 2H), 3.60 (m, 2H), 2.22-2.18 (m, 1H), 1.93-1.83 
(m, 2H), 1.71-1.63 (m, 2H), 0.89 (s, 9H), 0.88 (d, J = 5.6 Hz, ), 0.05 (s, 6H); 13C NMR 
(CDCl3, 75 MHz): δ 151.58, 138.5, 128.3, 127.6, 127.4, 94.5, 74.9, 73.0, 67.2, 63.0, 30.6, 
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29.5, 27.8, 25.9, 18.4, 13.9, -5.2, -5.3; IR (film) υmax 2955, 2856, 1471, 1461, 1253 cm
-1; 
HRMS (CI, NH3) m/z calc’d for C22H36NaO3Si [M+Na]
+ 399.2331, found: 399.2335. 
 
 
((2R,3S,5S,6S)-6-(2-(Benzyloxy)ethyl)-2-((tert-butyldimethylsilyloxy)methyl)-5-
methyl-tetrahydro-2H-pyran-3-yloxy)(tert-butyl)dimethylsilane (4a) silyl ether 17 
(1.23 g, 3.27 mmol) was dissolved in anhydrous THF (60 mL) under Ar and cooled to 0 
oC. Borane dimethyl sulfide complex (2 M in THF, 8.0 mL, 16.35 mmol) was introduced 
into the reaction and stirred for 3 hr at rt. The reaction was cooled again to 0 oC and H2O2 
(3 wt%, 37 mL, 32.7 mmol) was added dropwise. 1N NaOH (32.7 mL, 32.7 mmol) was 
added and the reaction was stirred for 30 min at rt. Ethyl acetate (100 mL) and water (50 
mL) were added and layers were separated. The organic phase was dried over magnesium 
sulfate, filtered, and concentrated under reduced pressure to obtain an oil. Purification 
over silica gel with hexane/ethyl acetate (20/1 to 5/1 gradient elution) afforded secondary 
alcohol 4 as a clear oil (1.17g, 90%): [α]D
20 = -41.5 (c 1.0, CHCl3) 
1H NMR (CDCl3, 400 MHz): δ 7.34-7.29 (m, 4H), 7.28-7.25 (m, 1H), 4.48 (q, J = 12.0 
Hz, 1H), 3.84 (dd, J = 4.8, 9.6 Hz, 1H), 3.74 (ddd, J = 4.0, 6.4, 8.8 Hz, 1H), 3.64 (dd, J = 
8.4, 10 Hz, 1H), 3.62-3.58 (m, 1H), 3.54-3.46 (m, 2H), 3.45 (br. s, 1H), 3.17 (dt, J = 4.8, 
8.4 Hz, 3H), 1.94 (ddd, J = 12.4, 5.2, 2.4, 1H), 1.84-1.79 (m, 1H), 1.75-1.69 (m, 1H), 
1.65-1.57 (m, 2H), 0.92 (d, J = 7.2 Hz, 3H) 0.88 (s, 9H) 0.07 (s, 6H); 13C NMR (CDCl3, 
75 MHz): δ 138.4, 128.2, 127.5, 127.4, 79.7, 76.0, 72.8, 67.0, 66.4, 39.1, 32.9, 32.2, 25.7, 
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18.0, 14.1, 12.5, -5.7; IR (film) υmax 3421, 2928, 2856, 1472, 1456 cm
-1; HRMS (CI, 
NH3) m/z calc’d for C22H38NaO4Si [M+Na]
+ 417.2437, found: 417.2441. 
 
A solution of secondary alcohol 4 (1.17 g, 2.96 mmol) and 2,6-lutidine (1.4 mL, 11.84 
mmol) in anhydrous CH2Cl2 (30 ml) was cooled to -78 
oC under Ar. TBSOTf (1.4 mL, 
5.92 mmol) was added at the same temperature and the reaction mixture was allowed to 
reach to 0 oC and stirred over a period of 1 hr. CH2Cl2 (50 mL) and water (25 mL) were 
added and layers were separated. The organic phase was dried over magnesium sulfate, 
filtered, and concentrated under reduced pressure to obtain an oil. Purification over silica 
gel with hexane/ethyl acetate (50/1) afforded silyl ether 4a as a clear oil (1.49g, 98%): 
[α]D
20 = +5.9 (c 1.0, CHCl3) 
1H NMR (CDCl3, 300 MHz): δ 7.34-7.21 (m, 5H), 4.47 (s, 2H), 3.78-3.69 (m, 3H), 3.60-
3.52 (m, 3H), 3.01 (ddd, J = 12.4, 5.6, 3.2 Hz, 1H), 1.82 (ddd, J = 16.4, 6.8, 3.2 Hz, 1H), 
1.78-1.70 (m, 2H), 1.16-1.53 (m, 2H), 0.92 (d, J = 9.6 Hz, 3H), 0.87 (s, 9H), 0.85 (s, 9H), 
0.03(s, 3H), 0.02 (s, 3H), 0.01 (s, 3H), 0.00 (s, 3H); 13C NMR (CDCl3, 75 MHz): δ 
138.6, 128.2, 127.5, 127.4, 83.4, 77.4, 76.9, 76.5, 75.8, 72.9, 67.4, 62.9, 62.8, 41.0, 33.2, 
33.0, 25.8, 25.7, 18.3, 17.9, 12.7, -4.2, -4.9, -5.0, -5.3; IR (film) υmax 2954, 2856, 1471, 
1368, 1251 cm-1; HRMS (CI, NH3) m/z calc’d for C28H52NaO4Si2 [M+Na]
+ 531.3302, 
found: 531.3299. 
 
O
Me
BnO
4a
OTBS
OTBS
O
Me
HO
19
OTBS
OTBS
 
 
 
31 
2-((2S,3S,5S,6R)-5-(tert-Butyldimethylsilyloxy)-6-((tert-
butyldimethylsilyloxy)methyl)-3-methyl-tetra-hydro-2H-pyran-2-yl)ethanol (19) To 
a solution of benzyl ether 4a (823 mg, 1.62 mmol) in ethyl acetate (16 mL) was added Pd 
(10 % on carbon, 82 mg). The reaction mixture was stirred for 40 hr under H2 
atmosphere. The mixture was then filtered through a pad of Celite® and concentrated in 
vacuo to afford 19 as a clear oil (678 mg, quantitative): [α]D
20 = +15.7 (c 1.1, CHCl3) 
1H NMR (CDCl3, 400 MHz): δ 3.81-3.76 (m, 3H), 3.68-3.58 (m, 3H), 3..15 (td, J = 6.8, 
2.0 Hz, 2H), 1.87-1.76 (m, 3H), 1.61 (td, J = 11.6, 4.0 Hz, 1H), 1.42-1.37 (m, 1H), 0.96 
(d, J = 6.8 Hz, 3H), 0.87 (s, 9H), 0.84 (s, 9H), 0.02 (s, 12H); 13C NMR (CDCl3, 75 
MHz): δ 83.6, 81.2, 63.2, 62.8, 40.8, 35.4, 33.5, 25.8, 25.6, 18.2, 17.8, 13.0, -4.2, -5.0, -
5.3, -5.4; IR (film) υmax 3402, 2955, 2857, 1472, 1252 cm
-1; HRMS (CI, NH3) m/z calc’d 
for C21H46NaO4Si2 [M+Na]
+ 441.2832, found: 441.2824. 
 
 
tert-Butyl(((2R,3S,5S,6S)-3-(tert-butyldimethylsilyloxy)-5-methyl-6-(pent-3-ynyl)-
tetrahydro-2H-pyran-2-yl)methoxy)dimethylsilane (21) A solution of primary alcohol 
19 (300 mg, 0.716 mmol) and 2,6-lutidine (0.25 mL, 2.15 mmol) in anhydrous CH2Cl2 
(14 mL) was cooled to -78 oC under Ar. Tf2O (0.18 mL, 1.07 mmol) was added and the 
mixture was stirred for 1 hr before adding 1N HCl (7 mL). The layers were separated and 
sat’d-NaHCO3 (7 mL) was added to organic phase. The resulting layers were then 
separated again and the organic phase was dried over anhydrous MgSO4. After filtering, 
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the organic phase was concentrated in vacuo to afford 20 as an oil that was used 
immediately. 
Propyne was passed through a THF (10 mL) solution of n-BuLi (1.7 mL, 2.5 M in 
hexane, 4.30 mmol) at -78 oC for 10 min. Then, a solution of triflic ether 20 in THF (4.0 
mL) was added and the reaction mixture was allowed to warm to rt and stirred for 3 h. 
Water (3 mL) was slowly added and the reaction mixture was extracted with ethyl acetate 
(3 x 10 mL). The combined organic layers were dried over anhydrous MgSO4, filtered, 
and concentrated in vacuo. The resultant residue was purified over silica gel with 
hexane/ethyl acetate (100/1) to give alkyne 21 as a clear oil (245 mg, 78%): [α]D
20 = +6.1 
(c 0.65, CHCl3). 
1H NMR (CDCl3, 400 MHz): δ 3.78-3.67 (m, 3H), 3.47 (ddd, J = 9.2, 4.0, 2.0, 1H), 3.02 
(ddd, J = 9.2, 4.8, 2.0, 1H), 2.23-2.15 (m, 2H), 1.82 (ddd, J = 12.4, 4.8, 2.4 Hz, 1H), 1.75 
(t, J = 2.4 Hz, 3H), 1.67-1.56 (m, 2H), 1.44-1.37 (m, 1H), 0.85 (d, J = 2.4 Hz, 3H), 0.86 
(s, 9H), 0.85 (s, 9H), 0.02 (s, 12H); 13C NMR (CDCl3, 75 MHz): δ 83.4, 79.0, 77.8, 75.3, 
63.0, 62.8, 41.0, 32.8, 32.2, 25.8, 25.7, 18.3, 17.9, 15.5, 12.7, 3.5, -4.3, -4.9, -5.0, -5.2; IR 
(film) υmax 2954, 2929, 2856, 1472, 1386, 1252 cm-1; HRMS (CI, NH3) m/z calc’d for 
C24H48NaO3Si2 [M+Na]
+ 463.3040, found: 463.3051. 
 
 
tert-Butyl(((2R,3S,5S,6S)-3-(tert-butyldimethylsilyloxy)-6-((E)-4-iodopent-3-enyl)-5-
methyl-tetrahydro-2H-pyran-2-yl)methoxy)dimethylsilane (2) Cp2ZrHCl (287 mg, 
 
 
33 
1.11 mmol) was added to a flame dried Schlenk tube and dried under vacuum for 3 hr. A 
solution of alkyne 21 (245 mg, 0.556 mmol) in THF (1 mL) was then added under Ar and 
the mixture was stirred for 1 hr at 50 oC. The reddish reaction mixture was cooled to 0 oC 
and a solution of iodine (169 mg, 0.667 mmol) in THF (1 mL) was slowly added. After 
30 min, sat’d-Na2S2O3 solution (2 mL) was added and the reaction mixture was stirred 
until it became clear. Ethyl acetate (5 mL) and water (3 mL) were added and layers were 
separated. The organic phase was dried over anhydrous MgSO4, filtered, and 
concentrated under reduced pressure to obtain an oil. Purification over silica gel with 
hexane/ethyl acetate (100/1) afforded iodoalkene 2 as an oil (280 mg, 88%): [α]D
20 = -
0.22 (c 0.90 , CHCl3). 
1H NMR (CDCl3, 400 MHz): δ 6.12 (td, J = 7.6, 1.6 Hz, 1H), 3.79-3.65 (m, 3H), 3.31 
(dt, J = 12.0, 3.2 Hz, 1H), 2.98 (ddd, J = 9.2, 4.4, 2.0, 1H), 2.35 (s, 3H), 2.09 (q, J = 3.6 
Hz, 1H), 1.84-1.78 (m, 1H), 1.76-1.70 (m, 1H), 1.63-1.53 (m, 2H), 1.31-1.21 (m, 1H), 
0.90 (d, J = 6.8 Hz, 3H), 0.86 (s, 9H), 0.85 (s, 9H), 0.02 (s, 12H); 13C NMR (CDCl3, 75 
MHz): δ 140.9, 94.0, 83.5, 77.8, 62.8, 41.0, 33.1, 31.8, 27.4, 27.3, 25.8, 25.7, 18.4, 17.9, 
12.8, -4.3, -4.9, -5.0, -5.3; IR (film) υmax 2954, 2856, 1471, 1385, 1252, 836 cm
-1; 
HRMS (CI, NH3) m/z calc’d for C24H49NaIO3Si2 [M+H]
+ 569.2343, found: 569.2353. 
 
 
(E)-tert-butyl(3-iodobut-2-enyloxy)diphenylsilane (3) To a solution of iodo allylic 
alcohol 3I21 (410 mg, 2.07 mmol) and imidazole (423 mg, 6.21 mmol) in anhydrous DMF 
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(7 mL) was added TBDPSCl (0.80 mL, 3.11 mmol) at 0 oC under Ar. This mixture was 
warmed to rt and stirred for 1hr before adding water (7 mL) and hexane (14 mL). The 
layers were separated and the organic phase was dried over anhydrous MgSO4. After 
filtering, the organic phase was concentrated in vacuo to afford an oil. Purification over 
silica gel with hexane/ethyl acetate (50/1) gave silyl ether 3 as a clear oil (836 mg, 93%):  
1H NMR (CDCl3, 300 MHz): δ 7.71-7.68 (m, 4H), 7.48-7.38 (m, 6H), 6.38 (tq, J = 6.3, 
1.2 Hz, 1H), 4.14 (d, J = 6.6 Hz, 2H), 2.20 (s, 3H), 1.07 (s, 9H); 13C NMR (CDCl3, 75 
MHz): δ 140.3, 135.8, 133.6, 130.0, 128.0, 96.8, 61.6, 28.3, 27.0, 19.4; IR (film) υmax 
3070, 2930, 2857, 1471, 822 cm-1. 
 
 
((2R,3S,5S,6S)-3-(tert-Butyldimethylsilyloxy)-6-((3E,5E)-7-(tert-
butyldiphenylsilyloxy)-4,5-dimethylhepta-3,5-dienyl)-5-methyl-tetrahydro-2H-
pyran-2-yl)methanol (24) To a solution of iodo allylic alcohol 3 (803 mg, 1.84 mmol) in 
anhydrous THF (1.5 mL) was added t-BuLi (1.7 M in pentane, 2.7 mL, 4.6 mmol) at -78 
oC under Ar and the mixture was stirred for 30 min. The reaction mixture was warmed to 
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0 oC and a solution of ZnCl2 (dried under vacuum for 12 hr at 150 
oC, 251mg, 1.84 
mmol) in THF (2.5 mL) was added. After 20 min, a solution of iodo alkene 2 (260 mg, 
0.46 mmol) and Pd(PPh3)4 (53 mg, 0.046 mmol) in THF (1.5 mL) was added and the 
reaction mixture was stirred overnight at rt. Water (5 mL) was slowly introduced and the 
mixture was extracted with ethyl acetate (3 x 10 mL). The combine organic phases were 
dried over anhydrous MgSO4, filtered and concentrated in vacuo to obtain an oil that was 
used directly. 
The crude product 24I was dissolved in MeOH/CH2Cl2 (1:1, 10 mL) and cooled to 0 
oC. 
Camphorsulfonic acid (CSA) (10 mg, 0.046 mmol) was added and stirred for 3 hr at the 
same temperature. After addition of Et3N (0.064 mL, 0.046 mmol), the mixture was 
concentrated in vacuo. Purification over silica gel with hexane/ethyl acetate (30/1) 
afforded alcohol 24 as a clear oil (170 mg, 58% over two step): [α]D
20 = +0.77 (c 0.65, 
CHCl3). 
1H NMR (CDCl3, 300 MHz): δ 7.73-7.68 (m, 4H), 7.42-7.35 (m, 6H), 5.67 (t, J = 5.7 Hz, 
1H), 5.47 (t, J = 7.2 Hz, 1H), 4.37 (d, J = 6.0 Hz, 2H), 3.82 (dd, J = 11.1, 3.0 Hz, 1H), 
3.72-3.67 (m, 1H), 3.63 (td, J = 11.4, 6.0 Hz, 1H), 3.45-3.40 (m, 1H), 3.18-3.12 (m, 1H), 
2.18 (q, J = 7.2 Hz, 2H), 1.90-1.81 (m, 2H), 1.79 (s, 3H), 1.67-1.63 (m, 2H), 1.58 (s, 3H), 
1.41-1.33 (m, 1H), 1.13 (s, 9H), 0.95 (d, J = 7.2 Hz, 3H), 0.87 (s, 9H), 0.06 (s, 6H); 13C 
NMR (CDCl3, 75 MHz): δ 136.6, 136.2, 135.5, 135.2, 134.7, 133.9, 130.5, 129.5, 126.1, 
125.3, 82.5, 78.9, 64.1, 63.1, 61.8, 40.9, 32.7, 32.5, 26.8, 26.5, 25.7, 25.1, 19.1, 17.8, 
14.1, 13.8, 12.8, -4.1, -4.9; IR (film) υmax 3444, 2931, 2857, 1471, 1427, 1253 cm-1; 
HRMS (CI, NH3) m/z calc’d for C38H60NaO4Si2 [M+Na]
+ 659.3928, found: 659.3938. 
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((2E,4E)-7-((2S,3S,5S,6R)-6-(Azidomethyl)-5-(tert-butyldimethylsilyloxy)-3-methyl-
tetrahydro-2H-pyran-2-yl)-3,4-dimethylhepta-2,4-dienyloxy)(tert-
butyl)diphenylsilane (26) To a solution of alcohol 24 (72 mg, 0.113 mmol) and 
diisopropyl azodicarboxylate ( 44 L, 0.226 mmol) in THF (0.4 mL) was added PPh3 (60 
mg, 0.226 mmol) at 0 oC. After 5 min, diphenylphosphoryl azide was added. The reaction 
mixture was warm to rt and stirred for 3 hr. Ethyl acetate (5 mL) and water (1 mL) were 
added and the layers were separated. The organic phase was dried over anhydrous 
MgSO4, filtered and concentrated in vacuo to afford an oil. Purification over silica gel 
with hexane/ethyl acetate (50/1) gave azide 26 as a clear oil (60 mg, 80%) : [α]D
20 = +1.8 
(c 0.50, CHCl3). 
1H NMR (CDCl3, 300 MHz): δ 7.71-7.68 (m, 4H), 7.46-7.33 (m, 6H), 5.66 (t, J = 6.0 Hz, 
1H), 5.49 (t, J = 7.5 Hz, 1H), 4.36 (d, J = 6.0 Hz, 1H), 3.72-3.64 (m, 1H), 3.44-3.39 (m, 
2H), 3.31-3.23 (m, 2H), 2.26-2.18 (m, 2H), 1.91-1.79 (m, 2H), 1.77 (s, 3H), 1.70-1.61 
(m, 2H), 1.59 (s, 3H), 1.39-1.28 (m, 1H), 1.05 (s, 9H), 0.98 (d, J = 6.9 Hz, 3H), 0.86 (s, 
9H), 0.05 (s, 6H); 13C NMR (CDCl3, 75 MHz): δ 136.7, 136.2, 135.5, 135.0, 133.9, 
130.3, 129.5, 128.0, 127.5, 126.3, 125.1, 82.4, 79.2, 64.4, 61.8, 51.9, 40.9, 32.8, 32.6, 
26.8, 25.6, 19.1, 17.8, 14.1, 13.7, 12.7, -4.0, -4.9; IR (film) υmax 3070, 2932, 2857, 1471, 
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1256 cm-1; HRMS (CI, NH3) m/z calc’d for C38H59N3NaO3Si2 [M+Na]
+ 684.3993, found: 
684.4009. 
 
 
N-(((2R,3S,5S,6S)-3-(tert-butyldimethylsilyloxy)-6-((3E,5E)-7-(tert-
butyldiphenylsilyloxy)-4,5-dimethyl-hepta-3,5-dienyl)-5-methyl-tetrahydro-2H-
pyran-2-yl)methyl)acetamide (27) Azide 26 (70 mg, 0.106 mmol) was dissolved in 
dioxane/MeOH (5:1, 2.5 mL) and was stirred for 1 hr. NH4OH (30 %, 0.25 mL) was 
added and the reaction was stirred for additional 24 hr. Then, the mixture was 
concentrated under reduced pressure and purified over silica gel with CH2Cl2/MeOH 
(30/1) to give a mixture of amine 26a and triphenyl phosphate. 
To a solution of amine 26a in CH2Cl2 (1 mL) was added DMAP (1.3 mg, 0.0106 mmol), 
Ac2O (12 L, 0.127 mmol), and triethylamine (18 L, 0.127 mmol). After 30 min, the 
reaction was concentrated under reduced pressure and purified over silica gel with 
CH2Cl2/MeOH (50/1) to afford amide 27 as a clear oil (60 mg, 83%): [α]D
20 = +4.5 (c 
0.55, CHCl3). 
1H NMR (CDCl3, 300 MHz): δ 7.68-7.66 (m, 4H), 7.42-7.33 (m, 6H), 5.79 (br. s, 1H), 
5.65 (t, 6.0 Hz, 1H), 5.46 (t, J = 7.2 Hz, 1H), 4.34 (d, J = 6.0 Hz, 2H), 3.76 (dq, J = 10.0, 
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6.4 Hz, 1H), 3.55-3.49 (m, 1H), 3.38-3.35 (m, 1H), 3.12-3.05 (m, 2H), 2.16 (q, J = 7.2 
Hz, 2H), 1.94 (s, 3H), 1.87-1.78 (m, 2H), 1.74 (s, 3H), 1.63-1.59 (m, 2H), 1.57 (s, 3H), 
1.39-1.30 (m, 1H), 1.07 (s, 9H), 0.93 (d, J = 7.2 Hz, 3H), 0.84 (s, 9H), 0.05 (s, 3H), 0.02 
(s, 3H); 13C NMR (CDCl3, 75 MHz): δ 169.6, 136.5, 136.2, 135.5, 133.8, 129.5, 127.5, 
126.1, 125.4, 81.1, 78.9, 65.7, 61.8, 41.4, 40.8, 32.6, 32.5, 26.8, 25.7, 25.1, 23.2, 19.1, 
17.8, 14.1, 13.8, 12.7, -4.1, -4.8; IR (film) υmax 3306, 2929, 2856, 1652, 1466, 1255 cm
-1; 
HRMS (CI, NH3) m/z calc’d for C40H63NaNO4Si2 [M+Na]
+ 700.4193, found: 700.4199. 
 
 
N-(((2R,3S,5S,6S)-3-Hydroxy-6-((3E,5E)-7-hydroxy-4,5-dimethylhepta-3,5-dienyl)-5-
methyl-tetrahydro-2H-pyran-2-yl)methyl)acetamide (28) To solution of disilyl ether 
27 (58 mg, 0.086 mmol) in THF (8 mL) was added TBAF (1 M in THF, 0.43 mL, 0.43 
mmol). After 4 hr, CH2Cl2 (8 mL) and sat’d-NH4Cl (2 mL) was added and layers were 
separated. The aqueous phase was extracted with CH2Cl2 (3 x 4 mL) and the combine 
organic phases were dried over anhydrous MgSO4, filtered, and concentrated in vacuo. 
Purification over silica gel with CH2Cl2/MeOH (30/1) afforded diol 28 as a clear oil (23 
mg, 83%): [α]D
20 = -52.3 (c 1.1, CHCl3). 
1H NMR (CD3OD, 400 MHz): δ 5.64 (t, J = 6.8 Hz, 1H), 5.60 (t, J = 7.2 Hz, 1H), 4.21 
(d, J = 6.4 Hz, 2H), 3.55 (dd, J = 14.0, 2.8 Hz, 1H), 3.44-3.36 (m, 2H), 3.32-3.32 (m, 
1H), 3.07 (ddd, J = 9.6, 4.4, 2.4 Hz, 1H), 2.27-2.07 (m, 2H), 1.93 (s, 3H), 1.91 (ddd, J = 
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12.4, 4.4, 2.0 Hz, 1H), 1.85-1.82 (m, 1H), 1.80 (s, 3H), 1.79 (s, 3H), 1.69-1.56 (m, 2H), 
1.45-1.32 (m, 1H); 13C NMR (CD3OD, 100 MHz): δ; 170.8, 139.2, 137.4, 127.8, 125.6, 
83.0, 80.2, 64.9, 60.0, 42.4, 40.8, 34.1, 33.7, 26.0, 22.4, 14.2, 14.1, 13.0; IR (film) υmax 
3357, 2929, 1636, 1465, 1380 cm-1; HRMS (CI, NH3) m/z calc’d for C18H31NaNO4 
[M+Na]+ 348.2151, found: 348.2162 
 
 
Brevisamide (1) To a solution of diol 28 (20 mg, 0.061 mmol) in CH2Cl2 (4.5 mL) was 
added MnO2 (activated at 150 
oC for 12 hr, 265 mg, 3.05 mmol) in 3 portion every an 
hour at rt. After being stirred at rt for 1 hr, CH2Cl2 was removed through N2 stream and 
reaction mixture was directly purified over silica gel with CH2Cl2/MeOH (30/1) to afford 
brevisamide 1 as a clear oil (13 mg, 66%) : [α]D
20 = -12.3 (c 0.65 , MeOH); literature 
[α]D
20 = -13 (c 0.18 , MeOH). 
1H NMR (CD3OD, 400 MHz): δ 10.10 (d, J = 7.6 Hz, 1H), 6.23 (dd, J = 7.6, 6.4 Hz, 
1H), 6.04 (d, J = 8.0 Hz, 1H), 3.54 (dd, J = 2.8, 13.6 Hz, 1H), 3.47-3.38 (m, 2H), 3.34 
(dd, J = 7.2, 14.4 Hz, 1H), 3.08 (ddd, J = 9.6, 6.8, 2.8 Hz, 1H), 2.36 (q, J = 7.2 Hz, 2H), 
2.33 (s, 3H), 1.96 (s, 3H), 1.91 (ddd, J = 12.4, 4.4, 2.4 Hz, 1H), 1.87 (s, 3H), 1.87-1.83 
(m, 1H), 1.71-1.58 (m, 2H), 1.49-1.39 (m, 1H), 0.97 (d, J = 8.0 Hz, 3H); 13C NMR 
(CD3OD, 100 MHz): δ 194.4, 173.8, 160.9, 137.2, 136.9, 126.2, 83.0, 80.3, 65.0, 42.5, 
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40.8, 34.2, 33.2, 26.9, 22.5, 14.5, 14.0, 13.0; IR (film) υmax 3316, 2928, 1653, 1617, 1456 
cm-1; HRMS(CI, NH3) m/z calc’d for C18H31NaNO4 [M+Na]
+ 348.2151, found: 348.2162. 
 
Table 1.1 Synthetic brevisamide spectral data compared to natural brevisamide data 
O
Me
Brevisamide 1
H
N
OH
Me
Me
Me
O
H
O
1
16
17
18
10
13
15
 
1H NMR (Synthetic at 400 MHz; Natural at 500 MHz) 
& 
13C NMR (Synthetic at 100 MHz; Natural at 125 MHz) 
Position 
1H NMR (mult, J in Hz) 13C NMR 
Synthetic Natural Synthetic Natural 
1 10.10 (d, 7.6) 10.10 (d, 7.9) 194.4 194.4 
2 6.04 (d, 8.0) 6.04 (d, 7.9) 126.2 126.3 
3   160.9 160.9 
4   137.2 137.2 
5 6.23 (dd, 7.6, 6.4) 6.23 (t, 7.1) 136.9 136.8 
6 2.36 (q, 7.2) 2.34 m 26.9 26.9 
7a 1.64 m 1.65 m 33.2 33.2 
7b 1.44 m 1.44 m   
8ax 3.42 m 3.39 m 80.3 80.3 
9eq 1.85 m 1.85 m 34.2 34.3 
10eq 1.91 (ddd, 2.4, 4.4, 
12.4) 
1.90 m 40.8 40.9 
10ax 1.64 m 1.65 m   
11ax 3.42 m 3.42 m 65.0 65.0 
12ax 3.08 (ddd, 2.8, 6.8, 
9.6) 
3.08 (ddd, 2.6, 7.0, 
9.3) 
83.0 83.1 
13a 3.54 (dd, 2.8, 13.6) 3.53 (dd, 2.6, 14.0) 42.5 42.5 
13b 3.34 (dd, 7.2, 14.4) 3.32(dd, 7.1, 14.0)   
14   173.8 173.7 
15 1.96 s 1.95 s 22.5 22.5 
16 2.33 s 2.33 s 14.5 14.6 
17 1.87 s 1.86 s 14.0 14.0 
18 0.97 (d, 8.0)  0.95 (d, 6.9) 13.0 13.1 
 
 
 
41 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2 
Development of Silicon-Directed Mukaiyama-type 
[3+2]-Annulation for Highly Substituted 
Tetrahydrofurans 
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2.1 Introduction 
Substituted tetrahydrofurans are commonly occurring subunits found in a broad array 
of natural products and other synthetic bioactive molecules.26 Specifically, many natural 
products bearing a tetrahydrofuran moiety have been isolated, and some of these 
compounds have been considered as promising leading compounds for drug development. 
Due to the importance of these molecules, considerable effort has been devoted towards 
the development of methods for the stereoselective construction of substituted 
tetrahydrofurans. 
 
 
 
 
To date, a number of methodologies have been developed to produce 
stereochemically well-defined hydrofurans, which include metal-mediated intramolecular 
etherification of -hydroxyl olefins, Prins-type cyclization of alkynyl or alkenyl alcohols, 
and cycloaddition of an aldehyde to donor-acceptor cyclopropanes. Among those 
examples, stereoselective methodologies for optically active tetrahydrofurans are also 
available utilizing a chiral catalyst or chirality transfer from enantioenriched substrates. 
Figure 2.1 An example of tetrahydrofuran-containing natural products 
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Although various successful methods have been developed and have been used in 
practical syntheses, it would still be valuable to establish efficient and convenient way to 
access highly functionalized tetrahydrofurans with high levels of stereocontrol.  
 
2.2 Previous efforts to synthesize tetrahydrofurans 
2.2.1 Etherifications of -hydroxyl olefins and alkynes 
Most of etherifications of -hydroxyolefins rely on an electrophilic intramolecular 
cyclization, which involves the addition of an electrophile or coordination of organometal 
species to the -system to activate the olefin toward nucleophilic addition of the internal 
hydroxyl group. In this context, haloetherification is one of the most representative 
examples for electrophilic cyclization. Kang and coworkers developed an asymmetric 
iodoetherification utilizing salen-Co complex E1.27 In this reaction, the active catalyst, 
generated by treating E1 with NCS and iodine, successfully catalyzed an enantioselective 
etherification of -hydroxyl-cis-alkene E2 to afford tetrahydrofuran E3 in high yield and 
enantiomeric excess (Scheme 2.1).  
  
 
 
Scheme 2.1 Asymmetric iodoetherification of -hydroxyolefins 
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Alternatively, the -acidic character of a late transition metal can execute an 
intramolecular etherification of a -hydroxyolefin via Wacker-type trans-oxypalladation 
process. 28 However, in Wolfe’s example using a palladium-catalyzed cyclization, 
concomitant additions of an aryl halide and heteroatom to the olefin took place through 
an unusual cis-oxypalladation to give an anti-1’,2-tetrahydrofuran (Scheme 2.2).29 For 
instance, the olefin E5 underwent cyclization in the presence of aryl halide E4 to 
construct E6 with anti-1’,2-selectivity, which can be evidence for the unusual cis-
oxypalladation intermediate E7. In their later study, use of bidentate ligands, such as 
BINAP and DPP-benzene, were proven to lead to the syn-1’,2-product arising from 
alkene insertion through the usual Wacker-type trans-oxypalladation.30  
 
 
 
Intramolecular conjugate addition of ε-hydroxy-α,β-unsaturated ketones can be a 
straightforward approach to access tetrahydrofurans. An interesting example of this 
category of cyclization appeared from Matsubara and coworker utilizing a thiourea-based 
intramolecular conjugate addition (Scheme 2.3).31 Asymmetric conjugate addition of ε-
hydroxy-α,β-unsaturated ketones E8 in the presence of cinchona-derived thiourea E9 was 
successfully achieved to give furan E10 in high yield and enantioselectivity. Substrates 
containing phenyl groups with electron donating substituents maintained an equal level of 
Scheme 2.2 Palladium-mediated etherification of -hydroxyolefins 
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efficiency, while those that containing an electron withdrawing group showed slight 
attenuation in enantioselectivity (85% ee). Additionally, this methodology can be 
extended to the formation of a tetrahydropyran starting from ahydroxyl-unsaturated 
ketone. 
 
 
 
 
2.2.2 Prins-type cyclizations involving oxonium ion  
To date, a number of Prins-type cyclizations have been utilized in the stereoselective 
construction of tetrahydrofurans. Usually, those examples involve formation of 
oxocarbenium intermediates that trigger intramolecular capture by nucleophilic olefins. 
One representative example appeared from Loh and coworkers describing an In(OTf)3-
mediated coupling of alcohol P1 with aldehyde P2 at 0 oC to construct tetrahydrofuran 
P3 in 77% yield with 65:35 2,3-trans:cis selectivity (Scheme 2.4).32 The observed 
stereoselectivity is attributed to the transition state P5, in which two substituents are 
positioned in the pseudo-equatorial orientation to form a favorable W-shaped 
conformation. In this context, the same reaction at 40 oC complementarily provided furan 
P4 through an acid-catalyzed 1,3-shift arising from the migration of the 2,3-substituent in 
Scheme 2.3 Thiourea-catalyzed conjugate addition of -hydroxy-unsaturated ketone 
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tetrahydrofuran P3. This 1,3-shift pathway was further confirmed by additional 
experiments, where P3 was transformed to P4 upon exposure to In(OTf)3 at 40 
oC.  
 
 
Similarly, Cho and coworkers reported a Prins-type cyclization of homopropargyl 
alcohol P6 with an aldehyde to furnish exo-3-furanylidene P7, which bears cis-2,5-
selectivity (Scheme 2.5). 33  The observed stereoselectivity can be rationalized by 
preference for the W-shaped transition state P9. Also, subsequent hydrolysis of the vinyl 
triflic ester in P7 afforded the corresponding 3-acyl-substituted tetrahydrofuran P8. 
 
 
Scheme 2.4 Prins-type cyclization of homoallylic alcohol 
Scheme 2.5 Prins-type cyclization of homopropargylic alcohol 
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Overman has developed a methodology for the construction of 3-acyl-
tetrahydrofurans, which are generated through Prins-type cyclization and subsequent 
pinacol rearrangement.34 For example, treatment of P8 with SnCl4 afforded P11 in 98% 
yield with a diastereoselectivity of 98:2. The mechanistic explanation for the 
transformation of P8 to the product P11 includes a Prins cyclization of oxonium ion P9 
to generate carbocation P10, which is followed by pinacol rearrangement to afford P11. 
Additionally, this methodology was successfully applied to the total synthesis of 
citreoviral to prove its efficiency in natural product synthesis. 
 
 
 
The Hoppe group disclosed an efficient methodology to construct various 2-
carboxaldehyde furans with high yield and diastereoselectivity utilizing a Mukaiyama-
type [3+2]-annulation of carbamoyl enol ethers with aldehydes (Scheme 2.7).35 The enol 
ether P12 underwent condensation with an aldehyde in the presence of BF3·OEt2 to form 
an oxocarbenium, which triggered an intramolecular Mukaiyama-type cyclization to 
produce tetrasubstituted tetrahydrofuran P14. Also, the diastereoselectivity of the 
resulting tetrahydrofuran was transferred from the stereochemistry of the allylic methyl 
Scheme 2.6 Cascade Prins cyclization/pinacol rearrangement of acetal derivative P8  
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substituent on the substrate P12 during the course of cyclization, which goes through a 
chair-like transition state P13. 
 
 
 
An elegant methodology for the synthesis of tetrahydrofuran utilizing silicon-
directed [3+2]-annulation reactions of enantioenriched silanes and aldehydes was 
developed by Panek in 1991 (Scheme 2.8).36 Specifically, this annulation was initiated 
by stereoselective crotylation of P15 with aldehyde P16 in the presence of a Lewis acid 
to give intermediate silane-bridged ion P18, which is stabilized by a -silicon effect of 
silicon group, and subsequent trapping of the cation with oxygen provided a silicon-
substituted tetrahydrofuran in high levels of yield and enantioselectivity. The silicon 
group could then be transformed to useful functionalities. For instance, exposure of P19 
to Tamao-Fleming oxidation conditions successfully provided a hydroxy-substituted 
tetrahydrofuran. Also, the silicon group undergoes protodesilylation in the presence of 
TBAF to give a tetrahydrofuran, which makes silicon functionality a more general 
directing group for the asymmetric induction. This annulation methodology has been 
widely employed for the synthesis of tetrahydrofurans and has been expanded to other 
types of silicon-based tetrahydrofuran constructions.37 
Scheme 2.7 Mukaiyama-type [3+2]-annulation of carbamoyl enol ether P12 
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2.2.3 Cycloadditions of acceptor-donor cyclopropanes 
An interesting tetrahydrofuran synthesis was also developed by Johnson, utilizing 
cycloaddition of an acceptor-donor (D-A) cyclopropane with an aldehyde (Scheme 2.9).38 
For example, treatment of C1 with benzaldehyde in the presence of a Sn(OTf)2 catalyst 
provided cis-2,5-tetrahydrofuran C2 in 97% yield with an near perfect 
diastereoselectivity (dr = 84:1). Interestingly in this reaction, the use of more electron-
rich aldehydes (p-methoxybenzaldehyde) showed a significant decrease in the reaction 
rate compared with those of electron-poor aldehydes (p-nitrobenzaldehyde), which 
supports nucleophilic O-addition of aldehyde to D-A cyclopropane (C3). Therefore, the 
cycloaddition reaction was proposed to proceed via a Lewis-acid mediated D-A 
cyclopropane opening with the more nucleophilic non-bonding electrons of the aldehyde 
to generate stabilized intermediate C4 with inversion of stereochemistry at the acceptor 
site of the cyclopropane. Then bond rotation takes place to increase proximity between 
the anion and oxonium ion, and subsequent cycloaddition provides the product 
tetrahydrofuran. In addition, pentasubstituted tetrahydrofurans are also accessible through 
Scheme 2.8 Silicon-directed [3+2]-annulation of crotylsilanes 
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this cycloaddition methodology, starting from cyclopropanes bearing a quaternary 
acceptor site.38a     
   
 
 
2.3 Development of silicon-directed Mukaiyama-type [3+2]-annulation 
Among the previous examples, the Mukaiyama-type [3+2]-cycloadditions35 of 
homoallylic alcohols with aldehydes reported by Hoppe particularly attracted our interest, 
since our group has previously investigated silicon-directed annulations to construct 
functionalized dihydropyrans and tetrahydrofurans from various enantioenriched 
allylsilane reagents. In our earlier studies, a crotyl silane, which contained C-Si chirality, 
proved to be a reliable substrate for the cycloaddition reaction to afford functionalized 
heterocycles with excellent stereocontrol.12,36 From a mechanistic point of view, the 
silicon-directed annulations have similarities with the Mukaiyama-type annulations in 
that cyclization is initiated by oxocarbenium formation from reaction between the 
Scheme 2.9 Cycloaddition of donor-acceptor cyclopropane 
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homoallylic hydroxyl group and an aldehyde under acidic conditions and the 
stereochemistry outcome was dictated by the allylic C-centered chirality. 
   
 
 
 
Considering these similarities between our silicon-mediated annulation and the 
Mukaiyama-type annulation, we set out to develop an efficient and diversified 
methodology for the construction of highly functionalized tetrahydrofurans utilizing an 
alkoxy allylsilane. Additionally, practical preparation methods of various silane reagents 
have been previously established and are available with high levels of enantiopurity.14 
We envisioned that an alkoxy allylsilane reagent bearing C-Si chirality could direct 
stereoselectivity in the course of the Mukaiyama-type [3+2]-annulation to construct 
stereochemically well-defined and highly functionalized tetrahydrofurans. Moreover, the 
resulting furans, which bear versatile substituents, such as aldehyde and silane group, 
could be utilized as a valuable intermediate in the synthesis of complex molecules. 
Scheme 2.10 Our plan for the development of Mukaiyama-type [3+2]-annulation 
methodology for highly functionalized tetrahydrofurans  
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Our study commenced with preparation of the anti- and syn-ethoxy allylsilanes, anti-
3 and syn-3, from the known epoxy silanes syn- and anti-5 (Scheme 2.11).14 The 
annulation substrate anti-3 was synthesized through epoxide opening of cis-5, which was 
previously prepared through epoxidation of a (Z)-allylic alcohol and enzymatic resolution. 
The substrate cis-5 was then exposed to an ethoxy ethynyllithium, which was generated 
in situ by treating ethyl ethynyl ether with n-BuLi, to afford a propargyl silane anti-6 with 
inseparable byproducts. Partial reduction of the alkyne in anti-6 to a (Z)-olefin was 
conducted utilizing Lindlar catalyst (10 wt%) to provide the pure annulation substrate 
anti-3 after column chromatography.  
 
 
OMe
OEt SiMe2Ph
OH
OMePhMe2Si
O
OEt
OMe
SiMe2Ph
OHEtO
anti-3cis-5 anti-6
OMe
SiMe2Ph
OH
OEt
PhMe2Si OMe
O OMe
SiMe2Ph
OHEtO
syn-3trans-5 syn-6
aReagents & conditions; a) n-BuLi, BF3 OEt2, Et2O, -78 oC; b) H2, pyr., Lindlar cat., EtOAc, rt,
80% (2 steps) for anti-6, 94% for syn-6; c) n-BuLi, BF3 OEt2, Me3Al, Et2O, -78 oC, 85%
OEt
a)
c) b)
b)
 
 
Similarly, the syn-3 was also prepared through epoxide opening of trans-epoxide 
trans-5 and subsequent Lindlar reduction of the resulting propargylic silane syn-6. It was 
known that a trans-epoxide is less labile to the epoxide opening reaction of a nucleophile. 
As expected, the same reaction conditions, which were previously used in the epoxide 
Scheme 2.11 Preparation of ethoxy allylsilanes anti- and syn-3a 
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opening reaction of the cis-epoxide, were shown to be inapplicable in this case. Therefore, 
the epoxide opening utilizing a AlMe3-BF3·OEt2 mixture to form the more reactive 
ethynyl aluminum ate complex effectively proceeded to afford the annulation substrate 
syn-3 as a single regioisomer.39 
After establishing a practical preparation of anti- and syn-3, the proposed 
Mukaiyama-type [3+2]-annulation was investigated under various Lewis and Brönsted 
acid conditions to establish an optimal condition. Following Hoppe’s examples, our 
investigation began with the use of BF3·OEt2 in CH2Cl2 at -50 
oC (Table 2.1, entry 1), 
which provided the desired tetrahydrofuran 4a in high yield and excellent 
diastereoselectivity (> 20:1). When the reaction was scaled up to multigram scale, 
Table 2.1 Optimization of [3+2]-annulation conditions 
SiMe2Ph
OH
OEt
Acids
CH2Cl2
temp
temp.(oC) yieldb
-50 oC
entrya
1
2
67%
4
aThe reactions run in 0.3M solution of ethoxyl allyl silane ant i-3 in CH2Cl2.
b Purification yield after SiO2 column chromatography.
OMe
3
CHO
Br
+
O
O
H
Br OMe
SiMe2Ph
5
6
7
BF3 OEt (2.0)
58%Sc(OTf)3 (0.5) 0 oC to rt
0 oC 30%In(OTf)3 (0.5)
57%
57%
TCA (1.0)
TFA (1.0)
53%
CSA (1.0)
87%PTSA(1.0)
0 oC
0 oC
0 oC
0 oC
acids (equiv) dr
> 20:1
> 20:1
> 20:1
> 20:1
> 20:1
> 20:1
> 20:1
anti-3 7a
4a
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however, the same result was not reproducible and resulted in a low yield (~20%). The 
reactions utilizing other Lewis acids, such as In(OTf)3 and Sc(OTf)3, proceeded with high 
diastereoselectivities, but gave low yields (entry 2, 3).  
Various Brönsted acids were also evaluated (Table 2.1, entry 4-7). The series of 
reactions using trichloroacetic acid (TCA), TFA, and camphorsulfonic acid (CSA) 
provided the tetrahydrofuran 4a in moderate yield. Fortunately, the optimal conditions 
were found utilizing 1.0 equiv of PTSA at 0 oC, which gave 4a in 87% with high levels of 
diastereoselectivity in a short reaction time (10 min). The relative stereochemistry of the 
tetrasubstituted tetrahydrofuran 4a was determined by NOE analysis, which clearly 
confirmed the expected cis-trans-cis relationship among the alkyl and silane substituents. 
 
 
 
Table 2.2 [3+2]-Annulation reaction of anti-3 with various aldehydesa 
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With optimized reaction conditions in hand, a number of different aldehydes were 
evaluated to explore the reaction scope of the Mukaiyama-type [3+2]-annulation of syn-3. 
Aliphatic aldehydes and anti-3 were effective reaction partners in the [3+2]-annulation 
giving good yields and diastereoselectivities (Table 2.2). Reaction conditions required for 
the annulation are compatible with a wide range of functional group such as alkenes and 
cycloalkanes. In addition, -branched aldehydes 7c and cyclopropanecarboxylic 
aldehydes 7d underwent annulation without any attenuation of yield and 
diastereoselectivity. Some aromatic aldehydes were also effective reaction partners in this 
annulation. Additionally, functional groups in aromatic aldehydes were tolerated under 
the given reaction conditions. It is noteworthy that unsaturated aldehyde 7a (Table 2.1) 
Table 2.3 [3+2]-Annulation reaction of syn-3 with various aldehydesa 
aReactions were carried under 0.3 M concentration and 2.0 equiv of aldehydes and 1.0 equiv
of acids were used.
H
O
H
O
H
O
H
O
H
O
H
O
OMe
OEt SiMe2Ph
OH
OMe
O
H
O
R
SiMe2Ph
OMeMeSO3H
CH2Cl2, 0
oC
10 min
89%
dr = 6:1
83%
dr > 20:1
70%
dr > 20:1
74%
dr = 3:1
86%
dr = 6:1
76%
dr > 20:1
H
O
96%
dr > 20:1
H
O
84%
dr > 20:1
syn-3
cis-tr ans-cis-furan
8 (b-i)
7b
7e
7h 7i
7f
7c 7d
7g
Br
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was able to serve as an efficient annulation partner to give a tetrahydrofuran without 
erosion of yield and diastereoselectivity, which is one of the limitations found in our 
silicon-directed [4+2]-annulation reactions. 
Annulation of syn-3 was also investigated utilizing the same array of aldehydes used 
in the annulations of anti-ethoxy allylsilane anti-3 (Table 2.3). In this series of reactions, 
the annulations utilizing MeSO3H consistently resulted in superior yields and 
diastereoselectivities (up to 96%, 20:1 dr) relative to those using PTSA, and the expected 
cis-trans-cis tetrahydrofurans 8 were produced as a major diastereomer. Similarly, 
aromatic aldehydes (7f-7i) turned out to be excellent reaction partners in the annulation 
of syn-ethoxy allylsilane syn-3, which furnished tetrahydrofurans 8f-8i with high yields 
and diastereoselectivities. In the case of aliphatic aldehydes (7b, 7c, and 7e), however, 
the annulations took place with an attenuation of diastereoselectivity although providing 
the desired product (8a, 8b, and 8e) in a useful level of yield. 
The majority of the annulations proceeded with high levels of yields and 
stereoselectivities, which demonstrates that the configuration of the C-SiR3 bond 
functions as a reliable directing group in the Mukaiyama-type [3+2]-annulation. 
Transition state analysis was deduced from the stereochemical outcome of the resulting 
furans of the [3+2]-annulations of anti- and syn-ethoxy allylsilane 3. As reported in 
Hoppe’s earlier study,35 the annulations seemed to proceed through a chair-like transition 
state in which a bulky silane group is positioned at the pseudo-equatorial orientation and 
the enol ether is oriented in a way to miminize a possible A1,3-allylic strain between the 
R3Si and OEt groups. 
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In the proposed transition state of annulations with anti-3, all substituents, the silane, 
methoxy methylene, and enol ether groups, are positioned in a pseudo-equatorial 
orientation to minimize potential diaxial interactions (Figure 2.2). Therefore, TS-1, which 
is responsible for the trans-trans-cis furan, is mostly favored in the transition state of this 
annulation. Actually, there would be little chance that TS-1 is able to flip to its less 
favored transition state TS-2 because of a destabilizing 1,3-diaxial interaction between H 
and R. For this reason we postulated, annulation of the anti-ethoxy silane anti-3 with an 
aliphatic or aromatic aldehyde provides the trans-trans-cis furan 4 with good to excellent 
levels of yield and diastereoselectivity. 
 
 
 
 
Although simultaneous equatorial substitutions of both of the silyl and methoxy 
methylene group are conformationally incompatible, in the case of syn-3, equatorial 
orientation of the bulky silane group would be still favored to form the more stable TS-3 
Figure 2.2 Transition state of [3+2]-annulation of anti-3 
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(Figure 2.3). Accordingly, it would allow more flexibility to be partially equilibrated with 
the less stable TS-4. Although relative stereochemistries of the minor isomers are still 
ambiguous due to purification issues, we envision that TS-4 may be responsible for the 
formation of the minor diastereomer resulting in a cis-trans-trans furan. The observed 
attenuation of diastereoselectivity in the reactions of aliphatic aldehydes can be 
rationalized by the flexibility of the illustrated transition state.  
 
 
 
 
However, the transition state may be stabilized by a presumable -stacking 
interaction between the enol ether and aryl group to form a more rigid transition state. In 
the annulations utilizing an aromatic aldehyde as the annulation partner (Table 2.3, 7f-7i), 
the observed high levels of diastereoselectivities may give support to this possible -bond 
interaction. Additionally, it is known that C-C bond of cyclopropane has sp2 character in 
its carbocycle since the ring strain in cyclopropane forces the bonding orbital to distort to 
Figure 2.3 Transition state of [3+2]-annulation of syn-3 
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form a 104o angle.40 The observed preservation of diastereoselectivity in the reaction 
with cyclopropanecarboxaldehyde 7d also supports a possible stabilization raised from a 
-bond interaction in the transition state (Table 2.3, 7d).     
 
2.4 Conclusion 
We have developed a silicon-directed Mukaiyama-type [3+2]-annulation to construct 
highly functionalized tetrahydrofurans. This reaction displays remarkable compatibility 
with various aromatic and aliphatic aldehydes, and would provide highly diversified 
access to a wide range of useful hydrofurans. In addition, this methodology could be 
extended to the synthesis of functionalized furan core in the total synthesis of furan-
containing natural products and bioactive molecules. 
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2.5 Experimental section 
 
(2S,3R,Z)-3-(dimethyl(phenyl)silyl)-5-ethoxy-1-methoxypent-4-en-2-ol (anti-3) A 
solution of ethoxy acetylene (50 wt. % in hexane, 2.5 mL, 12.8 mmol) in diethyl ether 
(60 mL) was cooled to -78 oC under Ar. n-BuLi (2.5 M in hexane, 5.1 mL, 12.8 mmol) 
was added dropwise and stirring was continued at -78 oC for 1 hr. A solution of cis-514 
(1.91 g, 6.75 mmol) in ethyl ether (20 mL) and BF3·OEt2 (1.7 mL, 13.5 mmol) were 
successively added. After 30 min at -78 oC, sat’d-NaHCO3 (80 mL) was added and 
stirring was continued for 15 min warming up to rt. Ethyl acetate (80 mL) was added and 
the resulting layers were separated and the aqueous phase was extracted with ethyl 
acetate (2 x 50 mL). The combined organic phases were dried over magnesium sulfate, 
filtered, and concentrated in vacuo to obtain an oil. Purification over silica gel with 
hexane/ethyl acetate (10/1) afforded an inseparable mixture of anti-6 and unidentified 
byproduct (2.25 g). 
1H NMR (CDCl3, 500 MHz): δ 7.58-7.56 (m, 2H), 7.35-7.31 (m, 3H), 4.00 (q, J = 7.0 
Hz, 2H), 3.73 (m, 1H), 3.38 (dd, J = 7.0, 9.5 Hz, 1H), 3.30 (dd, J = 5.0, 9.5 Hz, 1H), 3.27 
(s, 3H), 2.07 (d, J = 3.0 Hz, 1H), 2.02 (d, J = 7.0 Hz, 1H), 1.30 (t, J = 7.5 Hz, 3H), 0.42 
(s, 3H), 0.41 (s, 3H) 
 
To a solution of impure anti-6 (2.25g, 7.69 mmol) and pyridine (1.3 mL, 15.4 mmol) in 
ethyl acetate (50 mL) was added Lindlar’s catalyst (157 mg). The air in the reaction 
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vessel was substituted with H2 gas under vacuum and stirring was continued for 1 hr. The 
mixture was then filtered through a pad of Celite®, and the solution was concentrated 
under reduced pressure to give a yellow residue. Purification over silica gel with 
hexane/ethyl acetate (10/1) afforded pure anti-3 as a clear oil (2 g, 80 %, two steps): 
1H NMR (CDCl3, 500 MHz): δ 7.57-7.55 (m, 2H), 7.32-7.29 (m, 3H), 5.99 (d, J = 6.5, 
1H), 4.42 (dd, J = 5.2, 11.0 Hz, 1H), 3.85 (m, 1H), 3.66 (qd, J = 4.5, 22.5 Hz, 2H), 3.28-
3.20 (m, 2H), 3.25 (s, 3H), 2.36 (dd, J = 1.0, 3.5 Hz, 1H), 2.30 (dd, J = 3.5, 10.5, 1H), 
1.15 (t, J = 7.0 Hz, 3H), 0.34 (s, 3H), 0.30 (s, 3H); 13C NMR (CDCl3, 75 MHz): δ 144.3, 
138.4, 134.0, 128.7, 127.4, 101.9, 77.0, 69.9, 67.2, 58.6, 28.4, 15.1, -3.5, -3.9; IR (film) 
υmax: 3465.8, 2976.8, 2895.3, 1652.7, 1427.1, 1251.8 cm
-1;  
 
 
(2S,3S)-3-(dimethyl(phenyl)silyl)-5-ethoxy-1-methoxypent-4-yn-2-ol (syn-6) A 
solution of ethoxy acetylene (40 wt. % in hexane, 3.2 mL, 13.5 mmol) in diethyl ether 
(25 mL) was cooled to -78 oC under Ar. n-BuLi (2.5 M in hexane, 5.4 mL, 13.5 mmol) 
was added dropwise and stirring was continued at -78 oC for 1 hr. Me3Al (2M in heptane, 
6.75 mL, 13.5 mmol) and a solution of trans-514 (1.5 g, 6.75 mmol) in ethyl ether (9 mL) 
were added followed by BF3·OEt2 (1.7 mL, 13.5 mmol). After 30 min at -78 
oC, sat’d-
NaHCO3 (34 mL) was added and stirring was continued for 15 min warming up to rt. 
Ethyl acetate (50 mL) was added and the resulting layers were separated and the aqueous 
phase was extracted with ethyl acetate (2 x 50 mL). The combined organic phases were 
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dried over magnesium sulfate, filtered, and concentrated in vacuo to obtain an oil. 
Purification over silica gel with hexane/ethyl acetate (10/1) afforded syn-6 as a yellowish 
oil (1.67 g, 85 %): 
1H NMR (CDCl3, 400 MHz): δ 7.65-7.63 (m, 2H), 7.37-7.34 (m, 3H), 3.95 (q, J = 6.8 
Hz, 2H), 3.79-3.73 (m, 1H), 3.57 (dd, J = 2.8, 9.6 Hz, 1H), 3.38 (dd, J = 7.6, 9.6 Hz, 1H), 
3.33 (s, 3H), 2.55 (d, J = 4.8 Hz, 1H), 2.11 (d, J = 8.8 Hz, 1H), 1.29 (t, J = 6.8 Hz, 3H), 
0.47 (s, 3H), 0.46 (s, 3H); 13C NMR (CDCl3, 100 MHz): δ 137.5, 134.0, 128.9, 127.4, 
92.2, 76.4, 58.7, 35.3, 22.3, 14.2, -3.2, -3.3; IR (film) υmax: 3453.4, 2896.6, 2258.3, 
1427.5, 1247.1 cm-1; 
 
 
(2S,3S,Z)-3-(dimethyl(phenyl)silyl)-5-ethoxy-1-methoxypent-4-en-2-ol (syn-3) To a 
solution of syn-6 (1.57g, 5.37 mmol) in ethyl acetate (50 mL) was added Lindlar’s 
catalyst (157 mg). The air in the reaction vessel was substituted with H2 gas under 
vacuum and stirring was continued for 6 hr. The mixture was then filtered through a pad 
of Celite®, and the solution was concentrated under reduced pressure to give a yellow 
residue. Purification over silica gel with hexane/ethyl acetate (10/1) afforded syn-3 as a 
clear oil (1.45 g, 92 %): 
1H NMR (CDCl3, 500 MHz): δ 7.57-7.55 (m, 2H), 7.31-7.29 (m, 3H), 5.91 (d, J = 6.5 
Hz, 1H), 4.10 (dd, J = 6.0, 11.0 Hz, 1H), 3.75-3.71 (m, 1H), 3.66 (qd, J = 4.0, 22.0 Hz, 
2H), 3.15 (t, J = 9.0 Hz, 1H), 2.44 (dd, J = 9.0, 11.0 Hz, 1H), 2.32 (d, J = 3.5 Hz, 1H), 
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1.16 (t, J = 7.0 Hz, 3H), 0.35 (s, 3H), 0.32 (s, 3H); 13C NMR (CDCl3, 75 MHz): 144.4, 
135.5, 134.0, 128.5, 127.2, 103.3, 76.9, 71.9, 67.2, 58.6, 29.3, 15.1, -2.81, -3.34; IR 
(film) υmax: 3461.6, 2977.5, 2894.0, 1653.5, 1245.8 cm
-1;  
 
General procedure for silyl-directed Mukaiyama-type [3+2]-annulation of anti-3 
 
Ethoxy allyl silane anti-3 (1.0 equiv) and aldehyde 7 (2.0 equiv) were added into a round 
bottom flask followed by methylene chloride (0.3M concentration). The reaction was 
cooled to 0 °C and PTSA monohydrate (1.0 equiv) was added in one portion. The 
solution was allowed to stir for 10 min at 0 °C before quenching with sat’d-NaHCO3 
solution. Upon warming to room temperature, the layers were separated and the aqueous 
phase was extracted with ethyl acetate. The combined organic phases were dried over 
magnesium sulfate, filtered, and concentrated in vacuo to obtain an oil. Purification over 
silica gel with hexane/ethyl acetate (20/1 to 10/1 gradient elution) afforded a furan 4 as a 
clear oil :  
 
(2R,3R,4R,5S)-2-(2-bromostyryl)-4-(dimethyl(phenyl)silyl)-5-
(methoxymethyl)tetra-hydrofuran-3-carbaldehyde (4a) Aldehyde 
7a was used following the general procedure. Furan 4a was obtained 
as a clear oil (87 % yield). 
O
O
H
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1H NMR (CDCl3, 500 MHz): δ 9.53 (d, J = 3.5 Hz, 1H), 7.50-7.48 (m, 3H), 7.40-7.35 
(m, 4H), 7.29 (dt, J = 1.0, 7.5 Hz, 1H), 7.07 (dt, J = 2.0, 8.0 Hz, 1H), 6.97 (d, J = 16.0 
Hz, 1H), 6.09 (dd, J = 7.0, 16.0 Hz, 1H) 4.49 (td, J = 1.0, 7.5, 1H), 4.07 (ddd, J = 2.5, 
6.5, 8.5 Hz, 1H), 3.32 (ddd, J = 2.5, 10.5, 25.5 Hz, 2H), 3.29 (s, 3H), 3.01 (ddd, J = 3.5, 
7.0, 10.5 Hz, 1H), 1.92 (dd, J = 7.0, 9.5 Hz, 1H), 0.38 (s, 3H), 0.36 (s, 3H); 13C NMR 
(CDCl3, 75 MHz): δ 200.7, 136.0, 135.8, 133.7, 132.8, 131.7, 129.7, 129.1, 128.0, 127.8, 
127.4, 127.2, 123.6, 81.3, 81.2, 74.6, 59.2, 58.2, 28.0, -3.9, -4.6; IR (film) υmax: 2881.9, 
2729.4, 1719.9, 1466.8, 1428.4, 1254.1 cm-1; HRMS (CI, NH3) m/z calc’d for 
C23H28BrO3Si [M+H]
+ 481.0811, found: 481.0790 
 
(2R,3R,4R,5S)-2-butyl-4-(dimethyl(phenyl)silyl)-5-(methoxy-
methyl)-tetrahydrofuran-3-carbaldehyde (4b) Aldehyde 7b was 
used following the general procedure. Furan 4b was obtained as a clear oil (89 % yield). 
1H NMR (CDCl3, 500 MHz): δ 9.52 (d, J = 5.0 Hz, 1H), 7.47-7.45 (m, 2H), 7.37-7.32 
(m, 3H), 3.96 (ddd, J = 2.5, 6.5, 9.0 Hz, 1H), 3.60 (ddd, J = 6.0, 6.0, 8.0 Hz, 1H), 3.27-
3.19 (m, 2H), 3.25 (s, 3H), 2.68 (ddd, J = 4.5, 4.5, 6.0 Hz, 1H), 2.68 (ddd, J = 4.5, 4.5, 
6.0 Hz, 1H), 1.67 (dd, J = 4.5, 9.0 Hz, 1H), 1.65-1.60 (m, 1H), 1.54-1.47 (m, 1H), 1.40-
1.33 (m, 1H), 1.25-1.20 (m, 3H), 0.82 (t, J = 7.0 Hz, 3H), 0.33 (s, 3H), 0.32 (s, 3H); 13C 
NMR (CDCl3, 125 MHz): δ 201.8, 135.9, 133.7, 129.6, 128.0, 82.0, 80.3, 74.7, 59.2, 
56.3, 30.3, 28.6, 28.0, 22.4, 13.7, -4.1, -4.7; IR (film) υmax: 3069.8, 2955.9, 1718.7, 
1427.7, 1252.3, 1114.0 cm-1; HRMS (CI, NH3) m/z calc’d for C19H30O3Si [M+Na]
+ 
357.1862, found: 357.1852. 
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(2R,3R,4R,5S)-4-(dimethyl(phenyl)silyl)-2-isopropyl-5-(methoxy-
methyl)tetrahydrofuran-3-carbaldehyde (4c) Aldehyde 7c was used 
following the general procedure. Furan 4c was obtained as a clear oil (87 
% yield). 
1H NMR (CDCl3, 500 MHz): δ 9.53 (d, J = 5.4 Hz, 1H), 7.52-7.42 (m, 2H), 7.42-7.27 
(m, 3H), 3.95 (ddd, J = 8.5, 6.0, 2.4 Hz, 1H), 3.28 (dd, J = 10.7, 2.4 Hz, 1H), 3.26 (s, 
3H), 3.19 (dd, J = 10.7, 6.0 Hz, 1H), 3.11 (dd, J = 10.3, 5.5 Hz, 1H), 2.69 (td, J = 5.4, 3.5 
Hz, 1H), 1.84 (dp, J = 10.3, 6.5 Hz, 1H), 1.61 (dd, J = 8.6, 3.5 Hz, 1H), 0.97 (d, J = 6.4 
Hz, 3H), 0.81 (d, J = 6.7 Hz, 3H), 0.34 (d, J = 7.7 Hz, 6H); 13C NMR (CDCl3, 125 
MHz): δ 206.19, 138.59, 132.82, 93.27, 85.05, 81.81, 79.42, 64.09, 60.19, 33.80, 33.09, 
25.91, 23.30, 0.63, 0.00; IR (film) υmax: 3049.5, 2875.4, 1716.8, 1470.5, 1252.95 cm-1; 
HRMS (CI, NH3) m/z calc’d for C18H28O3Si [M+Na]
+ 343.1705, found: 343.1708. 
 
(2R,3R,4R,5S)-2-cyclopropyl-4-(dimethyl(phenyl)silyl)-5-(methoxy-
methyl)tetrahydrofuran-3-carbaldehyde (4d) Aldehyde 7d was used 
following the general procedure. Furan 4d was obtained as a clear oil (85 
% yield). 
1H NMR (CDCl3, 500 MHz): δ 9.70 (dd, J = 3.9, 0.6 Hz, 1H), 7.50-7.39 (m, 2H), 7.41-
7.26 (m, 3H), 3.92 (dddd, J = 9.5, 6.1, 2.8, 0.6 Hz, 1H), 3.27-3.23 (m, 5H), 0.31-0.29 (m, 
4H), 3.02 (dd, J = 9.1, 7.1 Hz, 1H), 1.84 (ddd, J = 9.5, 6.4, 0.6 Hz, 1H), 0.32-0.29 (m, 
7H), 2.82 (dddd, J = 7.0, 6.3, 3.9, 0.6 Hz, 1H), 0.91-0.82 (m, 1H), 0.63-0.54 (m, 1H), 
0.48 (ddd, J = 9.2, 8.4, 5.5 Hz, 1H), 0.39-0.32 (m, 2H), 0.38-0.32 (m, 2H), 0.32 (s, 3H), 
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0.30 (s, 3H), 0.17-0.10 (m, 1H); 13C NMR (CDCl3, 125 MHz): δ 201.46, 135.98, 133.77, 
129.60, 127.98, 86.14, 80.67, 74.83, 59.16, 57.19, 27.66, 11.15, 5.29, 1.84, -4.06, -4.72; 
IR (film) υmax: 3048.1, 2884.05, 1718.9, 1456.50, 1252.6 cm-1; HRMS (CI, NH3) m/z 
calc’d for C18H26O3Si [M+Na]
+ 341.1549, found: 341.1538. 
 
(2R,3R,4R,5S)-2-cyclohexyl-4-(dimethyl(phenyl)silyl)-5-(methoxy-
methyl)tetrahydrofuran-3-carbaldehyde (4e) Aldehyde 7e was used 
following the general procedure. Furan 4e was obtained as a clear oil 
(82 % yield). 
1H NMR (CDCl3, 500 MHz): δ 9.53 (d, J = 5.4 Hz, 1H), 7.50-7.43 (m, 2H), 7.40-7.30 
(m, 3H), 3.93 (ddd, J = 8.5, 6.0, 2.5 Hz, 1H), 3.28 (dd, J = 10.7, 2.5 Hz, 1H), 3.26 (s, 
1H), 3.18 (ddd, J = 10.1, 9.2, 5.7 Hz, 3H), 2.69 (td, J = 5.4, 3.4 Hz, 1H), 2.06-1.94 (m, 
1H), 1.64-1.52 (m, 7H), 1.23-1.00 (m, 4H), 0.93-0.74 (m, 2H), 0.34 (d, J = 7.0 Hz, 6H); 
13C NMR (CDCl3, 125 MHz): δ 201.41, 135.96, 133.78, 129.64, 128.00, 87.03, 80.01, 
74.62, 59.28, 55.00, 38.18, 31.30, 28.55, 28.06, 26.14, 25.43, 25.21, -4.18, -4.82; IR 
(film) υmax: 2924.2, 2851.8, 1716.6, 1450.3, 1252.4 cm-1; HRMS (CI, NH3) m/z calc’d 
for C21H32O3Si [M+Na]
+ 383.2018, found: 383.2010. 
 
 (2S,3R,4R,5S)-4-(dimethyl(phenyl)silyl)-5-(methoxymethyl)-2-
phenyltetrahydrofuran-3-carbaldehyde (4f) Aldehyde 7f was used 
following the general procedure. Furan 4f was obtained as a clear oil 
(88 % yield).  
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1H NMR (CDCl3, 500 MHz): δ 8.99 (d, J = 3.5 Hz, 1H), 7.54-7.51 (m, 2H), 7.40-7.34 
(m, 3H), 7.29-7.19 (m, 5H), 4.83 (d, J = 7.5 Hz, 1H), 4.14 (ddd, J = 3.5, 5.5, 9.5 Hz, 1H), 
3.40-3.39 (m, 2H), 3.33 (s, 3H), 3.07 (ddd, J = 3.5, 5.5, 7.0 Hz, 1H), 1.94 (dd, J = 6.0, 9.5 
Hz, 1H), 0.39 (s, 3H), 0.37 (s, 3H); 13C NMR (CDCl3, 100 MHz): δ 200.8, 136.6, 135.8, 
133.85, 129.7, 128.4, 128.0, 127.8, 125.9, 82.1, 81.0, 74.6, 59.2, 58.1, 27.9, -3.9, -4.6; IR 
(film) υmax: 3068.3, 2878.2, 1719.6, 1427.4, 1252.5, 1110.9 cm-1; HRMS (CI, NH3) m/z 
calc’d for C21H26O3Si [M+H]
+ 355.1729, found: 355.1727. 
 
 (2S,3R,4R,5S)-4-(dimethyl(phenyl)silyl)-5-(methoxymethyl)-2-(p-
tolyl)tetrahydrofuran-3-carbaldehyde (4g) Aldehyde 7g was used 
following the general procedure. Furan 4g was obtained as a clear oil 
(84 % yield). 
1H NMR (CDCl3, 500 MHz): δ 9.01 (dd, J = 3.8, 0.7 Hz, 1H), 7.55-7.49 (m, 2H), 7.42-
7.33 (m, 3H), 7.15 (d, J = 8.0 Hz, 2H), 7.08 (d, J = 8.0 Hz, 2H), 4.82 (d, J = 7.4 Hz, 1H), 
4.16-4.09 (m, 1H), 3.42-3.37 (m, 2H), 3.33 (s, 2H), 3.04 (dtd, J = 7.4, 3.8, 1.9 Hz, 1H), 
2.28 (s, 3H), 1.93 (ddd, J = 9.5, 5.9, 1.0 Hz, 1H), 0.38 (d, J = 10.5 Hz, 6H); 13C NMR 
(CDCl3, 125 MHz): δ 200.98, 137.39, 135.94, 133.85, 133.61, 129.69, 129.09, 128.05, 
125.86, 82.10, 80.97, 74.66, 59.26, 58.09, 27.99, 21.07, -3.96, -4.66; IR (film) υmax: 
3047.6, 1715.51, 1515.8, 1455.1, 1252.8 cm-1; HRMS (CI, NH3) m/z calc’d for 
C22H28O3Si [M+Na]
+ 391.1705, found: 391.1700. 
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 (2S,3R,4R,5S)-4-(dimethyl(phenyl)silyl)-5-(methoxymethyl)-2-(2-
methoxyphenyl)tetrahydrofuran-3-carbaldehyde (4h) Aldehyde 7h 
was used following the general procedure. Furan 4h was obtained as a 
clear oil (71 % yield). 
1H NMR (CDCl3, 500 MHz): δ 9.00 (d, J = 3.5 Hz, 1H), 7.57-7.51 (m, 2H), 7.49 (ddd, J 
= 7.7, 1.8, 0.9 Hz, 1H), 7.42-7.35 (m, 3H), 7.23-7.14 (m, 1H), 6.94-6.85 (m, 1H), 6.79 
(dd, J = 8.2, 1.0 Hz, 1H), 5.03 (dd, J = 7.1, 0.9 Hz, 1H), 4.11 (ddd, J = 9.5, 5.7, 3.1 Hz, 
1H), 3.79 (s, 3H), 3.43-3.34 (m, 2H), 3.32 (s, 3H), 3.30-3.22 (m, 2H), 1.86 (dd, J = 9.5, 
5.9 Hz, 1H), 0.39 (d, J = 16.9 Hz, 6H); 13C NMR (CDCl3, 125 MHz): δ 201.14, 155.25, 
136.24, 133.89, 129.57, 128.53, 127.97, 126.39, 125.33, 120.53, 109.75, 80.47, 77.56, 
74.86, 59.25, 55.70, 55.24, 27.88, -3.91, -4.72; IR (film) υmax: 2979.7, 2837.0, 1719.4, 
1602.1, 1491.8, 1246.7 cm-1; HRMS (CI, NH3) m/z calc’d for C22H28O4Si [M+Na]
+ 
407.1655, found: 407.1661. 
 
 (2S,3R,4R,5S)-2-(2-bromophenyl)-4-(dimethyl(phenyl)silyl)-5-
(methoxymethyl)tetrahydrofuran-3-carbaldehyde (4i) Aldehyde 7i 
was used following the general procedure. Furan 4i was obtained as a 
clear oil (81 % yield).  
1H NMR (CDCl3, 500 MHz): δ 8.98 (d, J = 3.9 Hz, 1H), 7.51 (dd, J = 7.4, 1.9 Hz, 2H), 
7.45-7.31 (m, 5H), 7.18-7.11 (m, 2H), 4.78 (d, J = 7.4 Hz, 1H), 3.46-3.33 (m, 3H), 4.13 
(ddd, J = 9.5, 5.9, 2.5 Hz, 1H), 3.43-3.33 (m, 2H), 3.32 (s, 3H), 1.93 (dd, J = 9.5, 6.0 Hz, 
1H), 0.38 (d, J = 9.9 Hz, 6H); 13C NMR (CDCl3, 125 MHz): δ 200.46, 135.84, 135.70, 
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133.83, 131.58, 129.80, 128.11, 127.85, 127.71, 121.67, 103.07, 81.41, 81.23, 74.45, 
59.26, 58.02, 28.06, -3.99, -4.67; IR (film) υmax: 2979.7, 2884.7, 1718.9, 1488.1, 1399.5, 
1253.0 cm-1. HRMS (CI, NH3) m/z calc’d for C21H25BrO3Si [M+Na]
+ 455.0654, found: 
455.0649. 
 
General procedure for silyl-directed Mukaiyama-type [3+2]-annulation of syn-3 
 
Ethoxy allyl silane syn-3 (1.0 equiv) and aldehyde 7 (2.0 equiv) were added into a round 
bottom flask followed by methylene chloride (0.3M concentration). The reaction was 
cooled to 0 °C and methanesulfonic acid (1.0 equiv) was added in one portion. The 
solution was allowed to stir for 10 min at 0 °C before quenching with sat’d-NaHCO3 
solution. Upon warming to room temperature, the layers were separated and the aqueous 
phase was extracted with ethyl acetate. The combined organic phases were dried over 
magnesium sulfate, filtered, and concentrated in vacuo to obtain an oil. Purification over 
silica gel with hexane/ethyl acetate (20/1 to 10/1 gradient elution) afforded a furan 8 as a 
clear oil : 
 
(2S,3S,4S,5S)-2-butyl-4-(dimethyl(phenyl)silyl)-5-(methoxy-
methyl)tetrahydrofuran-3-carbaldehyde (8b) Aldehyde 7b was 
used following the general procedure. Furan 8b was obtained as a clear oil (89 % yield).  
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1H NMR (CDCl3, 500 MHz): δ 9.42 (d, J = 4.5, 1H), 7.48-7.35 (m, 2H), 7.35-7.30 (m, 
3H), 4.43 (ddd, J = 3.5, 6.0, 8.0 Hz, 1H), 4.21 (ddd, J = 4.5, 9.0, 9.0, 1H), 3.24 (dd, J = 
3.5, 10.0, 1H), 3.18-3.13 (m, 1H), 3.16 (s, 3H), 3.05 (ddd, J = 4.5, 9.0, 13.5 Hz, 1H), 2.21 
(dd, J = 8.5, 9.0 Hz, 1H), 1.57-1.49 (m, 1H), 1.45-1.40 (m, 2H), 1.29-1.24 (m, 3H), 0.84 
(t, J = 7.5 Hz, 3H), 0.34 (s, 3H), 0.39 (s, 3H); 13C NMR (CDCl3, 125 MHz): δ 202.5, 
137.3, 133.6, 129.3, 127.9, 80.6, 80.5, 74.0, 58.6, 56.3, 31.4, 30.8, 28.7, 22.6, 13.8, -2.4, -
3.1; IR (film) υmax: 3069.5, 2929.8, 1719.8, 1427.7, 1251.5, 1111.7 cm-1; HRMS (CI, 
NH3) m/z calc’d for C19H30O3Si [M+H]
+ 357.1862, found: 357.1857. 
 
 (2S,3S,4S,5S)-4-(dimethyl(phenyl)silyl)-2-isopropyl-5-(methoxy-
methyl)tetrahydrofuran-3-carbaldehyde (8c) Aldehyde 7c was used 
following the general procedure. Furan 8c was obtained as a clear oil (74 
% yield). 
1H NMR (CDCl3, 500 MHz): δ 9.52 (dd, J = 5.0, 0.6 Hz, 1H), 7.52-7.42 (m, 2H), 7.38-
7.31 (m, 3H), 4.46 (ddd, J = 8.3, 6.3, 3.7 Hz, 1H), 3.73 (dd, J = 9.1, 7.2 Hz, 1H), 3.26 
(dd, J = 10.3, 3.7 Hz, 1H), 1.89-1.77 (m, 1H), 3.22-3.18 (m, 1H), 3.18 (s, 3H), 2.97 (td, J 
= 7.0, 5.0 Hz, 1H), 2.14 (dd, J = 8.4, 6.9 Hz, 1H), 1.91-1.74 (m, 1H), 0.97 (d, J = 6.5 Hz, 
3H), 0.87 (d, J = 6.6 Hz, 3H), 0.36 (s, 3H), 0.29 (s, 3H); 13C NMR (CDCl3, 125 MHz): δ 
201.74, 137.47, 133.59, 129.36, 127.92, 86.11, 80.55, 73.85, 58.71, 56.01, 31.00, 29.24, 
20.26, 19.32, -2.18, -3.04; IR (film) υmax: 2958.9, 2890.5, 1718.1, 1470.4, 1389.5, 
1252.0 cm-1; HRMS (CI, NH3) m/z calc’d for C18H28O3Si [M+Na]
+ 343.1705, found: 
343.1819. 
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 (2S,3S,4S,5S)-2-cyclopropyl-4-(dimethyl(phenyl)silyl)-5-(methoxy-
methyl)tetrahydrofuran-3-carbaldehyde (8d) Aldehyde 7d was used 
following the general procedure. Furan 8d was obtained as a clear oil (96 
% yield). 
1H NMR (CDCl3, 500 MHz): δ 9.57 (d, J = 4.4 Hz, 1H), 7.50-7.46 (m, 2H), 7.37-7.31 
(m, 3H), 4.43 (ddd, J = 7.8, 5.3, 3.5 Hz, 1H), 3.59 (t, J = 8.9 Hz, 1H), 3.25-3.18 (m, 2H), 
3.12 (s, 3H), 2.36-2.31 (m, 1H), 0.88 (dddd, J = 12.5, 10.7, 6.1, 2.9 Hz, 1H), 0.66-0.56 
(m, 1H), 0.48-0.36 (m, 2H), 0.34 (s, 3H), 0.30 (s, 3H), 0.22-0.13 (m, 1H); 13C NMR 
(CDCl3, 125 MHz): δ 202.06, 137.27, 133.69, 129.35, 127.92, 85.12, 81.15, 74.45, 58.59, 
56.82, 31.12, 12.38, 4.92, 2.05, -2.45, -3.22; IR (film) υmax: 2980.3, 2828.2, 1772.0, 
1394.9, 1251.8 cm-1; HRMS (CI, NH3) m/z calc’d for C18H26O3Si [M+Na]
+ 341.1549, 
found: 341.1548. 
 
 (2S,3S,4S,5S)-2-cyclohexyl-4-(dimethyl(phenyl)silyl)-5-(methoxy-
methyl)tetrahydrofuran-3-carbaldehyde (8e) Aldehyde 7e was used 
following the general procedure. Furan 8e was obtained as a clear oil 
(86 % yield). 
1H NMR (CDCl3, 500 MHz): δ 9.52 (dt, J = 5.0, 0.9 Hz, 1H), 7.52-7.43 (m, 2H), 7.37-
7.30 (m, 3H), 4.45 (ddd, J = 8.8, 6.4, 3.7 Hz, 1H), 3.77 (dd, J = 8.9, 7.1 Hz, 1H), 3.27-
3.22 (m, 1H), 3.21-3.17 (m, 1H), 3.17 (s, 3H), 2.96 (td, J = 6.9, 5.0 Hz, 1H), 2.11 (ddd, J 
= 7.6, 6.5, 1.0 Hz, 1H), 1.95-1.88 (m, 1H), 1.71-1.57 (m, 5H), 1.22-1.07 (m, 4H), 0.35 (s, 
3H), 0.29 (s, 3H); 13C NMR (CDCl3, 125 MHz): δ 201.68, 137.46, 133.57, 129.35, 
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127.95, 85.10, 80.38, 73.79, 58.74, 55.76, 38.72, 30.76, 30.49, 29.55, 26.22, 25.65, 25.49, 
-2.14, -3.02; IR (film) υmax: 2924.0, 2852.2, 1718.5, 1450.2, 1251.8, 1110.6 cm-1. 
 
 (2R,3S,4S,5S)-4-(dimethyl(phenyl)silyl)-5-(methoxymethyl)-2-
phenyltetrahydrofuran-3-carbaldehyde (8f) Aldehyde 7f was used 
following the general procedure. Furan 8f was obtained as a clear oil 
(83 % yield). 
1H NMR (CDCl3, 500 MHz): δ 8.65 (d, J = 4.5, 1H), 7.51-7.48 (m, 2H), 7.36-7.33 (m, 
3H), 7.30-7.27 (m, 2H), 7.25-7.19 (m, 3H), 5.40 (d, J = 9.0, 1H), 4.68 (ddd, J = 3.5, 5.0, 
8.0 Hz, 1H), 3.40 (ddd, J = 4.5, 9.0, 11.0 Hz, 1H), 3.35 (dd, J = 3.5, 10.0 Hz, 1H), 3.25 
(dd, J = 5.0, 10.0 Hz, 1H), 3.19 (s, 3H), 2.34 (dd, J = 8.0, 10.5 Hz, 1H), 0.37 (s, 3H), 0.31 
(s, 3H); 13C NMR (CDCl3, 100 MHz): δ 202.0, 138.1, 137.0, 133.7, 133.6, 129.4, 129.0, 
128.4, 127.9, 127.8, 127.7, 126.1, 82.2, 81.5, 74.4, 58.6, 57.8, 30.7, -2.4, -3.2; IR (film) 
υmax: 2923.3, 1719.6, 1427.4, 1251.5, 1111.0 cm-1; HRMS (CI, NH3) m/z calc’d for 
C21H26O3Si [M+Na]
+ 377.1549, found: 377.1555. 
 
 (2R,3S,4S,5S)-4-(dimethyl(phenyl)silyl)-5-(methoxymethyl)-2-(p-
tolyl)tetrahydrofuran-3-carbaldehyde (8g) Aldehyde 7g was used 
following the general procedure. Furan 8g was obtained as a clear oil 
(84 % yield). 
1H NMR (CDCl3, 500 MHz): δ 8.66 (d, J = 4.6 Hz, 1H), 7.54-7.48 (m, 2H), 7.37-7.32 
(m, 3H), 7.13 (d, J = 8.1 Hz, 2H), 7.09 (d, J = 7.7 Hz, 2H), 5.38 (d, J = 9.0 Hz, 1H), 4.68 
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(ddd, J = 8.1, 5.4, 3.6 Hz, 1H), 3.42-3.33 (m, 2H), 3.25 (dd, J = 10.1, 5.3 Hz, 1H), 3.20 
(s, 3H), 2.35 (dd, J = 10.8, 7.9 Hz, 1H), 2.29 (s, 3H), 0.37 (s, 3H), 0.31 (s, 3H); 13C NMR 
(CDCl3, 125 MHz): δ 202.18, 137.36, 137.09, 135.12, 133.71, 129.39, 129.13, 127.95, 
126.02, 82.12, 81.46, 74.45, 58.69, 57.83, 30.73, 21.06, -2.39, -3.20; IR (film) υmax: 
2980.0, 2829.4, 1718.5, 1427.5, 1251.5, 1111.3 cm-1; HRMS (CI, NH3) m/z calc’d for 
C22H28O3Si [M+Na]
+ 391.1705, found: 391.1694. 
 
 (2R,3S,4S,5S)-4-(dimethyl(phenyl)silyl)-5-(methoxymethyl)-2-(2-
methoxyphenyl)tetrahydrofuran-3-carbaldehyde (8h) Aldehyde 7h 
was used following the general procedure. Furan 8h was obtained as a 
clear oil (76 % yield). 
1H NMR (CDCl3, 500 MHz): δ 8.74 (d, J = 4.7 Hz, 1H), 7.54 (dd, J = 4.8, 2.5 Hz, 2H), 
7.50 (dd, J = 7.7, 1.9 Hz, 1H), 7.38 (s, 3H), 7.24 (td, J = 7.8, 1.9 Hz, 1H), 6.97 (t, J = 7.4 
Hz, 1H), 6.80 (d, J = 8.2 Hz, 1H), 5.62 (dd, J = 8.6, 2.4 Hz, 1H), 4.74-4.59 (m, 1H), 3.79 
(s, 3H), 3.50-3.42 (m, 1H), 3.36 (dd, J = 10.2, 3.5 Hz, 1H), 3.29 (ddd, J = 10.2, 6.1, 2.0 
Hz, 1H), 3.24 (s, 3H), 2.28-2.19 (m, 1H), 0.41 (s, 3H), 0.33 (s, 3H); 13C NMR (CDCl3, 
125 MHz): δ 201.55, 155.03, 137.24, 133.74, 129.33, 128.54, 127.90, 126.71, 126.57, 
120.54, 109.64, 81.60, 76.40, 74.12, 58.78, 56.21, 54.98, 30.52, -2.26, -3.14; IR (film) 
υmax: 2980.1, 2835.1, 1720.2, 1600.5, 1589.7, 1284.7 cm-1; HRMS (CI, NH3) m/z calc’d 
for C22H28O4Si [M+Na]
+ 407.1655, found: 407.1670. 
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 (2R,3S,4S,5S)-2-(2-bromophenyl)-4-(dimethyl(phenyl)silyl)-5-
(methoxymethyl)tetrahydrofuran-3-carbaldehyde (8i) Aldehyde 7i 
was used following the general procedure. Furan 8i was obtained as a 
clear oil (70 % yield). 
1H NMR (CDCl3, 500 MHz): δ 8.65 (d, J = 4.7 Hz, 1H), 7.52-7.45 (m, 2H), 7.44-7.39 
(m, 2H), 7.35 (dd, J = 5.0, 2.1 Hz, 3H), 7.15-7.10 (m, 2H), 5.35 (d, J = 9.0 Hz, 1H), 4.66 
(ddd, J = 8.3, 5.1, 3.4 Hz, 1H), 3.37-3.33 (m, 1H), 3.40 (ddd, J = 10.8, 9.0, 4.7 Hz, 1H), 
3.35 (dd, J = 10.2, 3.4 Hz, 1H), 3.24 (dd, J = 10.2, 5.2 Hz, 1H), 3.19 (s, 2H), 2.29 (dd, J = 
10.8, 7.9 Hz, 1H), 0.37 (s, 3H), 0.31 (s, 3H); 13C NMR (CDCl3, 125 MHz): δ 201.64, 
137.33, 136.84, 133.69, 131.58, 129.50, 128.00, 127.85, 121.62, 82.32, 80.96, 74.46, 
65.79, 58.70, 57.83, 30.94, 15.23, -2.48, -3.26; IR (film) υmax: 2980.1, 2831.0, 1718.5, 
1507.1, 1395.0, 1251.9 cm-1. 
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Chapter 3 
Total Synthesis of (+)-Isatisine A:  
Application of   
Silicon-Directed Mukaiyama-type [3+2]-
Annulation 
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3.1 Introduction 
The roots and leaves of Isatis indigotica Fort. (Cruciferae), a plant species widely 
cultivated in China and East Asia, have been traditionally used for treatment of viral 
diseases such as influenza, viral pneumonia, mumps, and hepatitis. In 2007, Chen and co-
workers reported the isolation of isatisine A (1), which was the only alkaloid among 12 
compounds isolated from I. Indigotica.1 Initially, it was isolated as its acetonide 
derivative 2, and the structure elucidation was established by 1D and 2D NMR 
experiments. Subsequent X-ray crystallographic analysis confirmed the structure 
assignment, as well as the relative and absolute stereochemistries.41  
 
 
Biological evaluation of the acetonide derivative 2 revealed that this material 
exhibited cytotoxicity against C8166 with CC50 = 302 μM and anti-HIV activity of EC50 
= 37.8 μM. However, its unusual dioxolane group that is rarely found in natural products 
led to further investigations to determine whether the acetonide derivative 2 was an 
artifact formed during the isolation processes using acetone as an eluent, which led to the 
natural product, isatisine A (1). Recently, the first total synthesis was achieved by Kerr 
Figure 3.1 Structure of isatisine A and its isopropylidenyl derivative  
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and revealed that the assignment of absolute configuration originally provided by Chen’s 
group is antipodal to the natural product.42a 
The challenging structural features of isatisine A (1) include a fused tetracyclic 
framework containing a densely substituted furan subunit and two fully substituted 
carbon centers (C2 and C9) embedded in the core. In addition, an indole branch forms the 
C-2 quaternary carbon center. Our interest in this alkaloid arose from its challenging 
tetracyclic skeleton, as well as its potent anti-HIV activity, and a successful approach to 
developing an efficient synthetic strategy would allow further SAR (structure-activity 
relationship) and SSAR (stereostructure activity relationship) studies. 
 
3.2 Total synthesis efforts of isatisine A 
Isatisine A has been an interesting target since it is considered a promising lead 
compound which exhibits anti-HIV activity as well as anti-viral properties. Also, its 
unique structure, which features a fused-tetracyclic skeleton and indole branch, give rise 
to lot of interests from synthetic chemists. In 2010, Kerr’s group reported the first total 
synthesis of (+)-isatisine A and revision of its absolute configuration.42a This was 
followed by the separated two total syntheses from Panek (2011)42b and Liang (2011)42c 
group. Recently, Xie (2012)42d has disclosed the biomimetic synthesis of isatisine A , and, 
shortly after, Ramana (2012)42e reported another synthesis of isatisine A and its 
derivatives utilizing various metal-mediated transformations. All of these efforts are 
characterized by their unique synthetic approaches to construct the highly substituted 
tetrahydrofuran core.  
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3.2.1 Kerr’s total synthesis of (+)-isatisine A 
In 2010, Kerr and coworker disclosed the first total synthesis of (+)-isatisine A 
utilizing Johnson’s tetrahydrofuran synthesis starting from a donor-acceptor 
cyclopropane and acid catalyzed indole addition (Scheme 3.1).42a Thus, Johnson’s 
cycloaddition of cyclopropane K2 with aldehyde K1 in the presence of Sn(OTf)2 
provided the tetrahydrofuran K3 in 89% yield as an 11:1 mixture of 2,5-cis;2,5-trans 
isomers. Oxidation of the tetrahydrofuran core was conducted under Pd-mediated 
decarboxylation conditions to afford dihydrofuran K4. Dihydroxylation of K4 
stereoselectively occurred from the less hindered -face of the olefin to introduce the 
required hydroxyl groups. The indole branch present in the natural product was installed 
through the oxidation of K6 using mCPBA, and subsequent indole addition furnished the 
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advanced intermediate K7. Finally, cleavage of the acetonide under acidic conditions 
successfully provided the synthetic isatisine A (1), which showed the opposite optical 
rotation of the reported value and further determined the absolute configuration of the 
natural isatisine A.  
 
3.2.2 Liang’s total synthesis of (-)-isatisine A 
Liang’s total synthesis of (-)-isatisine A featured an intramolecular C-glycosylation 
and oxidative ring contraction to construct the tetracyclic skeleton (Scheme 3.2).42c Aldol 
reaction of an enolate generated by treating L1 with LDA with the ketone L2, derived 
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from D-ribose, produced the adduct L3. Protection of the tertiary alcohol L3 as a benzoyl 
ester followed by the key intramolecular C-glycosylation in the presence of BF3·OEt2 
furnished L4 in a useful yield. Treatment of L4 with SeO2 afforded dicarbonyl compound 
L5, which underwent oxidative ring contraction in the presence of H2O2 to furnish 
tetracyclic skeleton L6. L7 was prepared from L6 through conventional transformations 
including hydrolysis and a deprotection-protection sequence. L7, which is similar to 
Kerr’s indole addition precursor, was further transformed to the natural product utilizing 
Kerr’s protocol. Therefore, mCPBA oxidation of L7 followed by indole addition of the 
resulting aminal L8 afforded the acetonide derivative of (-)-isatisine A (1), which was 
previously synthesized as an advanced intermediate in Kerr’s total synthesis. 
 
3.2.3 Xie’s total synthesis of (-)-isatisine A 
In 2012, Xie and coworkers reported a biomimetic total synthesis of (-)-isatisine A. 
They commenced the synthesis from the known compound X1, which was prepared from 
triacetyl-D-glucial in two steps.42d Coupling precursor X2 was prepared from X1 through 
a conventional protection and oxidation process. The key coupling of two fragments took 
place under Mannich reaction conditions. Thus, treatment of X2 with LDA and 
subsequent addition of the indole fragment X3 afforded an inseparable mixture of 
diastereomers X4, which possess all of the required carbons to be converted to the natural 
product. Treatment of X4 with HCl provided a separable 1:2 mixture of diastereomers X5 
and X6, which differ at the quaternary carbon center. Based on Kerr’s observation in 
which diastereoselectivity of the indole branch can be equilibrated to the desired product 
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under acidic conditions, they attempted to convert the major undesired diastereomer X6 
to (-)-isatisine A. Therefore, cleavage of the BOM protecting group, subsequent oxidation 
of the resulting alcohol, and benzylic ester rearrangement afforded X8. The tosyl group 
of X8 was cleaved under microwave-assisted conditions to increase nucleophilicity of the 
indole. Then CSA-mediated equilibrium to the thermodynamic diastereomer and 
concomitant lactamization accomplished (-)-isatisine A from X1 in 8 steps and 8.6% 
overall yield. 
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3.2.4 Ramana’s total synthesis of (-)-isatisine A 
To date, the latest total synthesis of (-)-isatisine A was reported by Ramana and 
coworkers utilizing a series of metal-mediated transformations.42e Starting material R1 
was prepared from D-ribose following established procedures. Aldol reaction of R1 with 
formaldehyde followed by protection as a TBS ether gave R2. The compound R3 was 
synthesized through addition of TMS-ethynyllithium to the lactone and subsequent 
Sonogashira coupling with 2-iodonitrobenzene. The key nitroalkyne cycloisomerization 
of R3 in the presence of Pd(MeCN)2Cl2 gave the isatogen R4 in 72%. Indole addition in 
the presence of InCl3 also subsequently reduced the N-O bond to form an indole adduct 
R5. Then oxidative lactamization of R5 utilizing [RhCp*Cl2]2 at 100 
oC furnished the 
advanced intermediate R6 in 56% yield. Finally, concomitant cleavage of benzyl and 
Scheme 3.4 Ramana’s total synthesis of (-)-isatisine A 
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acetonide protection using TiCl4 successfully completed the total synthesis of (-)-isatisine 
A. 
 
3.3 Total synthesis of (+)-isatisine A 
We described our successful development of a silyl-directed Mukaiyama-type [3+2]-
annulation to yield versatile tetrahydrofurans in Chapter 2. We believe that this 
annulation strategy would allow for more convenient and diversified approaches to the 
syntheses of tetrahydrofuran-containing natural products and bioactive molecules with 
high levels of stereocontrol. In this study, we decided to apply our [3+2]-annulation to the 
total synthesis of natural product in order to demonstrate its usefulness in the complex 
molecule synthesis. Thus, isatisine A (1) was selected as a target for our study based on 
the structural accessibility of the silyl-directed Mukaiyama-type [3+2]-annulation, as well 
as its interesting biological activities.   
 
3.3.1 First generation approach toward the total synthesis of (+)-isatisine A 
As previously stated, our synthetic plan described in Scheme 1, we intended to apply 
a Mukaiyama-type [3+2]-annulation of silane anti-6 with a suitably functionalized 
aldehyde to construct the tetrahydrofuran core. Subsequent use of a Cu(I)-mediated aryl 
amidation would assemble the tetracyclic skeleton of isatisine A.43 The retrosynthetic 
plan began with disconnection of C7a-N to afford an intermediate secondary amide 3. 
Further disconnection at the indole side chain C2-C3′ led to an indole and aminal 4, 
which would be furnished through a series of oxidations of the intermediate furan 5. The 
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tetrahydrofuran intermediate 5 would be constructed from a silyl-directed Mukaiyama-
type [3+2]-annulation of silane anti-6 with bromocinnamyl aldehyde 7. 
 
 
Our studies directed toward the total synthesis of isatisine A commenced with 
preparation of the tetrahydrofuran 4 through [3+2]-annulation of anti-6 with aldehyde 7 
as we described in the Chapter 2, which afforded the tetrahydrofuran 5 in 87% yield. The 
resulting tetrahydrofuran 5 was oxidized to an acid 8 upon exposure to Pinnick oxidation 
conditions, which was directly converted to amide 9 through activation of the acid as a 
mixed anhydride and subsequent amidation treating with ammonia gas. 44 
Dihydroxylation of the styrenyl olefin in 9 afforded the diol 10 as a mixture of 
diastereomers in 73% yield. At this point, the diastereoselectivity of the diol 10 was 
inconsequential because the stereocenters will be removed by oxidation in the next step 
to construct an aminal. Therefore, treatment of the diol 10 with NaOCl in the presence of 
Scheme 3.5 Retrosynthetic analysis of (+)-isatisine A 
 
 
85 
TEMPO provided the desired aminal in 64% as a 6:1 mixture of diastereomers, although 
its stereochemistry is still ambiguous.45    
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Substrate-controlled stereoselective indole addition to an aminal has been fully 
documented, and various practical conditions are available to date.46 Indole additions to 
an aminal generally proceed under various acidic conditions through elimination of the 
hydroxyl group resulting in the formation of an iminium ion, which subsequently 
undergoes nucleophilic indole addition from the less hindered face to give an indole 
adduct with stereocontrol. In our case, it was envisioned that stereoselectivity would be 
determined by the difference in steric hindrance between the convex and concave face of 
cyclic aminal 4, and, consequently, the indole would approach from the less hindered 
convex face to give an -indole branch with the desired diastereoselectivity.  
Scheme 3.6 Preparation of intermediate aminal 4a 
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Our investigation for indole addition was also conducted utilizing various Brönsted 
and Lewis acids shown in Table 3.1. Initially, PTSA and CSA were used because they are 
the most common catalysts in indole additions. However, it turned out that the use of 
Brönsted acids gave disappointing results (entry 1-3). The reaction utilizing Sc(OTf)3 
afforded mostly starting aminal with trace amount of the desired indole adduct (entry 4). 
Fortunately, further investigation utilizing 2.0 equiv of In(OTf)3 gave useful amounts of 
indole adduct 3 with some unreacted starting material. Increasing the amount of In(OTf)3 
up to 4.0 equiv provided the desired indole adduct 3 in 70% yield as a single 
diastereomer (entry 6). 
 
 
Table 3.1 Indole addition of aminal 4 under acidic conditions  
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With the indole adduct 3 in hand, construction of the tetracyclic framework of 
isatisine A was conducted under modified amidation conditions originally developed by 
Buchwald.43 Previously, Cu-mediated amidation was studied in our group as a potential 
tool for macrocyclization and was used for the formation of macrolactones in the 
synthesis of the ansamycins, reblastatin and geldanamycin.44 In the present case, upon 
exposure of 3 to the modified Cu-mediated amidation conditions, the tetracyclic 
intermediate 11 was successfully generated in 90% yield. 
 
 
At this point, a series of oxidations at C9 and C13 to the required oxidation state 
were necessary to complete the total synthesis of (+)-isatisine A. Initially, oxidation of 
the silyl group to a hydroxyl group with retention of stereochemistry was investigated 
Scheme 3.7 Oxidation of 11 to (+)-isatisine A (1)a  
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under various Tamao-Fleming conditions to produce the hydroxyl furan 12.47 However, 
this series of oxidations gave unidentifiable byproduct, which may have arised from 
electrophilic aromatic substitutions on the indole or indolone core of the intermediate 11.  
Alternatively, isatisine A could be accessible through an oxidation at C9 to give -
hydroxyl amide 13 and a Peterson elimination followed by dihydroxylation. To this end, 
13 was exposed to various different -hydroxylation conditions utilizing strong bases, 
such as LDA, lithium diethylamide, and KHMDS.48 Surprisingly, the intermediate 11 
was completely unreactive under given conditions, and the starting material was always 
recovered. In order to test the acidity of 11, it was treated with strong bases, and the 
resulting potential anion was quenched with D2O. However, no incorporation of 
deuterium at C9 was observed, which confirmed that the acidity at C9 is significantly 
decreased in this system since the bulky dimethylphenyl silane group is aligned with the 
C-H bond at C9 to block the trajectory of base toward deprotonation.  
While intermediate 11 was efficiently synthesized from tetrahydrofuran 5 with 
minimal protection-deprotection steps, further transformations of 11 to the natural 
product under various oxidation conditions turned out to be problematic. Considering 
these issues in the oxidation steps, an alternative approach was developed to synthesize 
(+)-isatisine A. 
 
3.3.2 Second generation approach toward the total synthesis of (+)-isatisine A 
Since we had trouble in the late stage oxidation in our first approach, our modified 
synthetic strategy for isatisine A will be relied on an early stage oxidation of furan 5 to 
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intermediate 15, which would satisfy all required oxidation states present in isatisine A. 
In the course of [3+2]-annulation reaction, the dimethylphenyl silane group proved to be 
a useful directing group, which successfully transferred its C-Si centered chirality to the 
product furan with high levels of selectivity. However, it also revealed that direct 
oxidation of the silane group to a hydroxyl group was troublesome under Tamao-Fleming 
conditions. Meanwhile, a silane group is also known to undergo elimination arising from 
its -donating character to afford an olefin when a halogen group is on the adjacent 
carbon. Thus, elimination of the silane group and subsequent oxidation of the resulting 
alkene could serve as an alternative route for the direct oxidation of the silane group to 
hydroxyl groups at C9 and C13.  
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In this strategy (Scheme 3.8), the silane group will be removed in an early stage to 
give an unsaturated aldehyde 14. Through a series of oxidations of 14 involving 
Scheme 3.8 Revised strategy of the total synthesis of (+)-isatisine A (1) 
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dihydroxylation of the olefin and oxidation of the resulting diol, we would construct 
aminal 15. Indole addition will take place under acidic conditions with a substrate 
controlled facial selectivity as described in the first generation of synthesis. Then the total 
synthesis of (+)-isatisine A (1) will be achieved by an intramolecular copper-mediated 
amidation and subsequent deprotections. 
Our revised strategy began with the oxidation of tetrahydrofuran 5 to the 
dihydrofuran 17 (Scheme 3.9). On that account, selective -bromination of aldehyde 5 in 
the presence of the styrene-like olefin was conducted using PTAB 
(phenyltrimethylammoniumtribromide), which was directly treated with TBAF at 0 °C to 
form an unsaturated aldehyde 14 (shown in scheme 3.8).49 The resulting unstable 
intermediate 14 was immediately subjected to oxidation with MnO2 in the presence of 
NaCN to afford the unsaturated methyl ester 17 in 57% yield from tetrahydrofuran 5.50  
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Scheme 3.9 Preparation of lactone 21a 
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At this point, transformation of 17 to the desired lactone 21 seemed to require 
dihydroxylation and careful manipulations for the selective protection of the intermediate 
tetraol. We envisioned that concomitant dihydroxylation of both olefins in 17 would 
allow direct access to the lactone 20 through a lactonization of the resulting tetraol 18, 
which can be simply transformed to 21 by an acetonide protection. To this end, both the 
styrene-like olefin and unsaturated ester were concomitantly oxygenated by a catalytic 
OsO4 dihydroxylation using an excess amount of NMO, which afforded tetraol 18 as a 
1.5:1 mixture of diastereomers arising from the benzylic 1,2-diol. The tetraol 18 was 
treated with a range of acids and bases in attempt to induce lactonization as a self 
protection method of the benzylic 1,2-diol. However, all trials to produce lactone 20 from 
the tetraol 18 turned out to be problematic and usually showed no reaction. Although it is 
still unclear what disturbs the lactonization of 18, it seems that potentially complex 
hydrogen bonding between diols may result in the attenuation of nucleophilicity of the 
hydroxyl group. 
We also attempted a cascade-like acetonide protection and lactonization as an 
alternative pathway to a direct lactonization of 18 (Scheme 3.10). In this reaction, we 
thought that isopropylidene protection could be completely reversible process to form the 
acetonide protection and to cleave it back to diol. Thus, upon exposure of 19 to 
isopropylidenyl protection conditions, acetonide protection of both diols will first take 
place to give 23. Then, in the presence of acid, reversible cleavage of the more labile 
secondary benzylic dioxolane will occur in order to expose the benzylic 1,2-diol (24) and 
weaken the potential hydrogen bonding between the diols. Spontaneous lactonization of 
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25 would irreversibly take place to attain the desired product 21. To prove this hypothesis, 
the dihydrofuran 17 was subjected to a dihydroxylation and hydrolysis to produce an 
intermediate acid 19, which was treated with 2,2-dimethoxypropane (DMP) under reflux 
condition. Fortunately, our cascade attempt furnished the desired lactone 21 in 23% yield 
without any detectable diacetonide 22. Although the formation of an expected 
intermediate 22 was not confirmed and more evidence is required to fully elucidate this 
lactonization pathway, this result still indicated that somewhat reversible protection-
deprotection process took place during the course of reaction to give the lactone 21. 
 
Scheme 3.10 Cascade protection-lactonization of acid 19 to 21a 
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Since the concomitant dihydroxylation of both olefins in 17 provided low yield 
(26%), efforts to find a more feasible pathway to prepare useful quantities of the lactone 
21 were carried out. First, we planned to attempt a stepwise dihydroxylation-protection 
strategy (Scheme 3.11). In this approach, the more nucleophilic styrene-like olefin in 17 
underwent chemoselective dihydroxylation when 1.0 equiv of NMO was used to furnish 
diol 25 as a 1.5:1 mixture of diastereomers. Formation of the undesired diol or tetraol, 
which would arise from dihydroxylation at the dihydrofuran core or at both olefins, was 
not detected by spectroscopic methods.  
 
 
Protection of the diols to a cyclic carbonate and subsequent dihydroxylation of 
unsaturated ester 26 provided diol 27 with retention of diastereoselectivity (dr = 1.5:1) as 
observed in the first dihydroxylation. This meant that the second dihydroxylation 
proceeded in a fully stereoselective manner. Subsequent acetonide protection of the 
Scheme 3.11 Stepwise dihydroxylation process to 28a 
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resulting diol afforded an intermediate 28 in 67% yield (3 steps) from diol 25. The 
relative configuration of the diol was confirmed by NOE measurement of dioxolane 28 
after separation of the two diastereomers (see the Experimental section). 
 
 
Removal of the carbonate in 28 under basic conditions also resulted in the cleavage 
of the methyl ester to form intermediate dihydroxy acid 29, which underwent 
spontaneous lactonization to give the same bicyclic lactone 21 (Scheme 3.12). Treatment 
of this lactone 21 with a solution of anhydrous NH3 in MeOH provided an intermediate 
amide 30, which was subjected to oxidation with TEMPO and NaOCl at room 
temperature.45 As envisioned, the oxidation of the dihydroxy amide resulted in a 
spontaneous cyclization to afford a key intermediate aminal 15, which possessed all of 
the required oxidation states present in the natural product, as a single diastereomer. It is 
Scheme 3.12 Preparation of aminal 15a 
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noteworthy that these three steps of transformations required only one isolation process in 
the last oxidation.  
With availability of intermediate aminal 15, we turned our attention to the 
stereoselective indole incorporation.46 In our previous trials (Table 3.1), the use of 
In(OTf)3 successfully gave the desired indole adduct 3 as a single diastereomer. Similarly, 
in this case, it was also expected that the indole would approach to the iminium ion from 
the less hindered convex face of the bicycle. Surprisingly, aminal 15 turned out to be 
totally inactive under the same conditions (4.0 equiv of In(OTf)3) that was used in the 
previous indole addition. Additionally, other trials under various Lewis and Brönsted 
Table 3.2 Indole addition of aminal 15a 
condition yielda
MsCl, TEA 54%
82%
entry
5
6
solvent
aPurification yield after SiO2 chromatography.
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acidic conditions (BF3·OEt2, CSA, and PTSA) failed to give the desired indole adduct.  
In order to convert the aminal into a better leaving group, a mesylate was generated 
in situ by treatment of 4 with MsCl (1.2 equiv) and TEA at 0 °C, and subsequent addition 
of a solution of the indole (5.0 equiv) in CH2Cl2 gave the desired indole adduct 3 in 54% 
yield as a single diastereomer. Optimal conversion was acquired using TFAA instead of 
MsCl, which afforded 3 in 82% yield as a single stereoisomer. The stereochemistry and 
absolute configuration of the indole branched quaternary carbon center of 3 was 
confirmed by single crystal X-ray crystallographic analysis (Figure 3.2).  
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CH2Cl2, -30 oC to 0 oC, 80%  
 
At this point, we conducted the assembly of the fused tetracyclic framework under 
copper-mediated amidation conditions that were used in the first generation of the 
synthesis.43,44 As anticipated, the advanced tetracyclic intermediate 16 was successfully 
generated through Cu(I)-mediated coupling in 90% yield. Subsequent cleavage of the 
primary methyl ether51 and acetonide with excess BBr3 (9.0 equiv, added in three 
Scheme 3.13 Completion of total synthesis of (+)-isatisine Aa 
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portions) in the presence of 15-crown-5 and NaI (3.0 equiv) successfully provided (+)-
isatisine A (1) in 80% yield. 
 
3.4 Conclusion 
In conclusion, a total synthesis of (+)-isatisine A has been achieved in 13 steps with 
a 6.9% overall yield starting from allyl silane anti-6. A key element of our synthesis 
includes the formation of a highly substituted tetrahydrofuran using a silyl-directed 
Mukaiyama-type [3+2]-annulation strategy. In addition, construction of the nitrogen-
containing tetracyclic skeleton was accomplished through a CuI-mediated amidation and 
demonstrated that this method can be useful for the construction of fused polycyclic 
systems in complex molecule synthesis. 
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3.5 Experimental section 
 
(2R,3R,4R,5S)-2-(2-bromostyryl)-4-(dimethyl(phenyl)silyl)-5 (methoxymethyl)tetra-
hydrofuran-3-carbaldehyde (5) Ethoxy allyl silane 6 (1.3 g, 4.41 mmol) and 
bromocinnamyl aldehyde 7 (1.86 g, 8.82 mmol) were added into a round bottom flask 
followed by methylene chloride (15 mL). The reaction was cooled to 0 °C and PTSA 
monohydrate (0.83 g, 4.41 mmol) was added in one portion. The solution was allowed to 
stir for 10 min at 0 °C before quenching with sat’d-NaHCO3 solution. Upon warming to 
room temperature, the layers were separated and the aqueous phase was extracted with 
ethyl acetate (2 x 50.0 mL). The combined organic phases were dried over magnesium 
sulfate, filtered, and concentrated in vacuo to obtain an oil. Purification over silica gel 
with hexane/ethyl acetate (20/1 to 10/1 gradient elution) afford a furan 5 as a clear oil 
(1.76 g, 87 %) : [α]D
20 = -3.6 (c 1.5, CHCl3) 
1H NMR (CDCl3, 500 MHz): δ 9.53 (d, J = 3.5 Hz, 1H), 7.50-7.48 (m, 3H), 7.40-7.35 
(m, 4H), 7.29 (dt, J = 1.0, 7.5 Hz, 1H), 7.07 (dt, J = 2.0, 8.0 Hz, 1H), 6.97 (d, J = 16.0 
Hz, 1H), 6.09 (dd, J = 7.0, 16.0 Hz, 1H) 4.49 (td, J = 1.0, 7.5, 1H), 4.07 (ddd, J = 2.5, 
6.5, 8.5 Hz, 1H), 3.32 (ddd, J = 2.5, 10.5, 25.5 Hz, 2H), 3.29 (s, 3H), 3.01 (ddd, J = 3.5, 
7.0, 10.5 Hz, 1H), 1.92 (dd, J = 7.0, 9.5 Hz, 1H), 0.38 (s, 3H), 0.36 (s, 3H); 13C NMR 
(CDCl3, 75 MHz): δ 200.7, 136.0, 135.8, 133.7, 132.8, 131.7, 129.7, 129.1, 128.0, 127.8, 
127.4, 127.2, 123.6, 81.3, 81.2, 74.6, 59.2, 58.2, 28.0, -3.9, -4.6; IR (film) υmax: 2881.9, 
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2729.4, 1719.9, 1466.8, 1428.4, 1254.1 cm-1; HRMS (CI, NH3) m/z calc’d for 
C23H28BrO3Si [M+H]
+ 481.0811, found: 481.0790. 
 
 
(2R,3R,4R,5S)-2-((E)-2-bromostyryl)-4-(dimethyl(phenyl)silyl)-5-(methoxymethyl)-
tetrahydrofuran-3-carboxamide (9) The aldehyde 5 (586 mg, 2.07 mmol) was 
dissolved in t-butyl alcohol (0.1 M, 12.8 mL). The mixture was cooled to 0 ºC and 2-
methyl butane (6.7 mL, 63.8 mmol) was added quickly into the reaction followed by slow 
addition of freshly prepared NaClO2-NaH2PO4-H2O (2g-2g-20 mL) solution (12.8 mL). 
The yellow reaction mixture was stirred at rt for 3h before being concentrated under 
pressure. The residue was diluted with ethyl acetate water (ca. 10.0 mL each). The 
inorganic layer was acidified with 1N HCl till pH = 5.0. The inorganic layer was 
extracted with diethyl ether (3 X 10.0 mL). The combined organic layers were dried over 
anhydrous MgSO4 and concentrated under pressure to give a crude acid 8 as an oil. The 
crude acid was used for the next amidation step without purification. 
1H NMR (CDCl3, 500 MHz) δ 7.53-7.43 (m, 3H), 7.43-7.32 (m, 4H), 7.19-7.13 (m, 1H), 
7.04 (td, J = 7.7, 1.7 Hz, 1H), 6.89 (d, J = 15.7 Hz, 1H), 6.06 (dd, J = 15.7, 7.4 Hz, 1H), 
4.40 (td, J = 7.3, 1.1 Hz, 1H), 4.06 (ddd, J = 9.4, 4.8, 2.2 Hz, 1H), 3.49-3.42 (m, 1H), 
3.33 (d, J = 0.7 Hz, 3H), 3.29-3.21 (m, 1H), 3.16 (t, J = 7.1 Hz, 1H), 1.97 (dd, J = 9.4, 6.9 
Hz, 1H), 0.39 (s, 3H), 0.36 (s, 3H). 
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To a solution of crude acid 8 and TEA (0.38 mL, 1.92 mmol) in CH2Cl2 (60 mL) was 
added ethyl chloroformate (0.18 mL, 1.92 mmol) at -30 oC. After 30 min, anhydrous NH3 
gas was bubbled through the reaction mixture at the same temperature for 10min. Then 
reaction mixture was warmed up to rt and diluted with ethyl acetate (10.0 mL) washed 
with H2O (5.0 mL). The organic layer was dried over anhydrous MgSO4 and concentrated 
under pressure to give a crude acid 9 as an oil. Purification over silica gel with 
CH2Cl2/MeOH (50/1) afforded diol 9 as a viscous oil (586 mg, 96%). [α]D
20 = +1.3 (c 
1.5, CHCl3). 
1H NMR (CDCl3, 500 MHz): δ 7.53-7.49 (m, 2H), 7.48-7.42 (m, 2H), 7.40-7.33 (m, 3H), 
7.18 (tt, J = 7.9, 1.8 Hz, 1H), 7.06-7.01 (m, 1H), 6.90 (dt, J = 16.0, 1.6 Hz, 1H), 6.78 (s, 
1H), 6.12 (ddd, J = 15.7, 7.2, 1.9 Hz, 1H), 5.40 (s, 1H), 4.18 (ddt, J = 8.4, 6.6, 1.6 Hz, 
1H), 4.12-4.05 (m, 1H), 4.01 (ddd, J = 9.1, 3.4, 2.1 Hz, 1H), 3.59 (dd, J = 10.7, 2.2 Hz, 
1H), 3.32 (s, 3H), 3.05 (dd, J = 10.7, 3.1 Hz, 1H), 2.95-2.89 (m, 1H), 2.07-2.00 (m, 1H), 
0.41 (s, 3H), 0.38 (s, 3H); 13C NMR (CDCl3, 126 MHz): δ 175.65, 136.40, 135.85, 
133.86, 132.64, 132.22, 129.73, 129.04, 128.09, 127.82, 127.69, 127.42, 123.54, 81.76, 
80.23, 73.14, 59.23, 30.84, 14.48, -4.07, -5.19; IR (film) υmax: 3340.8, 3188.7, 2922.9, 
1671.5, 1467.3, 1428.9, 1255.3 cm-1; HRMS (CI, NH3) m/z calc’d for C22H28BrNO3Si 
[M+Na]+ 496.0920, found: 496.0943. 
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(2S,3R,3aR,6aS)-6-(2-bromobenzoyl)-3-(dimethyl(phenyl)silyl)-6-hydroxy-2-
(methoxymethyl)tetrahydro-2H-furo[2,3-c]pyrrol-4(5H)-one (4) Amide 9 (560 mg, 
1.18 mmol) was dissolved in a 9:1 mixture (12.0 mL) of acetone and H2O at rt. NMO 
(193 mg, 1.65 mmol) was added to the solution, which was stirred for 5 min at rt. OsO4 
(4 wt.% solution in H2O, 0.3 mL, 0.0340 mmol) was then added and the reaction mixture 
was stirred for 14 hr at rt. Aqueous sat’d-NaS2O3 (12.0 mL) was added and the mixture 
was stirred for additional 10 min at rt. Ethyl aceate (20.0 mL) was added and the resulting 
layers were separated. The aqueous phase was extracted with ethyl acetate (2 x 20 mL). 
The combined organic phases were dried over magnesium sulfate, filtered, and 
concentrated in vacuo to obtain an oil. Purification over silica gel with hexane/ethyl 
acetate (1/1) afforded diol 10 (2:1 mixture of diastereomers)as a viscous oil (440 mg, 
73%). 
1H NMR (CDCl3, 500 MHz): δ 7.55 (s, 1H) 7.52 (dd, J = 7.9, 1.7 Hz, 1H), 7.50-7.45 (m, 
3H), 7.40-7.34 (m, 3H), 7.30- 7.25 (m, 1H), 7.11-7.06 (m, 1H), 5.40 (s, 1H), 5.22 (s, J = 
1H), 3.97 (dt, J = 8.3, 2.1 Hz, 1H), 3.86 (dd, J = 9.3, 5.7 Hz, 1H), 3.80 (dd, J = 9.2, 1.9 
Hz, 1H), 3.53 (dd, J = 10.9, 1.8 Hz, 1H), 3.29 (s, 3H), 3.01 (dd, J = 5.7, 3.0 Hz, 1H), 2.96 
(dd, J = 11.0, 2.4 Hz, 1H), 1.94 (dd, J = 8.3, 3.1 Hz, 1H), 0.37 (d, J = 5.9 Hz, 6H). 
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The diol 10 (440 mg, 0.865 mmol) was dissolved in CH2Cl2 (8.0 mL), and NaBr (267 
mg, 2.60 mmol) and TEMPO (68 mg, 0.433 mmol) were added. A premixed solution of 
NaOCl (5 % in H2O, 17 mL) and NaHCO3 (272 mg) was added at rt, and the resulting 
brown mixture was stirred until turning light yellow (~30 min). CH2Cl2 (20 mL) and 
water (5 mL) was added and the layers were separated. The organic phase was dried over 
magnesium sulfate, filtered, and concentrated in vacuo to obtain a yellowish solid. 
Purification over silica gel with hexane/ethyl acetate (2/1) afford aminal 4 as a solid (260 
mg, 64 %): [α]D
20 = +29.6 (c 1.05, CHCl3). 
1H NMR (CDCl3, 500 MHz): δ 7.60-7.54 (m, 2H), 7.52-7.48 (m, 2H), 7.39-7.31 (m, 5H), 
7.28 (td, J = 7.8, 1.8 Hz, 1H), 6.52 (s, 1H), 5.62 (s, 1H), 4.71 (d, J = 7.6 Hz, 1H), 4.21 
(ddd, J = 8.3, 4.2, 2.7 Hz, 1H), 3.40 (dd, J = 10.5, 2.8 Hz, 1H), 3.22 (s, 3H), 3.10 (t, J = 
7.6 Hz, 1H), 2.90 (dd, J = 10.5, 4.3 Hz, 1H), 1.96 (dd, J = 8.4, 7.6 Hz, 1H), 0.44 (d, J = 
4.4 Hz, 6H); 13C NMR (CDCl3, 126 MHz): δ 200.00, 175.19, 138.20, 135.65, 133.85, 
133.30, 131.64, 129.76, 128.89, 128.13, 126.91, 119.53, 88.80, 84.50, 80.50, 73.09, 58.91, 
49.39, 30.81, -3.56, -5.51. IR (film) υmax: 3247.8, 3069.4, 2923.2, 1705.8, 1427.4, 1281.4 
cm-1; HRMS (CI, NH3) m/z calc’d for C23H26BrNO5Si [M+Na]
+ 526.0661, found: 
526.0663. 
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(2S,3R,3aR,6R,6aS)-6-(2-bromobenzoyl)-3-(dimethyl(phenyl)silyl)-6-(1H-indol-
3-yl)-2-(methoxymethyl)tetrahydro-2H-furo[2,3-c]pyrrol-4(5H)-one (3) A solution of 
aminal 4 (200 mg, 0.396 mmol) in anhydrous MeCN (4.0 mL) was cooled to 0 oC under 
Ar, and In(OTf)3 (0.8 g, 1.58 mmol) was added to the solution. After 10 min, indole (232 
mg, 0396 mmol) was added to the reaction mixture, which was warmed up to rt and 
stirred for 24 hr before adding sat’d-NaHCO3 (5 mL). Ethyl acetate (10 mL) was added, 
and the resulting layers were then separated and the organic phase was dried over 
anhydrous MgSO4. After filtering, the organic phase was concentrated in vacuo. The 
resultant residue was purified over silica gel with hexane/ethyl acetate (2/1) to give 3 as a 
fine yellow solid (167 mg, 70 %) : [α]D
20 = -23.0 (c 1.0, CHCl3). 
1H NMR (CDCl3, 400 MHz): δ 8.26 (s, 1H), 7.68-7.55 (m, 2H), 7.51-7.42 (m, 2H), 7.41-
7.25 (m, 6H), 7.22-7.14 (m, 2H), 7.11 (t, J = 2.4 Hz, 1H), 7.04 (ddd, J = 8.3, 7.0, 1.1 Hz, 
1H), 6.55 (s, 1H), 4.80 (dd, J = 4.7, 1.6 Hz, 1H), 4.21 (td, J = 6.7, 3.5 Hz, 1H), 3.25 (s, 
3H), 3.24-3.12 (m, 2H), 2.80 (dd, J = 4.9, 2.8 Hz, 1H), 1.88 (dd, J = 7.1, 2.9 Hz, 1H), 
0.31 (d, J = 10.8 Hz, 6H); 13C NMR (CDCl3, 126 MHz): δ 199.77, 177.73, 140.33, 
136.87, 135.85, 133.85, 132.86, 130.97, 129.61, 128.60, 128.00, 126.99, 124.71, 123.25, 
122.36, 120.66, 120.24, 118.82, 113.56, 111.48, 85.89, 82.31, 75.46, 72.64, 59.03, 49.12, 
29.67, -4.31, -4.82; IR (film) υmax: 3287.2, 2925.5, 1699.8, 1427.2, 1251.5 cm
-1; HRMS 
(CI, NH3) m/z calc’d for C31H31BrN2O4Si [M+Na]
+ 625.1134, found: 625.1124. 
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(2S,3R,3aR,10aR,10bS)-3-(dimethyl(phenyl)silyl)-10a-(1H-indol-3-yl)-2-
(methoxy-methyl)-3,3a-dihydro-2H-furo[2',3':3,4]pyrrolo[1,2-a]indole-
4,10(10aH,10bH)-dione (11) A solution of 3 (220 mg, 0.364 mmol) in anhydrous 
toluene (7.0 mL) was added into a seal tube under Ar. CuI (35 mg, 0.182 mmol), 
potassium carbonate (150 mg, 1.09 mmol), and N,N-dimethylenediamine (39 L, 0.364 
mmol) were successively added under Ar. Then the mixture was warmed up to 110 oC 
and stirred for 12 hr. The purple reaction mixture was cooled to rt and filtered through a 
pad of silica gel with ethyl acetate. The filtrate was concentrated under reduced pressure 
to give a yellowish solid. Purification over silica gel with hexane/ethyl acetate (2/1) 
afford 11 as a light yellow solid (150 mg, 80 %) : [α]D
20 = +174.2 (c 1.0, CHCl3). 
1H NMR (CDCl3, 500 MHz): δ 8.15 (s, 1H), 8.00 (ddt, J = 17.8, 8.1, 0.7 Hz, 2H), 7.68-
7.58 (m, 2H), 7.45 (dd, J = 7.9, 1.5 Hz, 2H), 7.35-7.25 (m, 4H), 7.22-7.13 (m, 4H), 4.76 
(dd, J = 4.0, 0.4 Hz, 1H), 4.17-4.09 (m, 1H), 3.25 (dd, J = 4.0, 2.3 Hz, 1H), 3.05 (dd, J = 
10.8, 3.3 Hz, 1H), 2.96 (dd, J = 10.9, 5.1 Hz, 1H), 2.85 (s, 3H), 2.06-2.01 (m, 1H), 0.28 
(d, J = 12.6 Hz, 6H); 13C NMR (CDCl3, 126 MHz): δ 195.57, 176.11, 151.02, 137.00, 
136.35, 135.81, 133.81, 129.66, 128.03, 125.39, 125.26, 125.02, 124.52, 122.78, 122.16, 
120.93, 120.51, 116.37, 111.50, 111.25, 83.60, 82.59, 75.55, 74.87, 59.00, 54.27, 30.00, -
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4.39, -4.68; IR (film) υmax: 3352.3, 2925.0, 1710.5, 1601.4, 1465.4, 1341.4, 1250.3 cm
-1; 
HRMS (CI, NH3) m/z calc’d for C31H30N2O4Si [M+H]
+ 523.2053, found: 523.2050. 
 
 
(2R,5R)-methyl 2-(2-bromostyryl)-5-(methoxymethyl)-2,5-dihydrofuran-3-
carboxylate (17) To a solution of tetrahydrofuran 5 ( 0.86 g, 1.87 mmol) in THF (18 mL) 
was added phenyltrimethyl tribromide (1.0 g, 2.8 mmol) at rt. The solution was allowed 
to stir for 12 hr at rt before cooling to 0 oC. TBAF (1M in THF, 1.87 mL, 1.87 mmol) 
was added dropwise, and the reaction mixture was stirred for 10 min at 0 oC. Ethyl 
acetate (50 mL) and water (10 mL) was added and the layers were separated. The organic 
layer was washed with H2O (3 x 10 mL) and dried over magnesium sulfate, filtered, and 
concentrated in vacuo (temperature of water bath must keep below 30 oC) to obtain 
unsaturated aldehyde 5a as an oil. Since this intermediate 5a is unstable in an acidic 
condition, it was directly used for the next reaction without purification.  
1H NMR (CDCl3, 500 MHz) δ 9.82 (s, 1H), 7.60-7.40 (m, 2H), 7.29 -7.17 (m, 1H), 7.14-
7.02 (m, 2H), 6.89 (td, J = 2.0, 0.8 Hz, 1H), 6.29 (ddd, J = 15.8, 5.7, 0.8 Hz, 1H), 5.65 
(dq, J = 3.8, 1.8 Hz, 1H), 5.16 (ddt, J = 3.9, 2.0, 0.9 Hz, 1H), 3.69 (ddd, J = 10.0, 5.1, 0.9 
Hz, 1H), 3.59 (ddd, J = 9.9, 5.3, 0.8 Hz, 1H), 3.43 (s, 3H). 
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To a solution of unsaturated aldehyde 5a (1.87 mmol, based on the SM) and NaCN (458 
mg, 9.35 mmol) in MeOH (37 mL) was added MnO2 (activated at 150 
oC for 12 hr, 4 g, 
46.7 mmol) in one portion at 0 oC. The reaction mixture was warming up to rt over the 
period of 1 hr and stirred for additional 3 hr at rt. The mixture was then filtered through a 
pad of Celite®, MeOH was removed under reduced pressure to give a yellow residue. 
Ethyl acetate (50 mL) and water (10 mL) was added and the layers were separated. The 
organic phase was washed with H2O (3 x 10 mL) and dried over magnesium sulfate, 
filtered, and concentrated in vacuo to obtain an oil. Purification over silica gel with 
hexane/ethyl acetate (10/1) afforded unsaturated methyl ester 17 as an oil (376 mg, 57 %, 
two steps): [α]D
20 = +770 (c 1.0, CHCl3) 
1H NMR (CDCl3, 500 MHz): δ ; 7.50 (td, J = 1.5, 7.0 Hz, 2H), 7.24-7.21 (m, 1H), 7.08-
7.04 (m, 2H), 6.08 (t, J = 2.0 Hz, 1H), 6.25 (dd, J = 6.5, 16.0 Hz, 1H), 5.60-5.57 (m, 1H), 
5.09-5.06 (m, 1H), 3.74 (s, 3H), 3.58 (ddd, J = 5.5, 10.0, 32.0, 2H), 3.40 (s, 3H); 13C 
NMR (CDCl3, 125 MHz): δ 162.5, 138.8; 136.5, 135.4, 132.7, 131.4, 130.1, 128.7, 
127.2, 127.1, 123.7, 84.9, 84.9, 74.8, 59.3, 51.7; IR (film) υmax: 2882.7, 1720.9, 1465.1, 
1436.2, 1260.5 cm-1; HRMS (CI, NH3) m/z calc’d for C16H17BrNaO4 [M+Na]
+ 375.0208, 
found: 375.0193 
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(2R,3S,4S,5S)-methyl 2-(2-(2-bromophenyl)-1,2-dihydroxyethyl)-3,4-dihydroxy-
5-(methoxymethyl)tetrahydrofuran-3-carboxylate (18) Methyl ester 17 (208 mg, 
0.589 mmol) was dissolved in a 8:1 mixture (6.0 mL) of acetone and H2O at rt. NMO 
(208 mg,  1.77 mmol) was added to the solution, which was stirred for 5 min at rt. OsO4 
(2.5 wt.% solution in H2O, 296 L, 0.024 mmol) was then added and the reaction mixture 
was stirred for 10 hr at rt. Aqueous sat’d-NaS2O3 (6.0 mL) was added and the mixture 
was stirred for additional 10 min at rt. Ethyl aceate (20 mL) was added and the resulting 
layers were separated. The aqueous phase was extracted with ethyl acetate (2 x 20 mL). 
The combined organic phases were dried over magnesium sulfate, filtered, and 
concentrated in vacuo to obtain an oil. Purification over silica gel with CH2Cl2/MeOH 
(20/1) afforded diol 18 as a viscous oil (64 mg, 26%). 
1H NMR (CDCl3, 500 MHz): δ 7.50 (ddd, J = 9.2, 7.9, 3.7 Hz, 2H), 7.34-7.26 (m, 1H), 
7.16-7.07 (m, 1H), 5.30 (d, J = 5.7 Hz, 1H), 4.71 (t, J = 8.0 Hz, 1H), 4.44 (s, 1H), 4.33 (d, 
J = 5.0 Hz 1H), 4.27 (ddd, J = 7.4, 4.3, 2.7 Hz, 1H), 4.14 (t, J = 7.4 Hz, 1H), 3.81 (s, 3H), 
3.65 (dd, J = 3.7, 1.5 Hz, 2H), 3.44 (s, 3H), 3.39 – 3.31 (m, 1H), 2.91 (d, J = 7.5 Hz, 1H), 
2.49 (d, J = 6.8 Hz, 1H). 
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(3aS,4S,5aR,8aR)-6-((2-bromophenyl)(hydroxy)methyl)-4-(methoxymethyl)-2,2-
dimethyldihydro-3aH-furo[3',4':2,3]furo[3,4-d][1,3]dioxol-8(4H)-one (21) Methyl 
ester 17 (45 mg, 0.127 mmol) was dissolved in a 2:1 mixture (1.3 mL) of t-BuOH and 
H2O at rt. NMO (45 mg, 0.382 mmol) was added to the solution, which was stirred for 5 
min at rt. OsO4 (2.5 wt.% solution in H2O, 64 L, 0.005 mmol) was then added and the 
reaction mixture was stirred for 48 hr at rt. Then 1N NaOH solution was successively 
added to the reaction mixture, which was stirred for 12 hr before acidifying with 1M HCl 
and quenching with sat’d-NaS2O3. Ethyl acetate (10 mL) and H2O (5 mL) were added 
and layers were separated. The organic phase was dried over magnesium sulfate, filtered, 
and concentrated under reduced pressure to obtain crude 19 as an oil. 
To a solution of crude acid 19 and 2,2-dimethoxypropane (16 L, 0.127 mmol) in CH2Cl2 
(1.3 mL) was added PTSA·H2O (2.4 mg, 0.013 mmol). The reaction mixture was stirred 
for 3hr at reflux condition. After cooling the reaction mixture to rt, ethyl acetate (10 mL) 
and H2O (5 mL) were added and layers were separated. The organic phase was dried over 
magnesium sulfate, filtered, and concentrated under reduced pressure to obtain an oil. 
The resultant residue was purified over silica gel with hexane/ethyl acetate (2/1) to give a 
dioxolane 21 as a clear oil (13 mg, 23%, 2 steps). 
1H NMR (CDCl3, 500 MHz): δ 7.59 (dd, J = 7.8, 1.7 Hz, 1H), 7.53 (dd, J = 8.0, 1.2 Hz, 
1H), 7.33-7.38 (m, 1H), 7.21-7.16 (m, 1H), 5.31-5.25 (m, 1H), 4.77 (dd, J = 10.0, 5.5 Hz, 
1H), 4.63 (t, J = 1.7 Hz, 1H), 4.39-4.34 (m, 1H), 3.63 (dd, J = 80.0, 10.5, 2.9 Hz, 1H), 
3.46 (dd, J = 3.6, 3.0 Hz, 2H), 3.29 (s, 2H), 1.59 (s, 3H), 1.58 (s, 3H). 
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(2S,5R)-methyl 2-(2-(2-bromophenyl)-1,2-dihydroxyethyl)-5-(methoxymethyl)-
2,5-dihydrofuran-3-carboxylate (25) Methyl ester 17 (300 mg, 0.849 mmol) was 
dissolved in a 8:1 mixture (8.0 mL) of acetone and H2O at rt. NMO (100 mg, 0.849 
mmol) was added to the solution, which was stirred for 5 min at rt. OsO4 (4 wt.% solution 
in H2O, 207 L, 0.0340 mmol) was then added and the reaction mixture was stirred for 
10 hr at rt. Aqueous sat’d-NaS2O3 (8.0 mL) was added and the mixture was stirred for 
additional 10 min at rt. Ethyl aceate (20 mL) was added and the resulting layers were 
separated. The aqueous phase was extracted with ethyl acetate (2 x 20 mL). The 
combined organic phases were dried over magnesium sulfate, filtered, and concentrated 
in vacuo to obtain an oil. Purification over silica gel with hexane/ethyl acetate (1/1) 
afford diol 25 as a viscous oil (164 mg, 50%). 
1H NMR (CDCl3, 500 MHz, major isomer): δ 7.60 (dd, J = 1.5, 11.5 Hz, 1H), 7.45 (dd, J 
= 1.0 7.5 Hz, 1H), 7.31 (td, J = 1.5, 7.5 Hz, 1H), 7.09 (td, J = 1.5, 8.0 Hz, 1H), 6.86 (t, J 
= 2.0 Hz, 1H), 5.32-5.30 (m, 1H), 5.25 (d, J = 6.0 Hz, 1H), 5.03-5.00 (m, 1H), 4.14 (d, J 
= 6.0 Hz, 1H), 4.04 (dd, J = 3.5, 7.5 H, 1H), 3.91 (d, J = 7.0 Hz, 1H), 3.76 (s, 3H), 3.06 
(dt, J = 2.5, 10.5, 2H); 13C NMR (CDCl3, 100 MHz): δ 163.8, 162.5, 141.5, 141.1, 140.3, 
139.1, 135.0, 134.5, 132.9, 132.7, 129.6, 129.4, 129.1, 129.1, 127.8, 127.8, 122.9, 121.7, 
88.7, 88.0, 85.5, 84.9, 74.4, 73.9, 73.5, 73.2, 73.0, 70.2, 59.8, 59.7, 52.5, 52.3; IR (film) 
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υmax: 3420.9, 2892.1, 1723.5, 1649.1, 1468.2, 1267.1 cm
-1; HRMS (CI, NH3) m/z calc’d 
for C11H19BrNaO6 [M+Na]
+ 409.0263, found: 409.0250 
 
 
(3aR,4R,6S,6aS)-methyl 4-(5-(2-bromophenyl)-2-oxo-1,3-dioxolan-4-yl)-6-
(methoxymethyl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxole-3a-carboxylate (28) 
Diol 25 (130 mg, 0.336 mmol) and DMAP (41 mg, 0.336 mmol) were dissolved in 
anhydrous CH2Cl2 (3.4 mL) under Ar and cooled to 0 
oC. Carbonyldiimidazole (272 mg, 
1.68 mmol) was introduced into the reaction, which was warmed up to rt. After 3 hr, 
ethyl acetate (10 mL) and water (5 mL) were added and layers were separated. The 
organic phase was dried over magnesium sulfate, filtered, and concentrated under 
reduced pressure to obtain crude 26 (138 mg) as an oil. 
1H NMR (CDCl3, 500 MHz): δ 7.55 (dd, J = 8.0, 1.2 Hz, 1H), 7.37-7.32 (m, 1H), 7.29 
(dd, J = 7.8, 1.8 Hz, 1H), 7.22 (ddd, J = 8.0, 7.2, 1.9 Hz, 1H), 7.01 (t, J = 1.6 Hz, 1H), 
6.26 (d, J = 4.2 Hz, 1H), 5.37 (dt, J = 5.2, 2.2 Hz, 1H), 5.12-5.08 (m, 2H), 3.70 (d, J = 3.4 
Hz, 3H), 3.60 (s, 3H), 3.38 (s, 3H). 
 
A solution of crude 26 (138 mg, 0.334 mmol) was dissolved in a 8:1 mixture (3.3 mL) of 
acetone and H2O at rt. NMO (60 mg, 0.501 mmol) was added to the solution, which was 
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stirred for 5 min at rt. OsO4 (4 wt.% solution in H2O, 1.0 mL, 0.167 mmol) was then 
added and the reaction mixture was stirred for 14 hr at rt. Aqueous sat’d-NaS2O3 (8.0 
mL) was added and the mixture was stirred for additional 10 min at rt. Ethyl aceate (20 
mL) was added and the resulting layers were separated. The aqueous phase was extracted 
with ethyl acetate (2 x 20 mL). The combined organic phases were dried over magnesium 
sulfate, filtered, and concentrated in vacuo to obtain crude diol 27 an oil (135 mg).  
1H NMR (CDCl3, 500 MHz): δ 7.62 (dd, J = 8.0, 1.2 Hz, 1H), 7.40-7.35 (m, 2H), 7.32 
(dd, J = 7.8, 1.9 Hz, 1H), 7.28-7.25 (m, 1H), 5.88 (d, J = 4.7 Hz, 1H), 4.75 (dd, J = 9.1, 
4.7 Hz, 1H), 4.37 (d, J = 8.7 Hz, 1H), 4.15 (d, J = 9.1 Hz, 1H), 3.87-3.84 (m, 1H), 3.83 (s, 
3H), 3.51 (dd, J = 10.8, 2.6 Hz, 1H), 3.40 (dd, J = 10.8, 4.4 Hz, 1H), 3.08 (s, 3H). 
 
To a solution of crude diol 27 (135 mg, 0.302 mmol) and 2,2-dimethoxypropane (0.37 
mL, 3.02 mmol) in acetone (3.0 mL) was added PTSA·H2O (29 mg, 0.151 mmol). The 
reaction mixture was stirred for 1hr at reflux condition. After cooling the reaction mixture 
to rt, ethyl acetate (10 mL) and H2O (5 mL) were added and layers were separated. The 
organic phase was dried over magnesium sulfate, filtered, and concentrated under 
reduced pressure to obtain an oil. The resultant residue was purified over silica gel with 
hexane/ethyl acetate (5/1) to give a dioxolane 28 as a clear oil (110 mg, 67%, 3 steps). 
1H NMR (CDCl3, 500 MHz, major isomer): δ 7.63 (dd, J = 1.0, 8.0 Hz, 1H), 7.41-7.35 
(m, 2H), 7.29-7.26 (m, 1H), 5.92 (d, J = 6.0 Hz, 1H), 4.93 (d, J = 3.0 Hz, 1H), 4.91 (dd, J 
= 5.5, 7.5 Hz, 1H), 4.30 (d, J = 7.5 Hz, 1H), 4.23 (td, J = 3.5, 5.0 Hz, 1H), 3.82 (s, 3H), 
3.41 (dd, J = 2.0, 5.0 Hz, 2H), 3.14 (s, 3H), 1.61 (s, 3H), 1.37 (s, 3H); 1H NMR (CDCl3, 
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500 MHz, minor isomer): δ 7.62 (dd, J = 1.0, 8.0 Hz, 1H), 7.43-7.38 (m, 2H), 7.30-7.27 
(m, 1H), 5.88 (d, J = 4.0 Hz, 1H), 4.96 (d, J = 3.0 Hz, 1H), (dd, J = 1.0, 3.5 Hz, 1H), 4.52 
(d, J = 1.5 Hz, 1H), 4.35 (td, J = 3.5, 6.5 Hz, 1H), 3.83 (s, 3H), 3.65 (dd, J = 2.0, 6.5 Hz, 
2H), 3.45 (s, 3H), 1.60 (s, 3H), 1.35 (s. 3H); 13C NMR (CDCl3, 100 MHz): δ 170.1, 
169.8, 153.7, 153.4, 135.8, 134.8, 133.8, 133.4, 131.1, 130.8, 129.2, 128.2, 128.1, 126.7, 
122.7, 120.6, 116.6, 116.5, 91.1, 89.4, 86.9, 86.8, 85.2, 84.5, 83.3, 79.7, 79.1, 78.9, 78.3, 
71.9, 65.8, 60.3, 59.5, 59.0, 53.2, 53.1, 27.5, 27.4, 25.6, 26.5; IR (film) υmax: 2934.2, 
1816.9, 1745.2, 1440.7, 1239.5 cm-1; HRMS (CI, NH3) m/z calc’d for C20H24BrO9 
[M+H]+ 487.0604, found: 487.0607. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
113 
Determination of the relative configuration of compound 28 
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(3aS,4S,6S,6aS)-4-(2-(2-bromophenyl)-2-oxoacetyl)-6-(methoxymethyl)-2,2-
dimethyltetrahydrofuro[3,4-d][1,3]dioxole-3a-carboxamide (15) To a solution of 
carbonate 28 (110 mg, 0.226 mmol) in MeOH (6 mL) was added potassium carbonate (47 
mg, 0.339 mmol) at rt, and this reaction mixture was stirred for 12 hr before adding 1N 
HCl (5 mL) and CHCl3 (20 mL). The layers were separated and the aqueous phase was 
extracted with CHCl3 (2 x 50.0 mL). The combined organic phases were dried over 
magnesium sulfate, filtered, and stood for 2 hr at rt to form lactone (screened by TLC). 
Then the organic phases were concentrated under reduced pressure to give a crude 21 as 
an oil, which was directly used for the next reaction without purification.  
1H NMR (CDCl3, 500 MHz) δ 7.59 (dd, J = 7.8, 1.7 Hz, 1H), 7.53 (dd, J = 8.0, 1.2 Hz, 
1H), 7.33-7.38 (m, 1H), 7.21-7.16 (m, 1H), 5.31-5.25 (m, 1H), 4.77 (dd, J = 10.0, 5.5 Hz, 
1H), 4.63 (t, J = 1.7 Hz, 1H), 4.39-4.34 (m, 1H), 3.63 (dd, J = 80.0, 10.5, 2.9 Hz, 1H), 
3.46 (dd, J = 3.6, 3.0 Hz, 2H), 3.29 (s, 2H), 1.59 (s, 3H), 1.58 (s, 3H). 
  
A crude lactone 21 was added to a round bottom flask followed by anhydrous NH3 
solution (7.0 M in MeOH, 2.3 mL) at rt. The reaction mixture was stirred for 12 hr before 
removing excess NH3 and MeOH under reduced pressure. Then the resultant residue was 
dissolved again in CH2Cl2 (2.3 mL), and NaBr (70 mg, 0.678 mmol) and TEMPO (17 
 
 
116 
mg, 0.113 mmol) were added. A premixed solution of NaOCl (5 % in H2O, 4.5 mL) and 
NaHCO3 (72 mg) was added at rt, and the resulting brown mixture was stirred until 
turning light yellow (~ 30 min). Ethyl acetate (20 mL) and water (5 mL) was added and 
the layers were separated. The organic phase was dried over magnesium sulfate, filtered, 
and concentrated in vacuo to obtain an yellowish solid. Purification over silica gel with 
hexane/ethyl acetate (2/1) afford aminal 15 as a solid (70 mg, 70 %, 3 steps) 
1H NMR (CDCl3, 500 MHz): δ ; 7.59 (td, J = 1.5, 7.5 Hz, 2H), 7.33 (td, J = 1.0, 7.5 Hz, 
1H), 7.28 (td, J = 2.0, 8.0 Hz, 1H), 7.01 (s, 1H), 5.77 (s, 1H), 4.81 (d, J = 1.5 Hz, 1H), 
4.80 (s, 1H), 3.56 (td, J = 2.0, 2.5 Hz, 1H) 3.76 (dd, J = 3.0, 10.5 Hz, 1H), 3.46 (dd, J = 
3.0, 10.5 Hz, 1H), 3.37 (s, 3H); 13C NMR (CDCl3, 125 MHz): δ 198.7, 170.3, 137.4, 
133.4, 131.8, 129.1, 126.9, 119.8, 116.2, 93.9, 87.2, 87.0, 86.6, 85.9, 72.7, 59.2, 27.0, 
26.0; IR (film) υmax: 3280.1, 2936.7, 1726.7, 1430.8, 1233.0 cm
-1; HRMS (CI, NH3) m/z 
calc’d for C18H20BrNNaO7 [M+Na]
+ 464.0321, found: 464.0325  
 
(3aR,4R,6S,6aS)-4-((S)-2-(2-bromophenyl)-1-(1H-indol-3-yl)-2-oxoethyl)-6-
(methoxymethyl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxole-3a-carboxamide 
(16) A solution of aminal 15 (68 mg, 0.153 mmol) in anhydrous CH2Cl2 (1.5 mL) was 
cooled to 0 oC under Ar. DMAP (1.9 mg, 0.0153 mmol) and pyridine (15 L, 0.184 
mmol) were added followed by Trifluoroacetic anhydride (26 L, 0.184 mmol), and the 
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progress of the formation of trifluoroacetic ester was screened by TLC (approximately 30 
min). Indole (90 mg, 0.765 mmol) was added to the reaction mixture, which was warmed 
up to rt and stirred for 10 hr before adding sat’d-NaHCO3 (5 mL). Ethyl acetate (10 mL) 
was added, and the resulting layers were then separated and the organic phase was dried 
over anhydrous MgSO4. After filtering, the organic phase was concentrated in vacuo. The 
resultant residue was purified over silica gel with hexane/ethyl acetate (2/1) to give 16 as 
a fine yellow solid (68 mg, 82 %) : [α]D
20 = +52 (c 0.50, CHCl3). 
1H NMR (CD3CN, 500 MHz): δ; 9.51 (s, 1H), 7.67-7.65(m, 3H), 7.50 (dd, J = 1.0, 8.0 
Hz, 1H), 7.41 (d, J = 8.5 Hz, 1H), 7.34 (td, J = 1.0, 7.5 Hz, 1H), 7.28-7.25 (m, 2H), 7.15 
(t, J = 8.0 Hz, 1H), 7.02 (t, J = 8.0 Hz, 1H), 5.18 (d, J = 1.5 Hz, 1H), 4.70 (d, J = 4.0 Hz, 
1H), 4.26 (q, J = 5.0 Hz, 1H), 3.54 (qd, J = 5.0, 11.0 Hz, 2H), 3.35 (s, 3H), 1.44 (s, 3H), 
1.42 (s, 3H); 13C NMR (CD3CN, 125 MHz): δ 198.7, 172.7, 140.2, 138.5, 135.0, 133.0, 
130.28, 128.3, 125.8, 125.7, 123.6, 121.6, 121.1, 119.1, 114.4, 113.2, 94.54, 86.9, 86.3, 
85.9, 73.1, 59.9, 27.7, 26.9; IR (film) υmax: 3246.2, 2931.6, 1713.1, 1459.8, 1246.3 cm-1; 
HRMS (CI, NH3) m/z calc’d for C26H26BrN2O6 [M+H]
+ 541.0974, found 541.0961. 
 
 
(3aR,4R,6S,6aS)-4-((S)-1-(1H-indol-3-yl)-2-oxo-2-phenylethyl)-6-(methoxymethyl)-
2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxole-3a-carboxamide (31) A solution of 16 
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(54 mg, 0.10 mmol) in anhydrous toluene (5 mL) was added into a seal tube under Ar. 
CuI (10 mg, 0.05 mmol), potassium carbonate (41 mg, 0.30 mmol), and N,N-
dimethylenediamine (11 L, 0.10 mmol) were successively added under Ar. Then the 
mixture was warmed up to 110 oC and stirred for 12 hr. The purple reaction mixture was 
cooled to rt and filtered through a pad of silica gel with ethyl acetate. The filtrate was 
concentrated under reduced pressure to give a yellowish solid. Purification over silica gel 
with hexane/ethyl acetate (2/1) afford 31 as a light yellow solid (41 mg, 90 %) : [α]D
20 = 
+66.6 (c 0.60 , CHCl3). 
1H NMR (CDCl3, 500 MHz): δ 8.15-8.13 (m, 2H), 8.00 (d, J = 8.0 Hz, 1H), 7.66-7.62 
(m, 2H), 7.33-7.31 (m, 1H), 7.24-7.18 (m, 4H), 4.90 (s, 1H), 4.82 (d, J = 2.0 Hz, 1H), 
4.35 (q, J = 2.5 Hz, 1H), 3.34 (dd, J = 2.5, 10.0 Hz, 1H), 3.26 (dd, J = 2.5, 10.0 Hz, 1H), 
2.61 (s, 3H), 1.51 (s, 3H), 1.38 (s, 3H); 13C NMR (CD3OD, 100 MHz): δ 195.8, 171.4, 
151.5, 139.2, 137.7, 127.5, 127.0, 126.2, 125.7, 124.2, 123.4, 121.3, 120.8, 118.4, 117.6, 
113.0, 111.8, 99.7, 88.6, 87.4, 86.0, 76.7, 73.6, 59.2, 27.4, 26.1; IR (film) υmax : 3384.6, 
2933.0, 1719.1, 1602.1, 1468.6, 1217.9 cm-1; HRMS (CI, NH3) m/z calc’d for 
C26H25N2O6 [M+H]
+ 461.1713, found: 461.1728. 
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(+)-Isatisine A (1) To a solution of methyl ether 31 (9.6 mg, 0.0208 mmol) in anhydrous 
CH2Cl2 (1.0 mL) was added NaI (10 mg, 0.0624 mmol) and 15-crown-5 (20 L, 0.124 
mmol) under Ar. The mixture was cooled to -30 oC, and BBr3 ( 100 mL, 0.098 mmol) 
was added in 3 portions every 1 hr. The reaction mixture was warmed to 0 oC and stirred 
for 12 hr. Diethyl ether (5 mL) was added to the reaction and stirred for 10 min at rt. 
Ethyl acetate (10 mL) and sat’d-NaHCO3 (5 mL) were added, and the resulting layers 
were then separated and the aqueous layer was extract with ethyl acetate (2 x 10 mL). 
The combined organic phase was dried over anhydrous MgSO4. After filtering, the 
organic phase was concentrated in vacuo. The resultant residue was purified over silica 
gel with CH2Cl2/MeOH (50/1 to 20/1 gradient elution) to give 1 as a fine yellow solid 
(6.8 mg, 80 %) : [α]D
20 = +165 (c 0.40, CHCl3). 
1H NMR (CD3OD, 500 MHz): δ 7.98 (dd, J = 1.0, 7.5 Hz, 1H), 7.93 (dt, J = 1.0, 8.0 Hz, 
1H), 7.76 (td, 1.0, 7.5 Hz, 1H), 7.63 (dt, J = 1.0, 8.0 Hz, 1H), 7.35-7.31(m, 2H), 7.29 (s, 
1H), 7.12 (td, J = 1.0, 7.0 Hz, 1H), 7.05 (td, J = 1.5, 7.0 Hz, 1H), 4.89 (s, 1H), 4.06 (d, J 
= 4.0 Hz, 1H), 3.85 (qd, J = 1.5, 4.5 Hz), 3.37 (ddd, J = 4.5, 11.5, 33.0, 2H); 13C NMR 
(CD3OD, 100 MHz): δ ; 196.8, 174.6, 151.9, 139.1, 137.9, 127.4, 126.9, 126.2, 126.1, 
124.6, 123.1, 121.1, 120.6, 117.8, 112.9, 110.6, 89.9, 89.0, 84.7, 76.8, 74.3, 63.2; IR 
(film) υmax: 3389.1, 2923.1, 1708.5, 1610.2, 1468.5, 1220.5 cm-1; HRMS (CI, NH3) m/z 
calc’d for C22H18N2NaO6 [M+Na]
+ 429.1063, found: 429.1082. 
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Figure 3.2 X-Ray structure of indole adduct 16 
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Chapter 4 
Synthesis of Fused-cyclic Compounds via One-pot 
Diels-Alder/annulation Reaction of a Silicon-
Substituted Hydroxy-diene 
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4.1 Introduction 
Polycyclic compounds bearing tetrahydrofuran and tetrahydropyran cores are 
frequently found in natural products and bioactive molecules. These categories of 
compounds are synthetically challenging, as they typically require many steps to access. 
Establishing a convenient and divergent synthetic methodology, which is able to build up 
complexity in a single manipulation, would provide a straightforward synthetic pathway 
to the synthesis of cyclic natural products. Furthermore, application of a divergent 
cyclization methodology to diversity-oriented synthesis (DOS) would allow for a 
powerful tool in studying the structure-activity relationship of cyclic compounds in 
screening for compounds that exhibit useful level of bioactivities. 
 
 
Recently our group began the process of attempting to find a simple and divergent 
preparation of complex allylsilane reagents. Since allylsilanes have been proven to be an 
excellent substrate in various annulation reactions, allylsilanes possessing a high 
complexity would be promising substrates for a silicon-directed transannular allylation or 
a cascade annulation process. In 2012, our group reported an efficient synthesis of fused 
cyclic compounds using allylsilane 2, which was rapidly prepared through an alkyne-
alkyne reductive coupling of propargyl silane 1 (Scheme 4.1).52 In this context, we 
Scheme 4.1 An example of annulation leading to fused bicyclic compound   
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demonstrated that properly tethered allylsilanes can undergo intramolecular annulations 
to construct fused cyclic compounds with similar efficiency as the annulation of a simple 
crotylsilane reagent.  
With this result in hand, our study was focused on searching for a simple and 
diversified synthetic methodology for more complicated cyclic allylsilane compounds 
and its potential application to construct synthetically challenging fused cyclic 
compounds. For that reason, we focused on the compatibility of the Diels-Alder and the 
silicon-directed [4+2]-annulation (Figure 4.1.a). In many examples, it was already 
demonstrated that the use of acids in Diels-Alder reaction facilitated the cycloaddition 
with enhanced regioselectivity and decreased reaction rate by lowering the LUMO 
energy of a dienophile. Similarly, acidic reaction conditions are also utilized in the [4+2]-
annulation of allylsilanes, which initiates oxonium ion formation between the aldehyde 
and hydroxyl group in the allylsilane reagent (Figure 4.1.b).  
In addition to the similarity in the reaction conditions, the Diels-Alder reaction was 
more intriguing in that it would generate an olefin and two allylic stereocenters from a 
conjugated diene. These functional groups appeared as key elements for the annulation 
reactions of allylsilane reagents, which illustrated that the Diels-Alder reaction could 
serve as a possible method for the preparation of cyclic allylsilane compounds. 
Additionally, a number of reports on the asymmetric version of the Diels-Alder reaction 
exist and demonstrate the concept of the chiral Lewis acid-catalysis.53 Application of this 
asymmetric Diels-Alder reaction to the synthesis of cyclic allylsilane could potentially 
provide an efficient synthetic pathway to enantioenriched cyclic allylsilanes.  
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Our primary goal for this project is to synthesize polycyclic compounds through one-
pot Diels-Alder/annulation reaction starting from silane-substituted diene 4 (Figure 4.1.c). 
In our plan, shown in Figure 4.1.c, this sequential reaction will be initiated by the Diels-
Alder reaction of vinyl silane 4 with a diene in the presence of an acid catalyst to provide 
intermediate cyclic allylsilane 5, which will be followed by acid-promoted oxonium ion 
formation (6) and subsequent [4+2]-annulation to give cyclic compound 7. In previous 
literature reports, the Diels-Alder reaction was proven to be compatible with other 
reactions in cascade or tandem cyclization processes to synthesize various cyclic 
compounds, and several examples involving Michael/Diels-Alder reaction 54 , Diels-
Alder/allylation with aldehyde55, and IMDA/[3+2]-cycloaddition56 were reported. Based 
on this high compatibility of Diels-Alder reaction, we envisioned that this three 
Figure 4.1 Our plan for developing a one-pot Diels-Alder/annulation reaction   
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component, one-pot Diels-Alder/annulation sequence will allow a rapid pathway to 
construct complex cyclic scaffolds.  
 
4.2 Development of a one-pot Diels-Alder/annulation sequence 
4.2.1 Optimization of Diels-Alder reaction of silyl-substituted diene 
Our investigation on the development of a one-pot Diels-Alder/annulation sequence 
began with establishing an efficient and scalable synthetic pathway to silyl-substituted 
diene 15 (Scheme 4.2). Thus, 3-butyn-1-ol 8 was iodinated in the presence of AgNO3 to 
afford iodobutynol 9 in 93% yield,57 which was then subjected to a copper-mediated 
coupling with TMS-acetylene 10 to produce diyne 11.58 Selective reduction of the 
internal alkyne to an alkene using LAH and subsequent protodesilylation provided 12 in 
62% yield.59 Regioselective hydrosilylation of 12 was conducted utilizing [Pt(DVDS)]-
PtBu3 (Chandra catalyst) to afford silane-substituted diene 14 in 93% as a single 
regioisomer.60  
OH OH
I
TMS
OH
TMS
OH OH
PhMe2Si
9 11
12 14
Si
Si
OPttBu3P
OTBS
PhMe2Si
15
aReagents & conditions; a) NIS, AgNO3, acetone, rt, 93%; b) CuCl, piperidine, rt, 80%; c) LAH, Et2O,
0 oC to rt; d) K2CO3, MeOH, rt, 62% (2 steps); e) [Pt(DVDS)]-PtBu3, PhMe2SiH, THF, rt, 93%; f)
TBSCl, DMAP, TEA, CH2Cl2, rt, 98%
8
10
a b c,d
e f
13
 
Scheme 4.2 Preparation of silane-substituted diene 15   
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At that point, it seemed that the selection of a proper protecting group for the 
hydroxy group in 14 would be crucial for a successful annulation reaction, as it has to be 
spontaneously removed after the Diels-Alder reaction to generate an oxocarbenium ion 
with the aldehyde under the given reaction condition, which would trigger the subsequent 
annulation (Figure 4.1.c). In our earlier three component propargylation reaction with 
allenylsilanes,61 a primary TBS ether successfully participated in the formation of an 
oxonium ion with an aldehyde under acidic conditions. In our initial study, therefore, 
TBS was determined to be the protecting group for the terminal hydroxy group to afford 
diene 15.  
Despite a lack of precedent for successfully conducting Diels-Alder reactions in the 
presence of a free hydroxyl group, we initially decided to investigate Diels-Alder reaction 
with diene 14 without protection of the hydroxyl group. However, our initial attempts 
revealed that [4+2]-cycloaddition of 14 with bromonaphthoquinone 16a under various 
Lewis acid conditions always afforded tetracyclic byproduct 17, which is generated 
through oxonium formation (18) between the hydroxyl group and the less hindered 
ketone followed by IMDA and protodesilylation.62  
With this result in hand, Diels-Alder reaction of the TBS protected diene 15 was 
explored with various Lewis acids. Fortunately, we found that aluminum-based Lewis 
acids, such as Me2AlCl, MeAlCl2, and AlCl3, efficiently catalyzed the cycloaddition 
between 15 and 16a to give the desired adduct 19a in a relatively short reaction time (30 
min) with satisfactory yields (Table 4.1). In addition, this reaction was proven to be 
highly regioselective to give the product as a single regioisomer. A cycloaddition in 
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benzene under reflux conditions also provided the adduct 19a as the sole product, albeit 
in low conversion. Further characterization to determine the relative stereochemistry of 
19a using 1D-NOE experiments revealed that the Diels-Alder reaction proceeded with 
endo-selectivity as an anti-relationship between the silyl group and hydrogen on the ring 
junction was observed. Meanwhile, the use of TiCl4 gave inferior results (30% yield), 
which was mostly a result of low conversion. Also, the reaction using BF3·OEt2 gave 
desilylated product 14 as a major product, while the use of Cu(OTf)2 as a Lewis acid 
catalyst completely inactivated the Diels-Alder reaction of 15 and gave no reaction.  
 
 
Table 4.1 Diels-Alder reaction of 14 & 15 with 2-bromonaphthoquinone 16a   
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The reaction scope of the Diels-Alder reaction of diene 15 was explored with several 
dienophiles in the presence of MeAlCl2 (Table 4.2). A series of 2-substituted quinones 
turned out to be excellent dienophiles. The reaction using naphthoquinone 16b 
successfully gave adduct 19b without any significant attenuation in yield (73%). Also, it 
seemed that alkyl substitution at the 2-position caused significant elongation of the 
reaction time. Cycloaddition of 2-methyl naphthoquinone 16c required 6 hours to reach 
full conversion, although it still furnished the product 19c in 77% yield as a single 
regioisomer. Alternatively, the same reaction utilizing AlCl3 as a catalyst showed a 
significant decrease in the reaction time with a comparable yield (1hr, 66%). Meanwhile, 
in the case of quinone, 2-alkyl substituent did not exhibit any significant effect on the 
reaction time. The reaction of xyloquinone 16d achieved full conversion in 1 hr to form 
the product 19d as a single regioisomer. Unfortunately, however, conventional aliphatic 
dienophiles, such as maleic anhydride, cyclohexenone, and methy acrylate, were 
completely inactive toward the Diels-Alder reaction under the optimized conditions.  
 
Table 4.2 Scope of dienophiles in Diels-Alder reaction of 15    
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To this date, regioselectivity in the Diels-Alder reaction of silane-substituted dienes 
is still not fully understood, because the silyl group is considered as both a -acceptor and 
-donator. Most likely, this ambivalent electronic characteristic is the reason why 
predicting and rationalizing the regioselectivity can be problematic. In 1981, Fleming 
reported on a Diels-Alder reaction using several trimethylsilyl-substituted dienes.63 As 
shown in Figure 4.2, Fleming’s FMO calculation revealed that silylsubstituted diene is 
polarized only to a small extent (Gaussian 70 program), which indicates its 
regioselectivity in consequent Diels-Alder reaction would be low. Expectably, the 
reaction of 1-trimethylsilylbutadiene gave an ortho-silyl substituted product as the major 
isomer with low regioselectivity (Figure 4.2, eq 1). In the case of 4-methyl-1,3-diene, 
however, the presence of one more alkyl substituent switched the regioselectivity to give 
a meta-silyl-substituted cyclohexene as the dominant product (eq 2).   
  
Figure 4.2 Fleming’s Diels-Alder reaction of 1-trimethylsilylbutadiene & 1-trimethylsilyl-
penta-1,3,-diene    
 
 
130 
In the present case, the Diels-Alder reactions of diene 15 with quinone-type 
dienophiles were shown to be highly regioselective, giving a single regioisomer in all 
cases shown in Table 4.2. Compared to previous examples, this high level of 
regioselectivity is particularly interesting, which led to further studies to elucidate the 
origin of this regiocontrol. Based on the observed regioselectivity in the Diels-Alder 
reaction of diene 15, we hypothesized that the -donating effect of the silyl group can 
stabilize the developing partial positive charge on the -carbon, which leads to the meta-
silyl substitution pattern observed in the adduct 19c (Scheme 4.3.a). Also, this 
supposition was consistent with our DFT calculation using Schrodinger ligprep 2.5 
program, although it was polarized in small extent.  
 
 
Scheme 4.3 Determination of the factors controlling regioselectivity 
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To further confirm this proposition, we planned to carry out the Diels-Alder reaction 
with 2-carbonyl substituted naphthoquinone 16e, which is known to reverse the 
regioselectivity based on the coordination mode of the given Lewis acid used. Therefore, 
if selectivity in the cycloaddition was dictated by the electronic polarization of diene 15, 
a significant turnover of regioselectivity should be observed and provide an ortho-silyl 
substituted product, because chelation of the Lewis acid between the two carbonyls will 
switch the electronic characteristic of the dienophile 16e. 
Taking this into account, the Diels-Alder reaction of diene 15 with dienophile 16e 
was performed under several different conditions (Scheme 4.3.b). Surprisingly, exposure 
of 16e to the previously optimized conditions (50 mol% MeAlCl2 in CH2Cl2) still 
afforded meta-silylsubstituted adduct 19e as a single regioisomer. The reactions using 
AlCl3 or Me2AlCl as a Lewis acid also gave 19e without detection of the expected 
product 19e-r. Base on this series of experiments, we tentatively concluded that the 
selectivity of the Diels-Alder reaction of the silyl-substituted diene 15 is dictated by steric 
factors and less by electronic factors.  
To further confirm this assertion, we planned to conduct Diels-Alder reactions of 
allylsilane 22, where the regioselectivity should be controlled by the electronic character 
of the diene and dienophile (Scheme 4.4). Diene 22 was prepared from the known allyl 
silane 2064 through Sonogashira coupling65 and selective reduction of the internal alkyne 
in 21 to a diene. The diene 22 appeared to be more reactive than 15 probably due to less 
steric demand on the reaction site and more polarization. Importantly, this set of 
experiments clearly revealed a turnover in regioselectivity depending on the electronic 
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nature of dienes. While the reaction of 22 with 2-methyl-naphthoquinone 16c afforded 
meta-silylsubstituted adduct 23c as a major regioisomer, the use of 16e provided ortho-
silylsubstituted product 23e as a only product. This observation further supports our 
conclusion that steric factors dominate the regioselectivity of the Diels-Alder reaction of 
diene 15. 
Br
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SiMe2Ph
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aReagents & conditions; a) 3-butyn-1-ol, Pd(PPh3)4, CuI, n-BuNH2, DMF, 50 oC, 79%; b) LAH,
THF, reflux; c) TBSCl, TEA, DMAP, CH2Cl2, rt, 76%
a b,c
 
 
4.2.2 One-pot Diels-Alder/annulation sequence 
The investigation of a one-pot Diels-Alder/annulation reaction began with a three 
component reaction, in which cycloaddition between the diene and dienophile was 
expected to occur first. Therefore, a mixture of the three reaction partners, diene 15, 
dienophile 16c, and iso-butyl aldehyde 24a, were exposed to AlCl3 to induce the tandem 
Scheme 4.4 Turnover of regioselectivity in the Diels-Alder reaction of diene 22 a 
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cyclization. However, this attempt led to a complex mixture of byproducts, which was 
generated from the starting diene 24a. Interestingly, the presence of aldehyde at the 
beginning of this one-pot operation totally inhibited the desired pathway for the initial 
Diels-Alder reaction, and the formation of the expected intermediate cyclic allylsilane 
19c was not detected.  
 
 
After these undesired results, a one-pot sequential Diels-Alder/annulation protocol 
was pursued (Table 4.3). In this case, Diels-Alder reaction took place prior to the addition 
of an aldehyde to secure the formation of adduct 19c, after which an aldehyde and Lewis 
acid were successively added to the reaction mixture to trigger the annulation. Initially, 
Table 4.3 Optimization of one-pot sequential Diels-Alder/annulation reaction 
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we examined a single catalyst system utilizing AlCl3, which was previously proven to 
give a shorter reaction time, without further addition of Lewis acid (entry 1). However, 
AlCl3 turned out to be inactive in catalyzing the annulation, and extended reaction caused 
decomposition of intermediate 19c, which suggested the need of a second Lewis acid in 
the sequential annulation reaction.  
The reaction using BF3·OEt2 as a second promoter gave cyclized product 25ca, 
which was generated through a migration of the resulting olefin into conjugation after 
annulation, in 17% yield as a single diastereomer (entry 2). The reactions using TiCl4 or 
In(OTf)3 as annulation promoters afforded similar or inferior results (entry 3,4). To our 
delight, we finally found that TMSOTf efficiently facilitates the second annulation step. 
The use of TMSOTf in the presence of AlCl3 showed significant improvement in yield 
(40%). The optimal conditions were found to be a combination of the milder MeAlCl2 
O
O
O
H
25ca
Figure 4.3 X-ray structure of compound 25ca 
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and TMSOTf, which produced the desired product 25ca in 66% as a single diastereomer 
(entry 6). The structure of 25ca was determined by NMR spectroscopic studies and 
further confirmed by X-ray crystallography (Figure 4.3). 
The scope of the one-pot Diels-Alder/annulation was explored with various 
aldehydes. Using the optimized conditions, the Diels-Alder reaction was initially carried 
out in the presence of MeAlCl2, and aldehyde 24 and TMSOTf were subsequently added 
to the reaction mixture at -50 oC to furnish desired fused-cyclic compounds (Table 4.4). 
The one-pot sequential reaction using carbocycliccarboxaldehydes 24b and 24c showed 
similar reactivities to the reaction of iso-butylaldehyde 24a and resulted in the formation 
of the desired cyclic scaffolds 25cb and 25cc in 63% and 60%, respectively, as a single 
diastereomer. Also, 2-ethylbutyraldehyde was proved to be a good reaction partner in this 
reaction sequence, which gave 25cd in 65% yield. From these results, it was concluded 
that -branched aldehydes served as excellent reaction partners in this annulation 
sequence given the observed results from the reaction of 24a, 24b, 24c and 24d. 
Other aldehydes without -branching were also investigated. In the case of 
valeraldehyde 24e, the product 25ce was produced with attenuated yield (40%). Next, the 
effect of -branching in the aldehyde on the annulations was examined using i-
valeraldehyde 24f. However, this trial provided the desired product 25cf in only moderate 
efficiency (30%). Possible acid-promoted side reaction pathways, such as homoaldol 
reaction, may be responsible for the attenuation in yields observed in the reactions of 
linear aldehydes, which bear relatively more acidic -protons compared with that of -
branched reaction partners. Also, the reaction of cyclopropanecarboxaldehyde 24g 
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proceeded with various side reactions and gave the product 25cg in only 24% yield. 
Beside these examples shown in Table 4.4, several aromatic and unsaturated aldehydes 
were explored under the same reaction conditions. However, these series of experiments 
always gave a complex mixture of unidentifiable byproducts, and no desired cyclized 
product was observed in these reactions. From these results, we concluded that the scope 
of aldehyde in one-pot sequential Diels-Alder/annulation reaction was limited to aliphatic 
aldehydes. 
 
 
Considering the relative stereochemistry of the Diels-Alder adduct 19c, the 
stereochemical outcome of the annulation reaction was particularly interesting, since a 
Table 4.4 One-pot sequential Diels-Alder/annulation with various aldehydesa 
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new C-C bond formation arose from the same face as the silane group to construct the 
cis-fused hydroisochromene core. A transition state analysis was proposed based on this 
unique stereochemical observation.  
 
 
Presumably, this annulation goes through a two step transition state involving C-C 
bond formation and conformational change. Initially, a Prins-type cyclization occurs in 
the chair-boat transition state T1, where the bulky silane group is positioned in a pseudo-
equatorial orientation to minimize the developing 1,3-diaxial interactions in the chair-
chair transition state. Subsequent bond rotation would then align the C-Si bond with the 
empty p-orbital (T2), which would maximize the electron donating effect of the silyl 
group (-silicon effect). After that, elimination of the silane group followed by migration 
of the double bond into conjugation would give the cyclic compound 25c. 
 
Figure 4.4 Proposed transition state of annulation 
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4.3 Conclusion 
We have initiated the development of a one-pot sequential Diels-Alder/annulation 
reaction starting from silyl-substituted diene 15. This reaction sequence rapidly 
assembles a complex fused-cyclic scaffold from a silyl-substituted diene, which can be 
easily prepared through simple manipulations. Since this process is technically three 
components, it will be useful in the establishment of a chemical library composed of 
various cyclic compounds, as well as in the synthesis of structurally-related cyclic natural 
compounds. Also, application of an asymmetric version of the Diels-Alder reaction will 
allow access to enantioenriched fused-cyclic scaffolds. The continuing study to broaden 
reaction scope and to synthesize different types of cyclic scaffolds, which include 
piperidine-bearing cyclic compounds, from properly functionalized silyl-substituted 
dienes is underway. 
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4.4 Experimental section 
 
4-Iodobut-3-yn-1-ol (9) N-iodosuccinimide (17.3 g, 77.0 mmol) and AgNO3 (1.1 g, 6.42 
mmol) were added to a solution of 3-butyn-1-ol 8 (4.5 g, 64.2 mmol) in acetone (120 
mL). The reaction was stirred at room temperature for 3 hr. Then acetone was removed 
under reduced pressure and the residue was quenched with aqueous sat’d-NaS2O3 (30 
mL) and diluted with Et2O (100 mL). The layers were separated and the aqueous layer 
was extracted with Et2O (50 mL). The resulting organics were combined, dried over 
MgSO4, and filtered and concentrated. The resulting residue was then purified by column 
chromatography with petroleum ether/Et2O (2/1) to give 9 as an oil (11.7 g, 93%). 
1H NMR (CDCl3, 500 MHz): δ 3.71 (t, J = 6.2 Hz, 2H), 2.62 (t, J = 6.2 Hz, 2H). 
 
 
6-(Trimethylsilyl)hexa-3,5-diyn-1-ol (11) Ethynyltrimethylsilane (2.9 mL, 20.4 mmol), 
piperidine (15 mL, 153 mmol), and 9 (2 g, 10.2 mmol) were combined at 0 oC. Copper(I) 
chloride (100 mg, 1.02 mmol) was added in one portion. The reaction mixture was stirred 
with gradual warming to room temperature. After 1 hr, the solution was quenched with 
sat’d-NH4Cl solution (30 mL) and washed three times with Et2O (30 mL). The organic 
layers were combined, dried with MgSO4, filtered, and concentrated under reduced 
pressure. The crude product was purified by silica gel chromatography with hexane/ethyl 
acetate (3/1) to provide 11 as a yellow oil (1.35 g, 80%). 
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1H NMR (CDCl3, 500 MHz): δ 3.73 (q, J = 6.3 Hz, 2H), 2.53 (t, J = 6.2 Hz, 2H), 1.69 (t, 
J = 6.4 Hz, 1H), 0.17 (s, 6H). 
 
 
(E)-Hex-3-en-5-yn-1-ol (12) Powdered LiAlH4 (400 mg, 10.5 mmol) was added quickly 
to a solution of 11 (1.16 g, 6.98 mmol) in Et2O (15.0 mL) at 0 °C. The reaction was 
warmed to rt and stirred for 3 hr. The reaction was cooled with an ice/water bath and 
quenched with 1N NaOH and filtered through a pad of Celite® to remove white solid. 
The mixutre was extracted with Et2O (2 x 30 mL), dried over MgSO4, and concentrated 
under reduced pressure to afford crude 11a as a light yellow oil. 
1H NMR (CDCl3, 500 MHz): δ 6.17 (dt, J = 16.3, 7.3 Hz, 1H), 5.59 (dt, J = 15.9, 1.5 Hz, 
1H), 3.66 (t, J = 6.3 Hz, 2H), 2.35 (td, J = 7.7, 7.0, 5.5 Hz, 2H), 0.16 (s, 6H). 
 
K2CO3 (1.1 g, 7.68 mmol) was added to a solution of crude 11a in MeOH (13 mL) at rt. 
The reaction was stirred for 1hr, and MeOH was removed under reduced pressure. The 
residue was dissolved with Et2O (30 mL), washed with H2O (10 mL). The organic layer 
was dried over MgSO4 and concentrated under reduced pressure. Purification over silica 
gel chromatography with petroleum ether/Et2O (3/1) provided 12 as a yellow oil (415 mg, 
62%, 2 steps). 
1H NMR (CDCl3, 500 MHz): δ 6.22 (dt, J = 16.0, 7.2 Hz, 1H), 5.56 (dq, J = 16.1, 1.9 Hz, 
1H), 3.68 (q, J = 6.1 Hz, 2H), 2.80 (d, J = 2.2 Hz, 1H), 2.37 (td, J = 6.4, 4.8 Hz, 2H), 
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1.39 (q, J = 5.4 Hz, 1H); 13C NMR (CDCl3, 126 MHz) δ 142.44, 110.88, 81.98, 76.34, 
61.01, 36.05. 
 
 
(3E,5E)-6-(Dimethyl(phenyl)silyl)hexa-3,5-dien-1-ol (14) To a solution of 12 (555 mg, 
5.77 mmol) in THF (19 mL) was added [Pt(DVDS)]-PtBu (17 mg, 0.029 mmol) under Ar 
atmosphere. Then dimethylphenylsilane (1.0 mL, 6.35 mmol) was added to the reaction 
mixture at rt. After 1hr, solvent was removed under reduced pressure and the crude 
mixture was purified by column chromatography with hexane/ethyl acetate (3/1) to afford 
14 as a clear oil (1.25g, 93%). 
1H NMR (CDCl3, 500 MHz): δ 7.54-7.47 (m, 2H), 7.37-7.30 (m, 3H), 6.54 (ddd, J = 18.4, 
10.0, 0.7 Hz, 1H), 6.19 (ddtd, J = 15.2, 10.0, 1.4, 0.8 Hz, 1H), 5.88 (dt, J = 18.4, 0.6 Hz, 
1H), 5.71 (td, J = 22.5, 7.5 Hz, 1H), 3.67 (q, J = 5.9 Hz, 2H), 2.28 (q, J = 5.9 Hz, 2H), 
0.33 (s, 6H); 13C NMR (CDCl3, 100 MHz): δ 145.4, 138.4, 135.41, 133.6, 131.6, 129.7, 
128.7, 127.6, 61.5, 35.6, -2.6; IR (film) υmax: 3328.1, 3011.7, 2895.2, 1643.2, 1426.9, 
1247.1 cm-1. 
 
OH
PhMe2Si
14
OTBS
PhMe2Si
15  
tert-Butyl(((3E,5E)-6-(dimethyl(phenyl)silyl)hexa-3,5-dien-1-yl)oxy)dimethylsilane 
(15) To a solution of alcohol 14 (940 mg, 4.04 mmol), triethylamine (1.1 mL, 8.08 mmol), 
and 4-dimethylaminopyridine (10 mg, 0.081 mmol) in CH2Cl2 (8.0 mL) was added 
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TBSCl (730 mg, 4.85 mmol) at rt. After 12 hr, hexane (100 mL) and water (40 mL) were 
introduced into the reaction and layers were separated. The combined organic layers were 
dried over MgSO4, filtered, and concentrated under reduced pressure to obtain an oil. 
Purification over silica gel with hexane/ethyl acetate (50/1) afforded TBS ether 15 as a 
clear oil (1.33 g, 98%). 
1H NMR (CDCl3, 500 MHz): δ 7.53-7.47 (m, 2H), 7.35-7.30 (m, 3H), 6.53 (dd, J = 18.4, 
10.0 Hz, 1H), 6.36 (dd, J = 18.5, 10.0 Hz, 1H), 5.83 (d, J = 18.5, 1H), 5.72 (dt, J = 14.8, 
7.1 Hz, 1H), 3.63 (t, J = 6.8 Hz, 2H), 2.30 (q, J = 6.8 Hz, 2H), 0.87 (s, 9H), 0.33 (s, 6H), 
0.03 (s, 6H); 13C NMR (CDCl3, 126 MHz): δ 145.91, 138.76, 135.00, 133.81, 132.26, 
129.24, 128.88, 127.72, 62.72, 36.24, 25.95, 18.32, -2.49, -5.24; IR (film) υmax: 3012.9, 
2928.3, 1471.3, 1386.0, 1249.0 cm-1; HRMS (CI, NH3) m/z calc’d for C20H34OSi2 
[M+H]+ 347.2226, found: 347.2227. 
 
 
6a-Bromo-2,3,3a,4-tetrahydrodibenzo[de,h]chromen-7(6aH)-one (17) To a mixture of 
bromonaphthoquinone 16a (31 mg, 0.129 mmol) and diene 14 (20 mg, 0.086 mmol) in 
dry CH2Cl2 (0.8 mL) was added 1M solution of Me2AlCl (22 L, 0.022 mmol) in hexane 
at rt. This reaction was stirred for 24 hr at the same temperature before addition of 
aqueous sat’d-NaHCO3, and diluted with ethyl acetate (10 mL). The resulting two layers 
were separated, and the organic layer was dried over MgSO4 and filtered. The filtrate was 
 
 
143 
concentrated under reduced pressure to obtain an oil. Purification over silica gel with 
hexane/ethyl acetate (1/1) afforded 17 as a clear oil (2 mg, 7%). 
 
1H NMR (CDCl3, 500 MHz): δ 8.10-7.90 (m, 2H), 7.81-7.62 (m, 2H), 5.83-5.75 (m, 1H), 
5.66 (dq, J = 10.0, 3.2 Hz, 1H), 3.87-3.71 (m, 2H), 3.78-3.66 (m, 1H), 3.01 (d, J = 7.5 Hz, 
1H), 2.55 (ddd, J = 15.2, 6.4, 4.1, Hz, 1H), 2.33 (ddd, J = 5.7, 4.9, 2.8 Hz, 2H), 2.31-2.22 
(m, 1H). 
 
General procedure for Diels-Alder reaction of diene 15 
 
To a mixture of naphthoquinone 16 (0.130 mmol) and diene 15 (30 mg, 0.0865 mmol) in 
dry CH2Cl2 (0.5 mL) was added 1M solution of MeAlCl2 (43 L, 0.0433 mmol) in 
hexane at rt. This reaction was stirred at the same temperature, and reaction progress was 
monitored by TLC. When the reaction ran to completion, aqueous sat’d-NaHCO3 (1 mL) 
and ethyl acetate (5 mL) was successively added to the reaction mixture. The resulting 
two layers were separated, and the organic layer was dried over MgSO4 and filtered. The 
filtrate was concentrated under reduced pressure to obtain an oil. Purification over silica 
gel with hexane/ethyl acetate (20/1) afforded 19 as a clear oil. 
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(±)-(1S,4R,4aS,9aS)-4a-Bromo-4-(2-((tert-butyldimethy-
lsilyl)oxy)ethyl)-1-(dimethyl(phenyl)silyl)-1,4,4a,9a-tetrahydro-
anthracene-9,10-dione (19a) Bromonaphthoquinone 16a (31 mg, 
0.130 mmol) was used following the general procedure. Diels-Alder adduct 19a was 
obtained as a clear oil (41 mg, 80 %). 
1H NMR (CDCl3, 500 MHz): δ 8.05-8.01 (m, 1H), 7.74 (dt, J = 7.7, 1.1 Hz, 1H), 7.67 (dtt, 
J = 20.7, 7.4, 1.3 Hz, 2H), 7.37 (ddd, J = 6.5, 2.2, 1.1 Hz, 2H), 7.29-7.23 (m, 5H), 5.84-
5.75 (m, 1H), 5.75-5.67 (m, 1H), 3.83 (d, J = 7.1 Hz, 1H), 3.57-3.51 (m, 2H), 3.46 (qd, J 
= 7.0, 1.1 Hz, 1H), 3.10 (dt, J = 11.3, 3.0 Hz, 1H), 2.63 (ddd, J = 7.0, 2.8, 1.0 Hz, 1H), 
1.57 (tdd, J = 10.3, 6.2, 3.5 Hz, 1H), 1.50-1.40 (m, 1H), 0.81 (s, 9H), 0.30 (s, 3H), 0.26 (s, 
3H), -0.05 (s, 6H); 13C NMR (CDCl3, 126 MHz): δ 194.31, 191.66, 138.40, 134.76, 
134.50, 134.34, 133.77, 133.73, 128.89, 127.70, 127.65, 126.41, 125.27, 124.50, 72.12, 
60.61, 58.52, 43.86, 36.27, 28.11, 25.85, 18.19, -1.92, -2.61, -5.36. 
 
 (±)-(1R,4S,4aS,9aR)-1-(2-((tert-Butyldimethylsilyl)oxy)ethyl)-4-
(dimethyl(phenyl)silyl)-1,4,4a,9a-tetrahydroanthracene-9,10-
dione (19b) Naphthoquinone 16b (16 mg, 0.104 mmol) was used 
following the general procedure. Diels-Alder adduct 19b was obtained as a clear oil (32 
mg, 73 %). 
1H NMR (CDCl3, 500 MHz): δ 8.05-8.01 (m, 1H), 7.89-7.83 (m, 1H), 7.72-7.63 (m, 2H), 
7.57-7.50 (m, 2H), 7.29 (dd, J = 5.1, 1.9 Hz, 3H), 5.78 (s, 2H), 3.55-3.39 (m, 4H), 2.79 
O
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(ddd, J = 10.5, 7.0, 3.5 Hz, 1H), 2.07 (dd, J = 6.2, 1.1 Hz, 1H), 1.17-1.07 (m, 1H), 1.07-
0.98 (m, 1H), 0.77 (s, 9H), 0.53 (s, 3H), 0.41 (s, 3H), -0.12 (d, J = 5.4 Hz, 6H). 
 
 (±)-(1S,4R,4aR,9aS)-4-(2-((tert-Butyldimethylsilyl)oxy)ethyl)-1-
(dimethyl(phenyl)silyl)-4a-methyl-1,4,4a,9a-
tetrahydroanthracene-9,10-dione (19c) Menadione 16c (18 mg, 
0.104 mmol)was used following the general procedure. Diels-Alder 
adduct 19c was obtained as a clear oil (38 mg, 77 %). 
1H NMR (CDCl3, 500 MHz): δ 8.08-8.04 (m, 1H), 7.82-7.78 (m, 1H), 7.70-7.61 (m, 2H), 
7.57-7.53 (m, 2H), 7.32-7.27 (m, 3H), 5.82-5.74 (m, 1H), 5.69 (ddd, J = 10.4, 4.8, 3.1 Hz, 
1H), 3.45-3.36 (m, 2H), 3.08 (dt, J = 6.1, 0.7 Hz, 1H), 2.33-2.23 (m, 1H), 2.03 (ddd, J = 
6.0, 3.0, 1.9 Hz, 1H), 1.48 (s, 3H), 1.11 (dtd, J = 12.6, 7.8, 3.6 Hz, 1H), 0.96 (ddt, J = 
12.6, 11.6, 4.9 Hz, 1H), 0.76 (s, 9H), 0.56 (s, 3H), 0.43 (s, 3H), -0.13 (d, J = 3.6 Hz, 6H). 
 
 (±)-(4aR,5R,8S,8aS)-5-(2-((tert-Butyldimethylsilyl)oxy)ethyl)-8-
(dimethyl(phenyl)silyl)-2,4a-dimethyl-4a,5,8,8a-
tetrahydronaphthalene-1,4-dione (19d) p-Xyloquinone 16d (10 mg, 
0.0762 mmol) and diene 15 (22 mg, 0.0635 mmol) was used following the general 
procedure. Diels-Alder adduct 19d was obtained as a clear oil (20 mg, 65%). 
1H NMR (CDCl3, 500 MHz):
 δ 7.55-7.46 (m, 2H), 7.30 (ddd, J = 3.3, 2.5, 1.4 Hz, 2H), 
6.40 (d, J = 6.3, 1H), 5.74-5.68 (m, 1H), 5.63 (ddd, J = 10.3, 4.8, 3.1 Hz, 1H), 3.62-3.41 
(m, 2H), 2.83 (d, J = 6.3 Hz, 1H), 2.14 (dt, J = 12.7, 4.5 Hz, 1H), 1.95-1.92 (m, 1H), 1.85 
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(d, J = 1.5 Hz, 3H), 1.40-1.34 (m, 1H), 1.33 (s, 3H), 1.08-0.97 (m, 1H), 0.82 (s, 9H), 0.49 
(s, 3H), 0.43 (s, 3H), -0.04 (s, 3H), -0.04 (s, 3H). 
 
 (±)-(1S,4R,4aS,9aS)-Methyl-4-(2-((tert-butyldimethylsilyl)oxy) 
ethyl)-1-(dimethyl(phenyl)silyl)-9,10-dioxo-1,4,4a,9,9a,10-
hexahydroanthracene-4a-carboxylate (19e) Naphthoquinone 16e 
(22 mg, 0.104 mmol) was used following the general procedure. 
Diels-Alder adduct 19e was obtained as a clear oil (25 mg, 50%). 
1H NMR (CDCl3, 500 MHz): δ 8.07-8.01 (m, 1H), 7.87-7.82 (m, 1H), 7.73-7.66 (m, 2H), 
7.55-7.48 (m, 2H), 7.29 (dd, J = 5.0, 2.1 Hz, 3H), 5.81-5.69 (m, 2H), 4.07-3.95 (m, 2H), 
3.78 (s, 3H), 3.54-3.42 (m, 2H), 3.42-3.31 (m, 1H), 1.93-1.85 (m, 1H), 1.10 (dtd, J = 12.6, 
7.7, 3.6 Hz, 1H), 1.01 (tt, J = 12.3, 5.1 Hz, 1H), 0.77 (s, 9H), 0.51 (s, 3H), 0.44 (s, 3H), -
0.11 (d, J = 6.4 Hz, 6H). 
 
 
5-((Dimethyl(phenyl)silyl)methyl)hex-5-en-3-yn-1-ol (21) A mixture of Pd(PPh3)4, CuI 
and a solution of vinyl bromide 2066 (656 mg, 2.57 mmol) in DMF was treated with n-
BuNH2 (0.64 mL, 6.43 mmol). After 10 min, propargyl alcohol was added, and stirring 
was continued for 1 hr at 50 oC. The mixture was poured into Et2O and filtered through a 
short pad of silica gel. All volatiles removed under reduced pressure, and the residue was 
O
O
H
SiMe2Ph
OTBS
O OMe
19e
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purified over column chromatography with hexane/ethyl acetate (3/1) to afford 21 as a 
yellow oil (496 mg, 79%). 
1H NMR (CDCl3, 500 MHz):
 δ 7.58-7.47 (m, 2H), 7.34 (dd, J = 4.7, 2.0 Hz, 3H), 5.12 (s, 
1H), 4.94 (s, 1H), 3.61 (q, J = 6.3 Hz, 2H), 2.45 (t, J = 6.2 Hz, 2H), 1.88 (s, 2H), 1.55 (t, 
J = 6.2 Hz, 1H), 0.33 (s, 6H). 
 
 
(E)-tert-Butyl((5-((dimethyl(phenyl)silyl)methyl)hexa-3,5-dien-1-yl)oxy) 
dimethylsilane (22) Powdered LiAlH4 (200 mg, 5.31 mmol) was added to a solution of 
enyne 21 (433 mg, 1.77 mmol) in THF (17 mL) at 0 °C. The reaction was stirred under 
reflux condition for 12 hr. The reaction was cooled with an ice/water bath and quenched 
with 1N NaOH. The mixture was filtered through a pad of Celite to remove white solid. 
The mixture was extracted with Et2O (2 x 30 mL), dried over MgSO4 and concentrated 
under reduced pressure to afford crude diene 21a as a light yellow oil (370 mg, 85% 
crude yield). 
1H NMR (CDCl3, 500 MHz):
 δ 6.08 (dt, J = 15.7, 1.0 Hz, 1H), 5.38 (dt, J = 15.1, 7.2 Hz, 
1H), 4.82 (s, 1H), 4.68 (s, 1H), 3.49 (q, J = 6.2 Hz, 2H), 2.23 (q, J = 6.2, 2H), 1.90 (s, 
3H), 0.26 (s, 6H). 
 
To a solution of alcohol 21a (370 mg, 1.50 mmol), triethylamine (0.5 mL, 3.75 mmol), 
and 4-dimethylaminopyridine (4 mg, 0.03 mmol) in CH2Cl2 (5.0 mL) was added TBSCl 
 
 
148 
(250 mg, 1.65 mmol) at rt. After 12 hr, hexane (30 mL) and water (10 mL) were 
introduced into the reaction and layers were separated. The combined organic layers were 
dried over MgSO4, filtered, and concentrated under reduced pressure to obtain an oil. 
Purification over silica gel with hexane/ethyl acetate (50/1) afforded TBS ether 22 as a 
clear oil (490 g, 90%). 
1H NMR (CDCl3, 500 MHz):
 δ 7.53-7.44 (m, 2H), 7.32 (dd, J = 5.0, 1.9 Hz, 3H), 6.06 (d, 
J = 15.9 Hz, 1H), 5.49 (dt, J = 15.2, 7.1 Hz, 1H), 4.78 (s, 1H), 4.63 (s, 1H), 3.53 (t, J = 
7.0 Hz, 2H), 2.29-2.15 (q, J = 7.0 Hz, 2H), 1.89 (s, 2H), 0.87 (s, 9H), 0.25 (s, 6H), 0.03 (s, 
6H). 
 
SiMe2Ph
OTBS
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O
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SiMe2Ph
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16c 23c
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(±)-(1S,4aR,9aS)-1-(2-((tert-Butyldimethylsilyl)oxy)ethyl)-3-((dimethyl(phenyl)silyl) 
methyl)-4a-methyl-1,4,4a,9a-tetrahydroanthracene-9,10-dione (23c) To a mixture of 
menadione 16c (17 mg, 0.0998 mmol) and diene 22 (30 mg, 0.0832 mmol) in dry CH2Cl2 
(0.8 mL) was added 1M solution of Me2AlCl (21 L, 0.021 mmol) in hexane at 0 oC. 
After 1hr, aqueous sat’d-NaHCO3 (1.0 mL) and ethyl acetate (5 mL) was successively 
added. The resulting two layers were separated, and the organic layer was dried over 
MgSO4 and filtered. The filtrate was concentrated under reduced pressure to obtain an oil. 
Purification over silica gel with hexane/ethyl acetate (10/1) afforded 23c as a clear oil (24 
mg, 54%). 
 
 
149 
1H NMR (CDCl3, 500 MHz):
 δ 8.04-7.98 (m, 1H), 7.98-7.90 (m, 1H), 7.75-7.65 (m, 2H), 
7.50-7.41 (m, 2H), 7.31-7.19 (m, 3H), 5.30-5.20 (m, 1H), 3.61-3.49 (m, 2H), 3.06 (d, J = 
5.0 Hz, 1H), 2.71 (s, 1H), 2.38-2.28 (m, 1H), 1.78-1.52 (m, 5H), 1.30 (s, 3H), 0.83 (s, 
9H), 0.30 (d, J = 1.9 Hz, 6H), -0.03 (d, J = 7.7 Hz, 6H). 
 
 
(±)-(4R,4aS,9aS)-Methyl-4-(2-((tert-butyldimethylsilyl)oxy)ethyl)-2-
((dimethyl(phenyl)silyl)methyl)-9,10-dioxo-1,4,4a,9,9a,10-hexahydroanthracene-4a-
carboxylate (24c) To a mixture of naphthoquinone 16e (27 mg, 0.125 mmol) and diene 
22 (30 mg, 0.0832 mmol) in dry CH2Cl2 (0.8 mL) was added 1M solution of Me2AlCl 
(21 L, 0.021 mmol) in hexane at 0 oC. After 1hr, aqueous sat’d-NaHCO3 (1.0 mL) and 
ethyl acetate (5 mL) was successively added. The resulting two layers were separated, 
and the organic layer was dried over MgSO4 and filtered. The filtrate was concentrated 
under reduced pressure to obtain an oil. Purification over silica gel with hexane/ethyl 
acetate (10/1) afforded 23e as a clear oil (42 mg, 94%). 
1H NMR (CDCl3, 500 MHz):
 δ 8.05-7.99 (m, 1H), 7.98-7.91 (m, 1H), 7.71 (pd, J = 7.3, 
1.6 Hz, 2H), 7.43 (dd, J = 7.4, 2.0 Hz, 2H), 7.24 (s, 3H), 5.30-5.25 (m, 1H), 3.75 (t, J = 
6.9 Hz, 1H), 3.63 (s, 3H), 3.57-3.39 (m, 2H), 3.00 (d, J = 11.3 Hz, 1H), 2.28 (ddt, J = 
18.4, 6.8, 2.2 Hz, 1H), 2.01-1.91 (m, 1H), 1.67 (dt, J = 14.0, 0.9 Hz, 1H), 1.64-1.54 (m, 
2H), 1.54-1.44 (m, 1H), 0.82 (s, 9H), 0.28 (d, J = 2.8 Hz, 6H), -0.05 (d, J = 5.1 Hz, 6H). 
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General procedure for one-pot Diels-Alder/annulation sequence 
 
 
To a mixture of menadione 16c (0.130 mmol) and diene 15 (50 mg, 0.144 mmol) in dry 
CH2Cl2 (0.7 mL) was added 1M solution of MeAlCl2 (72 L, 0.072 mmol) in hexane at rt. 
This reaction was stirred at the same temperature, and the reaction progress was 
monitored by TLC. Once the reaction run completion (~6 hr), the reaction was cooled to -
50 oC, and aldehyde 24 (0.288 mmol) and trimethylsilyl trifluoromethanesulfonate (43 
L, 0.288 mmol) was successively added. The reaction was stirred at the same 
temperature for 48 hr before addition of aqueous sat’d-NaHCO3 (1.0 mL) and ethyl 
acetate (5 mL). The resulting two layers were separated, and the organic layer was dried 
over MgSO4 and filtered. The filtrate was concentrated under reduced pressure to obtain 
an oil. Purification over silica gel with hexane/ethyl acetate (20/1 to 10/1) afforded 25 as 
a yellowish solid. 
 
 (±)-(4S,4aR,12aR,12bR)-4-Isopropyl-12a-methyl-4a,5,12a,12b-
tetrahydro-1H-naphtho[2,3-f]isochromene-7,12(2H,4H)-dione 
(25ca) iso-Butylaldehyde 24a (26 L, 0.288 mmol) was used 
following the general procedure. 25ca was obtained as a yellowish solid (31 mg, 66%). 
O
O
O
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1H NMR (CDCl3, 500 MHz):
 δ 8.26-8.21 (m, 1H), 8.16-8.10 (m, 1H), 7.79-7.69 (m, 2H), 
7.23 (t, J = 4.3 Hz, 1H), 3.70-3.55 (m, 2H), 3.04 (d, J = 10.5 Hz, 1H), 2.77 (ddd, J = 21.2, 
10.2, 3.2 Hz, 1H), 2.56 (dt, J = 12.3, 3.7 Hz, 1H), 2.48-2.31 (m, 2H), 2.27 (t, J = 9.0 Hz, 
1H), 1.45 (d, J = 13.0 Hz, 1H), 1.37 (s, 3H), 1.35-1.23 (m, 1H), 1.01 (d, J = 6.4 Hz, 3H), 
0.89 (d, J = 6.6 Hz, 3H); 13C NMR (CDCl3, 126 MHz): δ 198.4, 184.6, 140.4, 136.7, 
134.6, 134.4, 134.0, 133.6, 127.3, 125.4, 83.0, 60.1, 51.6, 34.2, 29.3, 27.9, 27.4, 24.9, 
23.0, 19.5, 19.3. 
 
(±)-(4S,4aR,12aR,12bR)-4-Cyclohexyl-12a-methyl-
4a,5,12a,12b-tetrahydro-1H-naphtho[2,3-f]isochromene-
7,12(2H,4H)-dione (25cb) Cyclohexanecarboxaldehyde 24b (35 
L, 0.288 mmol) was used following the general procedure. 25cb was obtained as a 
yellowish solid. (33mg, 63 %). 
1H NMR (CDCl3, 500 MHz):
 δ 8.23-8.18 (m, 1H), 8.13-8.08 (m, 1H), 7.75-7.67 (m, 3H), 
7.20 (dd, J = 4.4, 3.0 Hz, 1H), 3.61 (td, J = 11.9, 2.5 Hz, 1H), 3.54 (ddd, J = 11.6, 5.5, 1.6 
Hz, 1H), 3.11 (d, J = 10.4 Hz, 1H), 2.74 (ddd, J = 20.7, 9.8, 2.5 Hz, 1H), 2.53 (dt, J = 
12.5, 3.6 Hz, 1H), 2.35-2.20 (m, 2H), 2.13-1.94 (m, 2H), 1.81-1.70 (m, 2H), 1.70-1.56 (m, 
2H), 1.46-1.39 (m, 1H), 1.34 (s, 3H), 1.32-1.05 (m, 3H), 0.96-0.75 (m, 3H); 13C NMR 
(CDCl3, 126 MHz): δ 198.5, 184.5, 140.4, 136.6, 134.5, 134.3, 133.9, 133.5, 127.3, 127.3, 
81.6, 60.1, 51.6, 34.1, 34.0, 29.6, 29.4, 29.2, 27.8, 26.8, 26.3, 25.9, 25.7, 23.0, 15.1. 
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 (±)-(4S,4aR,12aR,12bR)-4-Cyclopentyl-12a-methyl-
4a,5,12a,12b-tetrahydro-1H-naphtho[2,3-f]isochromene-
7,12(2H,4H)-dione (25cc) Cyclopentanecarboxaldehyde 24c (31 
L, 0.288 mmol) was used following the general procedure. 25cc was obtained as a 
yellowish solid (30 mg, 60%). 
1H NMR (CDCl3, 500 MHz): δ 8.24-8.19 (m, 1H), 8.14-8.09 (m, 1H), 7.76-7.68 (m, 2H), 
7.20 (dd, J = 4.4, 3.2 Hz, 1H), 3.70 (td, J = 12.1, 2.8 Hz, 1H), 3.58 (ddd, J = 11.8, 5.3, 1.6 
Hz, 1H), 3.18 (d, J = 10.9 Hz, 1H), 2.84-2.55 (m, 3H), 2.35 (ddd, J = 21.5, 6.8, 4.4 Hz, 
1H), 2.12 (ddd, J = 10.5, 6.5, 3.4 Hz, 1H), 1.84 (td, J = 7.7, 4.0 Hz, 1H), 1.77-1.52 (m, 
6H), 1.46-1.40 (m, 1H), 1.34 (s, 3H), 1.28 (td, J = 12.7, 5.3 Hz, 1H), 1.08-0.96 (m, 1H); 
13C NMR (CDCl3, 126 MHz): 198.5, 184.5, 140.3, 136.7, 134.6, 134.4, 133.9, 133.5, 
127.3, 82.3, 65.7, 60.3, 51.5, 37.5, 34, 3, 29.9, 29.6, 29.3, 29.3, 27.9, 25.5, 25.3, 23.1. 
 
 (±)-(4S,4aR,12aR,12bR)-12a-Methyl-4-(pentan-3-yl)-
4a,5,12a,12b-tetrahydro-1H-naphtho[2,3-f]isochromene-
7,12(2H,4H)-dione (25cd) 2-Ethylbutyraldehyde 24d (36 L, 
0.288 mmol) was used following the general procedure. 25cd was obtained as a 
yellowish solid (33 mg, 65%). 
1H NMR (CDCl3, 500 MHz): δ 8.23-8.19 (m, 1H), 8.13-8.08 (m, 1H), 7.76-7.66 (m, 2H), 
7.21 (dd, J = 4.5, 3.2 Hz, 1H), 3.60 (dd, J = 12.1, 2.8 Hz, 1H), 3.55 (ddd, J = 11.8, 5.6, 
1.5 Hz, 1H), 3.29 (d, J = 11.1 Hz, 1H), 2.76 (ddd, J = 21.3, 10.4, 3.3 Hz, 1H), 2.55 (dt, J 
= 12.5, 3.7 Hz, 1H), 2.33 (ddd, J = 21.3, 6.6, 4.5 Hz, 1H), 2.28-2.21 (m, 1H), 2.11 (dp, J 
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= 11.0, 3.6 Hz, 1H), 1.62 (ddt, J = 13.8, 7.5, 3.6 Hz, 1H), 1.47-1.40 (m, 1H), 1.40-1.32 
(m, 2H), 1.35 (s, 3H), 1.32-1.20 (m, 2H), 0.86 (td, J = 7.5, 5.6 Hz, 6H); 13C NMR 
(CDCl3, 126 MHz): δ 188.4, 184.5, 140.4, 136.7, 134.6, 134.3, 133.9, 133.5, 127.4, 127.3, 
78.4, 60.1, 51.7, 35.6, 34.1, 29.2, 28.0, 27.2, 23.0, 20.9, 20.3, 10.2, 9.6. 
 
 (±)-(4S,4aR,12aR,12bR)-4-Butyl-12a-methyl-
4a,5,12a,12b-tetrahydro-1H-naphtho[2,3-f]isochromene-
7,12(2H,4H)-dione (25ce) Valeraldehyde 24e (30 L, 0.288 
mmol) was used following the general procedure. 25ce was obtained as a yellowish solid 
(19 mg, 40%). 
1H NMR (CDCl3, 500 MHz): δ 8.25-8.21 (m, 1H), 8.15-8.12 (m, 1H), 7.78-7.70 (m, 2H), 
7.22 (t, J = 4.4Hz, 1H), 3.68 (td, J = 12.2, 2.7 Hz, 1H), 3.64-3.54 (m, 2H), 2.75 (ddd, J = 
21.5, 10.5, 3.4 Hz, 1H), 2.63 (dt, J = 12.4, 3.7 Hz, 1H), 2.39 (ddd, J = 21.5, 6.8, 4.4 Hz, 
1H), 2.12-1.96 (m, 2H), 1.50-1.42 (m, 3H), 1.39 (ddt, J = 7.6, 6.1, 2.1 Hz, 1H), 1.36 (s, 
3H), 1.35-1.25 (m, 2H), 1.24 (d, J = 2.6 Hz, 1H), 0.93 (t, J = 7.0 Hz, 3H). 
 
  (±)-(4S,4aR,12aR,12bR)-4-Isobutyl-12a-methyl-
4a,5,12a,12b-tetrahydro-1H-naphtho[2,3-f]isochromene-
7,12(2H,4H)-dione (25cf) iso-Valeraldehyde 24f (31 L, 0.288 
mmol) was used following the general procedure. 25cf was obtained as a yellowish solid 
(15 mg, 31%). 
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1H NMR (CDCl3, 500 MHz): δ 8.25-8.19 (m, 1H), 8.16-8.10 (m, 1H), 7.78-7.66 (m, 2H), 
7.21 (t, J = 3.9 Hz, 1H), 3.75-3.69 (m, 1H), 3.66 (dd, J = 12.3, 2.7 Hz, 1H), 3.56 (ddd, J = 
11.7, 5.1, 1.5 Hz, 1H), 2.74 (ddd, J = 21.5, 10.5, 3.4 Hz, 1H), 2.63 (dt, J = 12.4, 3.7 Hz, 
1H), 2.40 (ddd, J = 21.4, 6.8, 4.4 Hz, 1H), 2.10 (ddd, J = 14.6, 9.9, 5.3 Hz, 1H), 1.94 
(ddd, J = 10.4, 6.4, 3.6 Hz, 1H), 1.77-1.67 (m, 1H), 1.46-1.41 (m, 1H), 1.35 (s, 3H), 1.28 
(td, J = 12.8, 5.2 Hz, 1H), 1.16 (ddd, J = 13.8, 8.7, 4.9 Hz, 1H), 0.95 (dd, J = 12.3, 6.6 Hz, 
6H); 13C NMR (CDCl3, 126 MHz): δ 198.5, 184.5, 140.2, 136.7, 134.6, 134.4, 134.0, 
133.6, 127.4, 127.3, 74.7, 59.8, 51.6, 38.1, 34.3, 31.1, 29.4, 27.8, 24.7, 23.4, 23.3, 22.0. 
 
 (±)-(4S,4aR,12aR,12bR)-4-Cyclopropyl-12a-methyl-
4a,5,12a,12b-tetrahydro-1H-naphtho[2,3-f]isochromene-
7,12(2H,4H)-dione (25cg) Cyclopropanecarboxaldehyde 24g (22 
L, 0.288 mmol) was used following the general procedure. 25cg was obtained as a 
yellowish solid (11 mg, 24%). 
1H NMR (CDCl3, 500 MHz): δ 8.26-8.22 (m, 1H), 8.17-8.12 (m, 1H), 7.79-7.70 (m, 2H), 
7.21 (t, J = 3.9 Hz, 1H), 3.91 (td, J = 12.2, 2.7 Hz, 1H), 3.67 (ddd, J = 11.7, 5.1, 1.5 Hz, 
1H), 2.78 (dt, J = 12.5, 3.7 Hz, 1H), 2.69-2.61 (m, 2H), 2.36 (ddd, J = 21.4, 6.9, 4.4 Hz, 
1H), 2.25 (d, J = 0.7 Hz, 1H), 1.59-1.52 (m, 1H), 1.49 (d, J = 13.5 Hz, 1H), 1.41 (s, 3H), 
1.30 (qd, J = 12.7, 5.1 Hz, 1H), 0.67-0.59 (m, 2H), 0.43 (dtd, J = 7.1, 4.8, 2.9 Hz, 1H), 
0.20-0.14 (m, 1H). 
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Chapter 5 
Studies Directed Toward the Total Synthesis of 
Leiodolide A: 
Preparation of the C13-C29 Fragment 
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5.1 Introduction 
A new species of the rare deep-water marine sponge Leiodermatium (order 
Lithistida, family Azoricidae) was collected by Fenical and coworkers at a depth of 720 
feet in Palau in 2006. Their exploration to identify new marine-derived anticancer agents 
from this rare sponge revealed two interesting cytotoxic 19-membered macrocyclic 
lactones, leiodolides A (1) and B (2).66 Assignment of the structures of leiodolide A and 
B was established by a combination of spectroscopic analyses, degradation, and chemical 
modification studies. However, since the lyophilized sponge (730 g) provided the 
extremely limited supply of leiodolide A (8 mg, 0.001%) and B (0.8 mg, 0.0001%), their 
structures were not fully assigned at that time and both macrolides have at least one 
unassigned stereogenic center. Recently, Fürstner reported a synthesis of the proposed 
structure of leiodolide B (2) along with three other diastereomers arising from the C13, 
C4, and C5 chiral centers.67 However, none of those synthetic compounds produced by 
Fürstner was spectroscopically identical to the naturally isolated leiodolide B, and the 
actual structure of leiodolide B remains unassigned. 
 
Figure 5.1 Structure of leiodolide A (1) and B (2)  
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Leiodolide A (1) and B (2) were found to be significantly cytotoxic against HCT-116 
human colon carcinoma, with IC50 values = 1.4 μg/mL (2.5 μM) and 3.8 μg/mL (5.6 μM), 
respectively. Leiodolide A was also screened against the National Cancer Institute’s 
(NCI) 60-cell line panel and exhibited cytotoxic activity against a number of unrelated 
cell lines including HL-60 (leukemia; 0.26 μM), NCI-H522 (non-small cell lung cancer; 
0.26 μM), and OVCAR-3 (ovarian cancer; 0.25 μM). 
Useful quantities of these scarce materials would be essential to identify their 
relative and absolute stereochemistries, as well as their structure. It would also permit 
further investigations in discovering the underlying biological properties of these 
compounds. Accordingly, our primary objective was to develop an efficient and 
convergent synthetic pathway that would provide sufficient quantities of the proposed 
leiodolide A and B and their diastereomers, which will shed light on the structural 
assignment and structure-activity relationships (SARs). 
 
5.2 Synthetic efforts toward the total synthesis of leiodolides 
To date, only a single synthesis effort toward proposed structure of leiodolide B (2) 
has been reported by Fürstner’s laboratory in 2011.67 Shortly after, Stambuli and 
coworkers reported key fragments synthesis of leiodolide A (1). 68  Although their 
synthetic strategies were similarly aimed to construct the macrocycle utilizing 
macrolactonization and to prepare the lower fragment (C1-C7) under Evans’ aldol 
reaction conditions, each synthesis featured its own unique synthetic pathway to the 
upper fragment, which bears the unassigned C-13 stereocenter.   
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5.2.1 Fürstner’s total synthesis of leiodolide B 
In 2011, Fürstner and coworkers disclosed the first total synthesis effort of leiodolide 
B (2) based on the proposed structure.67 The synthesis began with the preparation of the 
bromofuran core utilizing a silver(I)-mediated cyclization of a hydroxyl-allene. Allenol 
F2 was synthesized from the epoxide F1, which was prepared by an asymmetric 
epoxidation69 using a complex of Ti(Oi-Pr)4 and a salen ligand, through a SN2’ type 
epoxide opening of methyl cuperate. Cyclization of F2 in the presence of Ag(I) catalyst 
afforded dihydrofuran F3 in high yield, which was followed by bromoetherification and 
reduction of the resulting ester to give F4 as a single diastereomer (Scheme 5.1).  
Scheme 5.1 Fürstner synthesis of leiodolide B (2): preparation of fragment F7 
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At this point, the addition of a nucleophile to the aldehyde F4 under chelation-
controlled conditions was expected to follow a Cram-chelation mode of addition, which 
resulted in a secondary alcohol with the desired configuration. Therefore, lithium-halogen 
exchange by treating (S)-F5 with t-BuLi in the presence of MgBr2 and subsequent 
addition of aldehyde F4 successfully constructed intermediate F6 with useful levels of 
selectivity (dr = 4:1). The other C13 epimer was also prepared using (R)-F5 to produce 
the epi-F6 in 85% yield with 6.1:1 diastereoselectivity. Transformation of F6 to F7 was 
accomplished using conventional transformation process involving deprotection of the 
PMB group and iodination. 
 
 
 
Scheme 5.2 Fürstner synthesis of leiodolide B (2): fragments connection 
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The C3-C7 fragment of leiodolide B was efficiently synthesized through an Evans 
aldol reaction. Alkylboron-catalyzed aldol reaction between aldehyde F8 and 
vinylstannane F9 afforded the adduct F10 in 95% yield, and subsequent elimination of 
the auxiliary, protection of the resulting diol, and Stille coupling with 5-oxazolyl triflate 
constructed F11 without issue. Fragment coupling was carried out by alkylation of F11 
with F7 using Et2NLi as a base to furnish F12, which was subjected to a series of 
deprotection-protection and oxidation steps to afford aldehyde F13. The left-hand side 
chain (C26-C29), which bears a (Z)-olefin, was introduced by Wittig olefination, where 
ylide F15 reacted with aldehyde F13 to provide intermediate F14 (Scheme 5.2). 
 
 
The benzoyl group in F14 was removed and the resulting alcohol was oxidized to an 
aldehyde. The required conjugated acid functionality in lactonization precursor F16 was 
Scheme 5.3 Fürstner synthesis of leiodolide B (2): completion of synthesis 
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introduced by a Horner-Wadsworth-Emmons olefination to construct the complete 
carbon backbone of leiodolide B. Lactonization of seco-acid F16 was accomplished 
under Yamaguchi conditions to give advanced intermediate F17. Removal of PMB 
protecting group of F17 proceeded smoothly to give leiodolide B methyl ester F18. 
However, the selective hydrolysis of the methyl ester in the presence of the macrolactone 
turned out to be problematic, and leiodolide B (2) was obtained only in a limited quantity 
when trimethyltin hydroxide was used (Scheme 5.3). In addition, the other epimer epi-
F18 was synthesized following the same process starting from epi-F6.  
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Since the NMR spectrum obtained for the methyl ester F18 differed only in the 
carboxylate terminus region compared to that of synthetic leiodolide B (2), as well as the 
fact that the final hydrolysis step proved to be troublesome, intermediate F18 was used in 
Scheme 5.4 Fürstner synthesis of leiodolide B (2): the leiodolide B puzzle 
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the NMR comparison to the isolated natural product. However, both of the F18 epimers, 
which arose from the unassigned C13, were not matched with the reported spectroscopic 
data. After careful inspection of the NMR spectra, discrepancies were detected in the C2-
C9 region, which led to the synthesis of diastereomeric F18 at C4,C5 (Scheme 5.4). 
However, none of the newly synthesized diastereomers was spectroscopically identical in 
order to confirm the structure of natural leiodolide B (2).   
 
5.2.2 Stambuli’s synthesis of key fragments of leiodolide A 
Shortly after Fürstner’s synthesis, Stambuli and coworkers reported the key fragment 
synthesis of leiodolide A (1).68 Their retrosynthetic analysis revealed three distinct 
fragments: Julia-Kocienski olefination substrate S1, alkyl bromide S2, and vinyl stannane 
S3 (Figure 5.2). In their synthetic plan, fragment S2 and S3 would first be connected 
under Negishi coupling conditions to give a seco-acid, and macrolactonization under 
Mitsunobu conditions would give the macrocyclic core of leiodolide A (1). Finally, the 
left-hand side chain would be introduced by Julia-Kocienski olefination of S1 with an 
Figure 5.2 Stambuli’s synthetic plan for leiodolide A (1) 
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intermediate macrocycle possessing an aldehyde on its left terminus. 
Preparation of the fragment S1 began with sulfonylation of propargylic alcohol S4 
under Mitsunobu conditions, which was followed by SN2 allylation of the terminal alkyne 
to give enyne S5 (Scheme 5.5). The tertiary hydroxyl group in the fragment S1 was 
introduced with 90% ee through Sharpless asymmetric dihydroxylation, and subsequent 
oxidation of the resulting primary alcohol gave acid S6. Then protection of the acid 
followed by reduction of the alkyne to a (Z)-olefin provided the left-hand fragment S1.  
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The contiguous triol system in the fragment S2 was furnished using a chiral pool 
synthesis. Therefore, fragment S2 was synthesized starting from the known S7. 
Transamidation of lactone S7 to a Weinreb amide and subsequent TES protection of the 
Scheme 5.5 Key fragments synthesis of leiodolide A (1) 
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resulting alcohol gave intermediate S8. Reduction of the Weinreb amide S8 to an 
aldehyde and subsequent olefination provided benzyl homoallylic ether S9. A series of 
hydrogenations of S9 removed the olefin and benzyl ether, which was subjected to an 
Appel reaction to afford the desired fragment S2. Similarly, the lower fragment (C1-C7), 
unsaturated ester S3, of leiodolide A was constructed through Evans Aldol reaction 
between S10 and S11 and a subsequent HWE olefination process. 
 
5.3 Synthesis of the C13-C29 fragment of leiodolide A 
Our highest priority in this project was to develop an efficient synthetic pathway to 
upper fragment 3 (Scheme 5.6). An efficient procedure to access the intermediate S3 
(Scheme 5.5), which could be simply converted to the lower fragment 4 by Stille 
coupling, was established earlier by Stambuli using an Evans aldol reaction. For this 
reason, we planned to introduce the vicinal triol system at C15-17 through a directed 
epoxidation of an allylic alcohol followed by an epoxide opening. We anticipated that 
this pathway would be more atom economical compared to the conventional approaches 
to contiguous triol system construction, involving addition of a nucleophile to an ,-
dihydroxyl aldehyde, because an olefin, which showed relatively high tolerance to 
conventional reaction conditions, will be used as a precursor of the diol. 
Accordingly, our disconnection began at C13-14 and C17-O to lead to two distinct 
fragments, 3 and 4. The macrolactone in leiodolide A will be generated through an 
asymmetric conjugate addition between 3 and 4 followed by subsequent Mitsunobu 
esterification. By altering the configuration of the chiral auxiliary in fragment 3, both 
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diastereomers at C13 would be simply prepared. Fragment 5 can be assembled utilizing a 
metal-mediated cross coupling reaction of corresponding subfragments. The tertiary 
hydroxyl group present in the subunit 7 will be introduced by Sharpless asymmetric 
dihydroxylation, and the fragment 6 will be prepared through Noyori’s asymmetric 
reduction of the corresponding ketone. 
 
 
The synthesis of the upper fragment 3 of leiodolide A was initiated with the 
preparation of fragment 6, focusing on an enantioselective synthesis of the propargylic 
alcohol (Scheme 5.7). Initial attempts using Carreira’s asymmetric propargylation70 
between an aldehyde and silyl-protected acetylene were unsuccessful and resulted in the 
formation of an unsaturated homoaldol product. As such, our attention then focused on an 
Scheme 5.6 Retrosynthetic analysis of leiodolide A (1) 
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asymmetric reduction of propargylic ketone 10, which was prepared by addition of bis-
(trimethylsilyl)-acetylene to the acid chloride 8 in the presence of AlCl3.
71 We ultimately 
learned that asymmetric catalytic hydrogen transfer with 1 mol% of Noyori’s catalyst 
afforded the desired propargylic alcohol (S)-11 in 93% with excellent levels of 
enantioselectivity (ee = 97%, Scheme 5.7).72 Alternatively, the same reduction under 
Midland conditions utilizing (S)-Alpine-Borane provided the desired propargylic alcohol 
(S)-11 in 60% yield but after extended reaction time of 3 days.73 
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Since we initially planned to assemble the subfragments utilizing sp-sp2 or sp2-sp2 
coupling approach to construct fragment 5, two different coupling partners were prepared 
from (S)-11. Protodesilylation of (S)-11 using tetrabutylammonium floride (TBAF) 
buffered with acetic acid provided terminal alkyne 12, which will be used for 
Scheme 5.7 Preparation of enantioenriched propargylic alcohol (S)-11and coupling 
partners 12 and 14a 
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Sonogashira coupling. Also, displacement of the TMS group in (S)-11 with iodine in the 
presence of catalytic amount of silver nitrate and subsequent diimide reduction of the 
resulting acetylenyl iodide 13 successfully afforded (Z)-vinyl iodide 14 (four-steps 
overall 51% yield). 
 
 
 
We have carried out an efficient 6-step synthesis of (E)-vinyl stannane 22, which 
was initiated by propargylation of the allyl chloride 15 with trimethylsilylacetylene 16 in 
the presence of CuI to afford the enyne 17 in 70% yield (Scheme 5.8). The tertiary 
hydroxyl group at C28 was introduced through a Sharpless asymmetric dihydroxylation 
of the enyne 17, which provided diol 18 (er = 9:1). Subsequent protection of crude diol 
18 as an acetonide followed by removal of the TMS group afforded intermediate alkyne 
20 (76%, three steps). Deprotonation of the terminal alkyne 20 with n-BuLi and 
subsequent addition of allyl iodide 2174 , which was prepared in three-steps from 
Scheme 5.8 Preparation of vinyl bromide 7 and vinyltin 22a 
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methacrylic acid, provided Sonogashira coupling precursor, (E)-vinyl bromide 7. Also, a 
palladium-mediated stannylation of 7 afforded vinylstannane 22,75 which will be coupled 
with the previously prepared vinyl iodide 14 under Stille conditions. 
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With subfragments in hand, Sonogashira coupling between 7 and 12 was initially 
investigated under various different conditions (Table 5.1.a).76 However, it turned out 
that vinyl halide 7 was unreactive to Sonogashira coupling, while propargylic alcohol 12 
decomposed in the given reaction conditions. Alternatively, coupling reaction of vinyltin 
22 with 14 was explored under Stille conditions to construct conjugated diene 5 (Table 
5.1.b). The fragment connection under conventional coupling conditions, which was 
Table 5.1 Fragment couplings under Sonogashira and Stille conditions 
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reported by Stille,77 gave a mixture of byproducts (entry 1). Fortunately, the use of 
stoichiometric amount of copper(I)-thiophene-2-carboxylate (CuTC) provided the desired 
product 5 without any detectable double bond isomerized (E,E)-product.78 The optimal 
conditions for the coupling reactions utilized 2.0 equiv of CuTC at 0 oC, which provided 
the conjugated diene 5 in 66% yield (entry 3). The reaction utilizing CuCl instead of 
CuTC gave an inferior result (52% yield, entry 4). The same reaction in the absence of 
copper catalyst resulted in no reaction (entry 5), which demonstrated the necessity of the 
copper cocatalysts for successful coupling reaction. 
 
 
 
To introduce the vicinal triol at C15-C17 in the upper fragment 3, we initially 
planned to use a directed epoxidation of the allylic alcohol in 5 (Scheme 5.9). For that 
reason, allylic alcohol (E,Z)-5 was exposed to conventional epoxidation conditions using 
mCPBA in the presence of NaHCO3 to furnish epoxide 24.
79 However, it turned out that 
Scheme 5.9 Efforts to introduce the contiguous C15-C17 triol functionalitya 
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the resulting epoxide was highly unstable and quickly decomposed to give a complex 
mixture of unidentifiable compounds. Given this stability issue, the crude epoxide was 
directly used in further transformations without purification. Epoxide opening reactions 
utilizing benzoic acid as a nucleophile under acidic conditions failed to introduce the 
desired triol system.80 In addition, efforts to methylate the secondary hydroxyl group in 5 
under conventional O-methylation conditions using MeOTf, TMS-diazomethane, and 
Me3O·BF4 proved to be unsuccessful.  
For comparison, another epoxidation substrate (E,E)-5 was synthesized using 
racemic allylic alcohol 27, which was prepared from the corresponding propargyl ketone 
through an iodination and subsequent reduction of the ketone. Similarly, directed 
epoxidation of 5 using mCPBA gave the desired epoxide trans-26, which was expected to 
be more stable than cis-26. However, trans-26 also proved to be unstable, and further 
attempts to open the unstable epoxide under several conditions resulted in unidentifiable 
byproducts caused by decomposition of trans-26 (Scheme 5.10). 
 
 
Scheme 5.10 Our efforts to introduce the contiguous C15-C17 triol functionalitya 
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Considering the structure and functional groups of diene 5, halolactonization of 5 
was envisioned as an alternative route to the desired fragment 3. In this alternative 
process, the formation of an unstable epoxide intermediate would be avoided, and the 
configuration of the allylic alcohol could potentially dictate the stereoselectivity of the 
halolactonization. It was presumed that iodolactonization of 5 would operate differently 
depending on the reaction conditions used (kinetic vs thermodynamic control).81 In our 
transition state prediction, both conformers, TS1 and TS2, were predicted by considering 
those in which the OMe group would be aligned perpendicularly to the olefin to 
maximize the orbital interaction between the C-O and C=C, and, concomitantly, the 
allylic hydrogen would be eclipsed with the (Z)-double bond to minimize A1,3-strain 
(Figure 5.3).82 If this reaction goes through TS1, the iodonium bridged ion will be 
formed on the less hindered -face of the olefin, which may lower the transition state 
energy and decrease the rate of lactonization. However, this process will suffer from 
torsional strain in the cyclization step, because back-side attack of the iodonium ion will 
occur between the OMe and tethered carbons (TS1’). Conversely, if iodolactonization 
proceeds through TS2, it will suffer from more steric hindrance in the approaching mode 
of iodine to the olefin, because formation of an iodonium ion will occur on the same face 
as OMe group. However, it is expected that this pathway will proceed with less torsional 
strain in the cyclization step (TS2’). 
Usually, iodolactonization under basic conditions is known to operate under kinetic 
control to give a syn-lactone (TS1), while the reaction under non-basic conditions should 
allow for a reversible reaction pathway to construct the more stable anti-product (TS2).81 
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Based on the expectations, the syn-lactone should give direct access to the desired 
fragment 3 through simple transformation steps. Therefore, our initial attempts for the 
iodolactonization commenced under basic conditions to construct the desired syn-lactone, 
which can serve as an alternative route to the directed epoxidation through an additional 
hydrolysis of lactone.  
 
 
To this end, the allylic alcohol (E,Z)-5 was alkylated to afford the methyl ether, 
which is the required functionality at C15 in leiodolide A, to give intermediate 29 
(Scheme 5.11). Hydrolysis of the methyl ester utilizing LiOH and subsequent treatment 
of the resulting acid 28 (shown in Figure 5.3) with kinetic iodolactonization conditions in 
the presence of the base 2,6-lutidine constructed lactone 30 in 67% as a single 
diastereomer.83 In this reaction, formation of a 6-membered lactone was anticipated,84 as 
Figure 5.3 Possible pathways in iodolactonization of 28 
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the construction of the 7-membered ring is kinetically less favored over that of the 6-
membered ring. However, careful NMR analysis revealed that this iodolactonization 
selectively formed the 7-membered iodolactone 30 through the trapping of the iodonium 
ion at the allylic position. At this point, determination of relative stereochemistry of 30 
was crucial prior to pursuing further transformations. Our initial characterization was 
carried out using NOE experiments, but failed to provide sufficient evidence to confirm 
the relative stereochemistry of 30 because of inconsistent correlations between the -
protons at C13 and the allylic proton at C17. 
O
O
CO2MeHO
O
O
CO2MeMeO
(E,Z)-5 29
O
O
O
O
I
OMe
30
aReagents & conditions; a) MeOTf, di-(t-Bu)-Me-Pyr., CH2Cl2, rt, 67%; b) i. LiOH, THF/H2O, ii. NIS,
2,6-lutidine, CH2Cl2, 0 oC, 67% (2 steps)
a
b
13
17
 
 
To deduce the relative stereochemistry of lactone 30, a model system, which has the 
same reaction core as compound 29, was prepared through a Stille coupling between 
vinyltin 31 and vinyl iodide 32 in the presence of PdCl2(MeCN)2 (Scheme 5.12). 
Interestingly, the coupling reaction using CuTC as a cocatalyst gave an inferior result 
(75% yield) in this case. Hydrolysis of methyl ester 33 using LiOH and subsequent 
treatment of the resulting acid under basic conditions also gave 7-membered lactone 34 
Scheme 5.11 Iodolactonization pathway to lactone 30a 
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as a single diastereomer. To confirm the stereochemistry, protection of lactone 34 as a 
triphenylsilyl ether followed by oxidation of the double bond provided diol 35, which 
was successfully crystallized using a slow diffusion method in a hexane and CH2Cl2 
system and analyzed by X-ray crystallography. 
 
 
Disappointingly, however, X-ray crystal analysis revealed that iodolactonization of 
33 under kinetic conditions furnished the undesired anti-lactone 35, which was expected 
to be produced under thermodynamic conditions. Considering the similarity in the 
structure between the iodolactonization precursors, 29 and 33, this result is enough to 
Scheme 5.12 Assignment of the structure of lactone 34a 
 
 
175 
deduce the relativechemistry of 30. For comparison, the iodolactonization of 33 was 
perfomed under thermodynamic conditions in the absence of a base to see if a turnover in 
the stereoselectivity is possible. However, the reaction conditions caused decomposition 
of lactonization substrate 33 and gave a mixture of unidentifiable products.  
 
  
In the iodolactonization of 29 and 33, only one lactonized product was observed 
throughout the course of the reaction, which implied that no thermodynamic equilibration 
had occurred. However, the observed anti stereochemistry represents that this reaction 
was actually controlled through the thermodynamic pathway to give the more stable anti-
lactones. Based on these results, we concluded that this reaction was dictated by only one 
Scheme 5.13 Plausible pathway to anti-iodolactone 30 
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pathway to the thermodynamically stable products regardless of the conditions used. Also, 
it seemed that since the formation of iodonium ion is reversible and lactonization should 
irreversibly occur from the back side of the bridged ion in given conditions, the 
cyclization pathway, which suffers from less torsional strain in the cyclization step, 
determined the stereoselectivity outcome of this iodolactonization.      
 
5.4 Conclusion 
We established an efficient synthetic pathway to the conjugated (E,Z)-diene 5 
through a series of cross coupling reactions involving Stille reaction. This process is 
highly efficient and atom economic, because only one protection step was needed. 
Although proper conditions for the oxidation of the (Z)-olefin to introduce the contiguous 
C15-C17 triol system in leiodolide A have not been worked out yet, application of this 
synthetic route to the preparation of an C13-C29 fragment would be useful in the total 
synthesis of leiodolide A. 
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5.5 Experimental section 
 
Methyl 4-oxo-6-(trimethylsilyl)hex-5-ynoate (10) The anhydrous aluminum chloride 
(8.6 g, 64.5 mmol) in CH2Cl2 (20 mL) at 0 
oC was added to a mixture of 
bis(trimethylsilyl)ethyne 9 (5 mL, 22.6 mmol) and 3-carbomethoxypropanoyl chloride 8, 
(2.7 mL, 21.5 mmol) in CH2Cl2 (100 mL) over a period of 30 min. The black solution 
was allowed to stir at rt for 3 h. The mixture was cooled to 0 oC, and 1 M HCl was added 
cautiously with rapid stirring. Addition was continued until the white precipitate 
redissolved in the aqueous layer. After warming, the aqueous layer was extracted several 
times with CH2C12 (2 x 50 mL). The combined organic layers was dried over MgSO4 and 
filtered. The filtrate was concentrated under reduced pressure to obtain a clear oil. 
Purification over silica gel with hexane/ethyl acetate (10/1) afforded 10 as a clear oil (3.4 
g, 74%). The spectral data for compound 10 was in agreement with those previously 
reported.71 
1H NMR (CDCl3, 500 MHz): δ
 3.67 (s, 3H), 2.89 (t, J = 6.7 Hz, 2H), 2.62 (t, J = 6.7 Hz, 
2H), 0.22 (s, 8H). 
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(S)-Methyl 4-hydroxy-6-(trimethylsilyl)hex-5-ynoate (11) A solution of ((S,S)-
TsDPEN)Ru(p-cymene) (95 mg, 0.16 mmol) in 2-propanol (80 mL) degassed using 
freeze-pump-thaw method under Ar atmosphere. A solution of 10 (3.4 g, 16 mmol) in 
degassed 2-propanol (20 mL) was slowly added to the reaction mixture using syringe 
pump over 3hr at rt, and the reaction mixture was stirred for additional 12 hr. Then 2-
propanol was removed under reduced pressure, and the resulting residue was purified 
over silica gel with hexane/ethyl acetate (5/1) to afford 11 as a clear oil (3.2 g, 93%) 
[α]D
20 = -50.0 (c 1.5, CHCl3). 
1H NMR (CDCl3, 500 MHz): δ 4.44 (dt, J = 6.5, 5.7 Hz, 1H), 3.67 (s, 3H), 2.52 (qt, J = 
16.7, 7.3 Hz, 2H), 2.07-1.94 (m, 2H), 0.15 (s, 9H); 13C NMR (CDCl3, 126 MHz): δ 
173.99, 105.71, 69.28, 61.55, 51.68, 32.26, 29.63, 29.59, 27.70, -0.27; IR (film) υmax: 
3442.0, 2957.8, 1740.1, 1439.7, 1251.3 cm-1; HRMS (CI, NH3) m/z calc’d for 
C10H18O3Si [M+H]
+ 214.1025, found: 215.1109.  
  
 
(S)-Methyl 4-hydroxyhex-5-ynoate (12) 1M solution of TBAF (1.8 mL, 1.83 mmol) in 
THF and acetic acid (57 L, 0.996 mmol) were added simultaneously drop by drop to a 
solution of alkyne 11 (356 mg, 1.66 mmol) in THF (16 mL) via syringe at 0 °C. The 
reaction was allowed to react for 30 min before being concentrated under reduced 
pressure. Et2O (20 mL) and sat’d.-NH4Cl (10 mL) were successively added, and the 
resulting two layers were separated. The organic layer was dried over MgSO4 and filtered. 
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The filtrate was concentrated under reduced pressure to obtain an oil. Purification over 
silica gel with hexane/ethyl acetate (3/1) afforded 12 as a clear oil (226 mg, 96%). 
1H NMR (CDCl3, 500 MHz): δ 4.50-4.44 (td, J = 5.1, 2.2, 1H), 3.67 (s, 3H), 2.57 (qt, J = 
21.9, 7.4 Hz, 2H), 2.46 (d, J = 2.1 Hz, 1H), 2.07-1.98 (m, 2H). 13C NMR (CDCl3, 126 
MHz): δ 174.0, 83.9, 73.4, 61.2, 51.8, 32.1, 29.5; IR (film) υmax: 3455.3, 3293.9, 2953.6, 
1733.3, 1440.1, 1261.8 cm-1. 
 
 
(S,Z)-Methyl 4-hydroxy-6-iodohex-5-enoate (14) To a solution of (S)-11 (500 mg, 2.33 
mmol) in DMF (4.5 mL) was sequentially added N-iodosuccinimide (NIS) (630 mg, 2.80 
mmol) and AgNO3 (40 mg, 0.233 mmol). The mixture was stirred at room temperature 
for 30 min before addition of Et2O (20 mL) and sat’d-Na2SO3 (5 mL) solution. The 
resulting two layers were separated, and the organic layer was dried over MgSO4 and 
filtered. The filtrate was concentrated under reduced pressure to obtain a crude oil. (520 
mg, 85% crude yield). Crude 13 was directly used for the next reduction step without 
purification. 
1H NMR (CDCl3, 500 MHz): δ 4.59 (dt, J = 6.4, 5.7 Hz, 1H), 3.68 (s, 3H), 2.55 (qt, J = 
20.3, 7.4 Hz, 2H), 2.39 (d, J = 5.7 Hz, 1H), 2.09-1.95 (m, 2H). 
 
To a solution of dipotassium azodicarboxylate (2.3 g, 11.6 mmol), crude iodoalkyne 13 
(520 mg, 1.94 mmol), and pyridine (1.1 mL, 13.6 mmol) in methanol (19 mL) was added 
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acetic acid (0.7 mL, 13.6 mmol) dropwise over 1 hr. Following the addition, the reaction 
mixture was diluted with ethyl acetate (50 mL) and washed successively with H2O (5 
mL). The resulting two layers were separated, and the organic layer was dried over 
MgSO4 and filtered. The filtrate was concentrated under reduced pressure to obtain an oil. 
Purification by column chromatography hexane/ethyl acetate (3/1) afforded 25 as a clear 
oil (460 mg, 74%, two steps) [α]D
20 = -90.0 (c 1.4, CHCl3). 
1H NMR (CDCl3, 500 MHz): δ 6.34 (dd, J = 7.7, 1.0 Hz, 1H), 6.25 (t, J = 7.6 Hz, 1H), 
4.42 (dq, J = 8.3, 4.7, 4.0 Hz, 1H), 3.67 (s, 3H), 2.47 (td, J = 7.3, 1.7 Hz, 2H), 2.01-1.82 
(m, 2H); 13C NMR (CDCl3, 126 MHz): δ 174.11, 142.73, 82.46, 73.55, 51.73, 30.61, 
29.83; ; IR (film) υmax: 3491.5, 2950.9, 1735.1, 1438.7, 1270.1 cm
-1; HRMS (CI, NH3) 
m/z calc’d for C7H11IO3 [M-H2O]
+ 252.9725, found: 252.9722.  
 
 
Trimethyl(4-methylpent-4-en-1-yn-1-yl)silane (17) To a stirred solution of 
trimethylsilylacetylene 16 (4 mL, 28.3 mmol) in dry DMF (28 mL) under Ar was 
sequentially added K2CO3 (5.8 g, 42.4 mmol), tetrabutylammonium iodide (1.04 mg, 2.83 
mmol), and copper(I) iodide (268 mg, 1.42 mmol) at rt. After 15 min, 2-methylallyl 
chloride 15 (4.8 mL, 42.4 mmol) was added, and the reaction mixture was stirred for 12 
hr. Then the reaction was quenched with H2O (20 mL), extracted with Et2O (60 mL), and 
dried over MgSO4. The organic layer was concentrated under reduced pressure, and flash 
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column chromatography on silica gel (petroleum ether only) gave 17 as a clear oil (2.96 
g, 70%). 
1H NMR (CDCl3, 500 MHz): δ 5.00 (s, 1H), 4.82 (d, J = 2.3 Hz, 1H), 2.92 (s, 2H), 1.76 
(s, 3H), 0.15 (s, 9H); 13C NMR (CDCl3, 126 MHz): δ 140.1, 111.7, 103.9, 86.9, 28.5, 
22.3, 0.1; IR (film) υmax: 3078.9, 2960.6, 2177.9, 1657.2, 1444.7, 1249.8 cm
-1. 
 
17
TMS
HO
HO
18
TMS
 
 
(S)-2-Methyl-5-(trimethylsilyl)pent-4-yne-1,2-diol (18) To a solution of enyne 17 (1.8 
g, 11.7 mmol) in a mixture of tert-butylalcohol and H2O (100 mL, 10/1) was added AD-
mix- (16.3 g) at 0 oC. The yellow reaction mixture was stirred for 18 hr at 0 oC. Ethyl 
acetate (100 mL) and H2O (20 mL) were added to the reaction mixture, and the resulting 
two layers were separated. The organic layer was dried over MgSO4 and concentrated 
under reduced pressure to give an oil. Purification by column chromatography on silica 
gel (hexane/ethyl acetate = 1/1) afforded 18 as a clear oil (1.94g, 89%).  
1H NMR (CDCl3, 500 MHz): δ 2.52 (d, J = 16.8 Hz, 1H), 2.41 (d, J = 16.8 Hz, 1H), 1.25 
(s, 3H), 0.14 (s, 9H); 13C NMR (CDCl3, 126 MHz): δ 102.8, 87.8, 72.1, 68.5, 30.2, 23.2, -
0.05; IR (film) υmax: 3395.6, 2960.3, 2175.7, 1459.5, 1249.6 cm
-1. 
 
 
 
 
 
182 
(S)-2,2,4-Trimethyl-4-(prop-2-yn-1-yl)-1,3-dioxolane (20) To a solution of diol 18 
(1.94 g, 10.4 mmol) in CH2Cl2 (100 mL) was added 2,2-dimethoxypropane (12.8 mL, 
104 mmol) at rt. PTSA monohydrate (490 mg, 2.6 mmol) and MgSO4 (2.5g, 20.8 mmol) 
was successively added to the mixture, which was stirred for 30 min at rt. The reaction 
was quenched with sat’d.-NaHCO3 (20 mL), the resulting two layers was separated. The 
organic layer was dried over MgSO4 and concentrated under reduced pressure to give 
crude 19 as a clear oil.  
1H NMR (CDCl3, 500 MHz): δ 4.03 (d, J = 8.5 Hz, 1H), 3.69 (dd, J = 8.5, 0.8 Hz, 1H), 
2.53 (dd, J = 16.8, 0.6 Hz, 1H), 2.40 (dd, J = 16.8, 0.8 Hz, 1H), 1.38 (s, 3H), 1.36 (s, 3H), 
1.30 (s, 3H), 0.11 (s, 9H). 
 
To a solution of the crude alkyne 19 (10.4 mmol, based on 18 used in the previous step) 
in THF (35 mL) was added 1M solution of TBAF (11.4 mL, 11.4 mmol) in THF and 
acetic acid (0.36 mL, 6.24 mmol) at 0 °C. The reaction was allowed to react for 30 min 
before being concentrated under reduced pressure. Et2O (50 mL) and sat’d.-NH4Cl (10 
mL) were successively added, and the resulting two layers were separated. The organic 
layer was dried over MgSO4 and filtered. The filtrate was concentrated under reduced 
pressure to obtain an oil. Purification over silica gel with petroleum ether/ Et2O (20/1) 
afforded 20 as a clear oil (1.37 g, 85% over two steps). 
1H NMR (CDCl3, 500 MHz): δ 3.99 (d, J = 8.6 Hz, 1H), 3.73 (dd, J = 8.5, 0.7 Hz, 1H), 
2.52-2.36 (m, 2H), 1.98 (t, J = 2.7 Hz, 1H), 1.40 (s, 6H), 1.37 (s, 3H); 13C NMR (CDCl3, 
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126 MHz): δ 109.7, 80.5, 79.8, 73.1, 70.0, 29.9, 27.1, 26.6, 24.0; IR (film) υmax: 3309.6, 
2986.4, 1457.0, 1380.0, 1244.0 cm-1. 
 
 
 
(S,E)-4-(6-Bromo-5-methylhex-5-en-2-yn-1-yl)-2,2,4-trimethyl-1,3-dioxolane (7) To a 
solution of terminal alkyne 20 (376 mg, 2.44 mmol) in dry THF (12 mL) was added 2.5M 
solution of n-BuLi (1.0 mL, 1.6 M in hexanes, 2.44 mmol) in hexane dropwise at 0 oC 
over 5 min under Ar atmosphere. After 10 min, allyl iodide 21 (0.7 g, 2.68 mmol) was 
added dropwise by syringe at 0 oC. The reaction mixture was allowed to warm to rt and 
stirred for 12 hr, diluted with H2O (5 mL), and extracted with ether (20 mL). The organic 
layer was dried over MgSO4 and concentrated. Purification by column chromatography 
with hexane/ethyl acetate (50/1 to 30/1) afforded 7 as a clear oil (624 mg, 88%). Since 
this compound was unstable, it was directly used for the next reaction after purification. 
1H NMR (CDCl3, 500 MHz): δ 6.18 (s, 1H), 3.96 (d, J = 8.5 Hz, 1H), 3.71 (dd, J = 8.5, 
0.7 Hz, 1H), 2.93 (s, 2H), 2.54-2.30 (m, 2H), 1.82 (s, 3H), 1.39 (s, 3H), 1.37 (s, 6H). 
LRMS (CI, NH3) m/z calc’d for C13H20BrO2 [M+H]
+ 287.0641, found: 287.1. 
 
 
 
(S,E)-Trimethyl(2-methyl-6-(2,2,4-trimethyl-1,3-dioxolan-4-yl)hex-1-en-4-yn-1-
yl)stannane (22) Vinyl bromide 7 (670 mg, 2.33 mmol) and Pd(PPh3)4 (135 mg, 0.117 
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mmol) was dissolved in dry toluene (23 mL) under Ar. The reaction mixture was 
degassed with a stream of argon for 30 min. Hexamethylditin (0.58 mL, 2.80 mmol, from 
Aldrich) and diisopropylethylamine (0.2 mL, 1.17 mmol) was added to the reaction, 
which was stirred for 12 hr at 90 oC. Then another portion of Pd(PPh3)4 (135 mg, 0.117 
mmol) was added, and the reaction was stirred for 12 hr. The reaction was cooled to rt 
and concentrated using a stream of N2 inside a fume hood to give brown oil. Purification 
by column chromatography over neutral Al2O3 with hexane/ethyl acetate (50/1) afforded 
22 as a clear oil (440 mg, 50%) [α]D
20 = -2.2 (c 1.4, CHCl3). 
1H NMR (CDCl3, 500 MHz): δ 5.81 (d, J = 0.7 Hz, 1H), 4.01 (d, J = 8.5 Hz, 1H), 3.71 
(dd, J = 8.5, 0.8 Hz, 1H), 3.01-2.92 (m, 2H), 2.56-2.37 (m, 2H), 1.80 (s, 3H), 1.39 (s, 
6H), 1.37 (s, 3H), 0.14 (s, 9H).; 13C NMR (CDCl3, 126 MHz): δ 148.64, 124.48, 109.64, 
80.45, 79.34, 79.23, 73.24, 31.15, 30.45, 27.19, 26.86, 24.45, 23.60, -8.93; IR (film) υmax: 
2982.2, 2930.8, 1615.3, 1434.8, 1242.1 cm-1. HRMS (CI, NH3) m/z calc’d for C16H28O2 
Sn [M+H]+ 373.1190, found: 373.1147. 
 
 
 
(S,5Z,7E)-Methyl 4-hydroxy-8-methyl-12-((S)-2,2,4-trimethyl-1,3-dioxolan-4-
yl)dodeca-5,7-dien-10-ynoate (5) Vinyltin 22 (470 mg, 1.27 mmol) and vinyl iodide 14 
(286 mg, 1.06 mmol) was dissolved in a mixture of THF (5 mL) and DMSO (5 mL) 
under Ar. The mixture was cooled to 0 oC, Pd2(dba)3 (49 mg, 0.053 mmol), AsPh3 (260 
mg, 0.848 mmol), and CuTC (400 mg, 2.12 mmol) were added. The reaction was stirred 
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for 2 hr at 0 oC before being quenched with sat’d.-NH4Cl (5 mL) and diluted with ethyl 
acetate (10 mL). Then the aqueous layer was removed, and the remaining organic layer 
was washed with sat’d.-NaHCO3 (5 mL). The organic layer was dried over MgSO4 and 
filtered. The filtrate was concentrated under reduced pressure to obtain an brown oil. 
Purification over silica gel with hexane/ethyl acetate (5/1 to 3/1) afforded 5 as a clear oil 
(245 mg, 66%). 
1H NMR (CDCl3, 500 MHz): δ 6.31 (d, J = 11.5 Hz, 1H), 6.24 (dd, J = 11.5, 10.5 Hz, 
1H), 5.36 (dd, J = 10.5, 9 Hz, 1H), 4.63 (td, J = 8.5, 5.5 Hz, 1H), 3.95 (d, J = 8.6 Hz, 1H), 
3.67 (d, J = 8.6 Hz, 1H), 3.60 (s, 3H), 2.89 (s, 2H), 2.50-2.32 (m, 4H), 1.89-1.79 (m, 1H), 
1.80-1.74 (m, 1H), 1.73 (s, 3H), 1.36 (s, 6H), 1.32 (s, 3H); 13C NMR (CDCl3, 126 MHz): 
δ 174.06, 135.94, 131.79, 125.84, 119.97, 109.69, 80.29, 79.11, 78.36, 73.16, 66.78, 
51.49, 32.13, 30.36, 29.93, 29.24, 27.11, 26.72, 24.40, 16.35; IR (film) υmax: 3517.8, 
2985.7, 1738.8, 1438.6, 1377.9, 1244.3 cm-1; HRMS (CI, NH3) m/z calc’d for C20H30O5 
[M+Na]+ 373.1991, found: 373.2001.  
 
 
(S)-Methyl 4-hydroxy-4-((2R,3S)-3-((E)-2-methyl-6-((S)-2,2,4-trimethyl-1,3-dioxolan 
-4-yl)hex-1-en-4-yn-1-yl)oxiran-2-yl)butanoate (cis-24) To solution of (E,Z)-5 (20 mg, 
0.057 mmol) in CH2Cl2 (0.6 mL) was added NaHCO3 (10 mg, 0.114 mmol) and mCPBA 
(77%, 15 mg, 0.0685 mmol) at 0 oC. The reaction was stirred for 1 hr at 0 oC and 
quenched with Me2S (2 L, 0.0285 mmol). Then the mixture was filtered through a pad 
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of Celite® and concentrated under reduced pressure to afford unstable epoxide cis-24, 
which was directly used for the next reaction. 
1H NMR (CDCl3, 500 MHz): δ 5.30 (dd, J = 8.2, 1.4 Hz, 1H), 3.96 (d, J = 8.5 Hz, 2H), 
3.73-3.69 (m, 2H), 3.66 (s, 3H), 3.54 (tdd, J = 8.2, 4.6, 3.5 Hz, 1H), 3.05 (dd, J = 7.7, 4.4 
Hz, 1H), 2.90 (d, J = 2.1 Hz, 2H), 2.57-2.35 (m, 4H), 2.17 (d, J = 3.6 Hz, 2H), 1.91-1.74 
(m, 1H), 1.81 (s, 3H), 1.38 (s, 3H), 1.37 (s, 3H), 1.36 (s, 3H). 
 
 
 
(5E,7E)-Methyl 4-hydroxy-8-methyl-12-((S)-2,2,4-trimethyl-1,3-dioxolan-4-
yl)dodeca-5,7-dien-10-ynoate ((E,E)-5) Vinyltin 22 (164 mg, 0.444 mmol) and vinyl 
iodide (E)-27 (100 mg, 0.370 mmol) was dissolved in a mixture of THF (2 mL) and 
DMSO (2 mL) under Ar. The mixture was cooled to 0 oC, Pd2(dba)3 (17 mg, 0.0185 
mmol), AsPh3 (90 mg, 0.296 mmol), and CuTC (141 mg, 0.740 mmol) were added. The 
reaction was stirred for 2 hr at 0 oC before being quenched with sat’d.-NH4Cl (2 mL) and 
diluted with ethyl acetate (5 mL). Then the aqueous layer was removed, and the 
remaining organic layer was washed with sat’d.-NaHCO3 (3 mL). The organic layer was 
dried over MgSO4 and filtered. The filtrate was concentrated under reduced pressure to 
obtain an brown oil. Purification over silica gel with hexane/ethyl acetate (3/1) afforded 
(E,E)-5 as a clear oil (100 mg, 77%). 
1H NMR (CDCl3, 500 MHz): δ 6.42 (dd, J = 15.1, 10.9 Hz, 1H), 6.04 (d, J = 11 Hz, 1H), 
5.60 (dd, J = 15.2, 6.6 Hz, 1H), 4.21 (q, J = 6.3 Hz, 1H), 4.00 (d, J = 8.5 Hz, 1H), 3.71 (d, 
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J = 8.5 Hz, 1H), 3.65 (s, 3H), 2.90 (s, 2H), 2.53-2.37 (m, 4H), 1.92-1.80 (m, 2H), 1.77 (s, 
3H), 1.39 (s, 3H), 1.38 (s, 3H), 1.36 (s, 3H). 
 
O
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trans-26(E,E)-5  
 
Methyl 4-hydroxy-4-(3-((E)-2-methyl-6-((S)-2,2,4-trimethyl-1,3-dioxolan-4-yl)hex-1-
en-4-yn-1-yl)oxiran-2-yl)butanoate (trans-26) To solution of (E,E)-5 (14 mg, 0.040 
mmol) in CH2Cl2 (0.4 mL) was added NaHCO3 (7 mg, 0.080 mmol) and mCPBA (77%, 
11 mg, 0.0480 mmol) at 0 oC. The reaction was stirred for 1 hr at 0 oC and quenched with 
Me2S (2 L, 0.0285 mmol). Then the mixture was filtered through a pad of Celite® and 
concentrated under reduced pressure to afford unstable epoxide trans-24, which was 
directly used for the next reaction. 
1H NMR (CDCl3, 500 MHz): δ 5.13 (d, J = 8.6 Hz, 1H), 3.96 (d, J = 8.8, 1H), 3.69 (d, J 
= 8.5 Hz, 1H), 3.66 (s, 3H), 3.65-3.54 (m, 2H), 2.95-2.89 (m, 1H), 2.87 (s, 2H), 2.53-2.35 
(m, 4H), 2.02-1.74 (m, 2H), 1.81 (s, 3H), 1.38 (s, 3H), 1.36 (s, 6H). 
 
 
 
(S,5Z,7E)-Methyl 4-methoxy-8-methyl-12-((S)-2,2,4-trimethyl-1,3-dioxolan-4-
yl)dodeca-5,7-dien-10-ynoate (29) To a solution of (E,Z)-5 (90 mg, 0.257 mmol) and 
2,5-di(tert-butyl)-4-methyl-pyridine (105 mg, 0.514 mmol) in dry CH2Cl2 (0.5 mL) was 
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added methyl trifluoromethansulfonate (85 mL, 0.771 mmol) at rt. The reaction was 
allowed to react for 48 hr at rt. Then ethyl acetate and H2O were added to the reaction, 
and the resulting two layers were separated. The organic layer was dried over MgSO4 and 
concentrated under reduced pressure to give an oil. Purification over silica gel with 
hexane/ethyl acetate (6/1) afforded 29 as an oil (63 mg, 67 %). 
1H NMR (CDCl3, 500 MHz): δ 6.36 (t, J = 11.5 Hz, 1H), 6.28 (d, J = 11.4 Hz, 1H), 5.23-
5.18 (d, J = 10 Hz,1H), 4.12 (dd, J = 8.9, 7.2 Hz, 1H), 3.98 (d, J = 8.5 Hz, 1H), 3.70 (d, J 
= 8.4 Hz, 1H), 3.62 (s, 3H), 3.21 (s, 3H), 2.92 (s, 2H), 2.45 (qt, J = 16, 2.5 Hz, 2H), 2.35 
(t, J = 7.6 Hz, 2H), 1.94-1.82 (m, 1H), 1.77 (s, 3H), 1.76-1.70 (m, 1H), 1.37 (s, 6H), 1.35 
(s, 3H); 13C NMR (CDCl3, 126 MHz): δ 173.86, 135.95, 130.10, 127.68, 119.99, 109.73, 
80.33, 79.18, 78.47, 75.52, 73.27, 56.15, 51.45, 30.53, 30.42, 29.88, 29.37, 27.20, 26.82, 
24.44, 16.40. IR (film) υmax: 2983.9, 2927.4, 1739.5, 1437.8, 1370.5, 1243.3cm
-1; HRMS 
(CI, NH3) m/z calc’d for C21H32O5 [M+Na]
+ 387.2148, found: 387.2155.  
 
 
(5S,6R,7R)-6-Iodo-5-methoxy-7-((E)-2-methyl-6-((S)-2,2,4-trimethyl-1,3-dioxolan-4-
yl)hex-1-en-4-yn-1-yl)oxepan-2-one (30) To a solution of methyl ester 29 (20 mg, 
0.0549 mmol) in a mixture of THF (0.5 mL) and H2O (0.5 mL) was added LiOH (3 mg, 
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0.11 mmol) at rt. The reaction was stirred for 12 hr at rt and acidified with 1N HCl until 
pH = 6. Then reaction mixture was extracted with ethyl acetate (5 mL), and the organic 
layer was dried over MgSO4 and concentrated under reduced pressure to give crude 28 as 
an oil. 
1H NMR (CDCl3, 500 MHz): δ 6.50-6.35 (m, 2H), 5.21 (t, J = 9.0 Hz, 1H), 4.14 (d, J = 
8.6 Hz, 1H), 3.70 (d, J = 8.6 Hz, 1H), 3.26 (s, 4H), 2.93 (s, 2H), 2.71 (d, J = 16.5 Hz, 1H), 
2.54-2.31 (m, 3H), 1.92 (td, J = 12.6, 11.5, 5.7 Hz, 1H), 1.76 (s, 3H), 1.74-1.66 (m, 1H), 
1.43 (s, 3H), 1.40 (s, 3H), 1.39 (s, 3H). 
 
Crude 28 (0.0549 mmol, based on 29 used in the previous hydrolysis) was dissolved in 
dry CH2Cl2 (0.6 mL), and 2,6-lutidine (10 L, 0.0824 mmol) was added at 0 oC. NIS (28 
mg, 0.126 mmol) was added to the reaction mixture in one portion, which was stirred for 
1 hr at 0 oC. The reaction was quenched with sat’d.-Na2SO3 (1 mL) and extracted with 
CH2Cl2 (5 mL). The organic layer was dried over MgSO4 and concentrated under reduced 
pressure to give an oil. Purification over silica gel with hexane/ethyl acetate (3/1 to 1/1) 
afforded 30 as an oil (18 mg, 67 %).  
1H NMR (CDCl3, 500 MHz): δ 5.68 (d, J = 7.7 Hz, 1H), 4.86 (d, J = 7.7 Hz, 1H), 4.30 
(dd, J = 4.0, 1.7 Hz, 1H), 4.01 (d, J = 8.5 Hz, 1H), 3.79-3.68 (m, 2H), 3.40 (s, 3H), 3.02 
(t, J = 13.9 Hz, 1H), 2.87 (s, 2H), 2.53-2.37 (m, 4H), 2.04-2.01 (m, 1H), 1.75 (s, 3H), 
1.39 (s, 3H), 1.38 (s, 3H), 1.36 (s, 3H); 13C NMR (CDCl3, 126 MHz): δ 173.79, 136.04, 
124.1, 109.7, 80.7, 80.4, 79.7, 77.7, 73.3, 70.0, 57.1, 36.1, 30.4, 28.6, 27.3, 27.2, 26.8, 
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24.5, 22.3, 17.0; HRMS (CI, NH3) m/z calc’d for C20H29IO5 [M+Na]
+ 499.0957, found: 
499.0961.  
 
 
(S,5Z,7E)-Methyl 9-hydroxy-4-methoxy-8-methylnona-5,7-dienoate (33) The (E)-
Vinylstannane 31 (153 mg, 0.422 mmol) and vinyl iodide 32 (100 mg, 0.352 mmol) was 
dissolved in dry DMF (3.5 mL) under Ar at rt. The reaction was stirred for 18 hr before 
being quenched with sat’d.-NH4Cl (2 mL) and diluted with ethyl acetate (5 mL). Then 
the aqueous layer was removed, and the organic layer was dried over MgSO4 and filtered. 
The filtrate was concentrated under reduced pressure to obtain an brown oil. Purification 
over silica gel with hexane/ethyl acetate (2/1) afforded (E,E)-33 as a clear oil (70 mg, 
87%). 
1H NMR (CDCl3, 500 MHz): 6.42 (td, J = 11.4, 1.1 Hz, 1H), 6.30 (dt, J = 11.6, 1.3 Hz, 
1H), 5.33-5.21 (m, 1H), 4.15 (ddd, J = 8.7, 7.1, 5.6 Hz, 1H), 4.09 (s, 2H), 3.65 (s, 3H), 
3.24 (s, 3H), 2.41-2.34 (m, 2H), 1.95-1.85 (m, 1H), 1.77 (m, 4H), 1.58 (s, 1H). 
 
 
(5S,6R,7R)-7-((E)-3-Hydroxy-2-methylprop-1-en-1-yl)-6-iodo-5-methoxyoxepan-2-
one (34) To a solution of methyl ester 33 (22 mg, 0.0964 mmol) in a mixture of THF (1.0 
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mL) and H2O (1.0 mL) was added LiOH (5 mg, 0.193 mmol) at rt. The reaction was 
stirred for 12 hr at rt and acidified with 1N HCl until pH = 6. Then the reaction mixture 
was extracted with ethyl acetate (5 mL), and the organic layer was dried over MgSO4 and 
concentrated under reduced pressure to give crude 33a as an oil. 
1H NMR (CDCl3, 500 MHz): δ 6.48-6.38 (m, 1H), 6.35-6.26 (m, 1H), 5.33-5.22 (m, 1H), 
4.21 (ddd, J = 8.9, 7.3, 5.8 Hz, 1H), 4.08 (s, 2H), 3.25 (s, 3H), 2.42 (tq, J = 16.7, 8.3, 7.1 
Hz, 2H), 1.91 (dq, J = 14.3, 7.2 Hz, 1H), 1.81-1.66 (m, 4H). 
 
Crude 23a (0.0964 mmol, based on 33 used) was dissolved in dry CH2Cl2 (1 mL), and 
2,6-lutidine (10 L, 0.0824 mmol) was added at 0 oC. NIS (50 mg, 0.222 mmol) was 
added to the reaction mixture in one portion, which was stirred for 1 hr at 0 oC. The 
reaction was quenched with sat’d.-Na2SO3 (1 mL) and extracted with CH2Cl2 (5 mL). 
The organic layer was dried over MgSO4 and concentrated under reduced pressure to 
give an oil. Purification over silica gel with hexane/ethyl acetate (3/1 to 1/1) afforded 30 
as an oil (15 mg, 46 %). 
1H NMR (CDCl3, 500 MHz): δ 5.68 (dq, J = 7.6, 1.5 Hz, 1H), 4.91 (d, J = 7.6 Hz, 1H), 
4.31 (ddd, J = 3.8, 1.8, 0.8 Hz, 1H), 4.02 (d, J = 1.5 Hz, 2H), 3.73 (td, J = 3.8, 1.9 Hz, 
1H), 3.41 (s, 3H), 3.14-2.92 (m, 1H), 2.52-2.35 (m, 2H), 2.13-1.99 (m, 1H), 1.27-1.21 
(m, 1H). LRMS (CI, NH3) m/z calc’d for C11H17IO4 [M+Na]
+ 363.0069, found: 363.0.  
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(5S,6R,7R)-7-((1S,2S)-1,2-Dihydroxy-2-methyl-3-((triphenylsilyl)oxy)propyl)-6-iodo-
5-methoxyoxepan-2-one (35) To a solution of 34 (9 mg, 0.0265 mmol), DMAP (1 mg, 
0.00265 mmol), and triethylamine (8 mL, 0.053 mmol) in CH2Cl2 (0.1 mL) was added 
triphenylchlorosilane (10 mg, 0.0318 mmol) at rt, and the reaction mixture was stirred for 
12 hr. The reaction was diluted with ethyl acetate (5 mL) and washed with H2O (2 x 1 
mL). The organic layer was dried over MgSO4 and concentrated under reduced pressure 
to give crude 34a as a white solid. 
1H NMR (CDCl3, 500 MHz): δ 7.63 (ddq, J = 7.7, 2.6, 1.3 Hz, 6H), 7.49-7.33 (m, 9H), 
5.82 (dq, J = 7.7, 1.5 Hz, 1H), 4.88 (d, J = 7.8 Hz, 1H), 4.27-4.13 (m, 2H), 3.71 (td, J = 
3.9, 2.1 Hz, 1H), 3.39 (s, 3H), 3.09-2.97 (m, 1H), 2.97 (s, 1H), 2.59 (q, J = 7.3 Hz, 1H), 
2.48-2.38 (m, 2H), 2.09-1.99 (m, 1H), 1.06 (t, J = 7.2 Hz, 1H). 
 
The crude 34a (0.0265 mmol, based on 34) and NMO (5 mg, 0.0398 mmol) were 
dissolved in acetone/H2O (8/1, 0.3 mL). OsO4 (4 wt% in H2O, 7 mL, 0.001 mmol) was 
added to the reaction, which was stirred for 4 hr at rt. The reaction was quenched with 
sat’d.-Na2SO3 (1 mL) and extracted with ethyl acetate (5 mL). The organic layer was 
dried over MgSO4 and concentrated under reduced pressure to give a white solid. 
Purification over silica gel with hexane/ethyl acetate (3/1 to 1/1) afforded 30 as a solid (8 
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mg, 48 % over two steps). The structure of 35 was confirmed by X-ray crystallography 
(Scheme 5.12) 
1H NMR (CDCl3, 500 MHz): δ 7.64-7.56 (m, 6H), 7.50-7.42 (m, 3H), 7.43-7.35 (m, 6H), 
5.11 (ddd, J = 3.9, 1.8, 0.8 Hz, 1H), 4.04 (d, J = 8.3 Hz, 1H), 3.94 (d, J = 10.1 Hz, 1H), 
3.80-3.70 (m, 2H), 3.38 (s, 3H), 3.31 (d, J = 4.4 Hz, 1H), 3.07 (s, 1H), 2.83 (td, J = 14.0, 
1.9 Hz, 1H), 2.47-2.36 (m, 1H), 2.30 (ddt, J = 14.7, 6.8, 1.1 Hz, 1H), 2.05-1.96 (m, 1H), 
1.19 (s, 3H). 
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